Document:

exv10w44

 

EXECUTION COPY

Exhibit 10.44

STOCK PURCHASE AGREEMENT

between

GLOBALSECURE HOLDINGS, LTD.

AND

VIRTUAL ALERT, INC.

AND

THE STOCKHOLDERS OF VIRTUAL ALERT, INC.

Dated February 28, 2005

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	ARTICLE I. DEFINITIONS
	 	 	1	 
	 
	 	 	 	 
	1.01 Definitions.
	 	 	 1	 
	 
	 	 	 	 
	ARTICLE II. PURCHASE AND SALE
	 	 	10	 
	 
	 	 	 	 
	2.01 Purchase and Sale.
	 	 	10	 
	2.02 Purchase Price.
	 	 	10	 
	2.03 Payment of Initial Purchase Price; Delivery of Certain Closing Documents.
	 	 	10	 
	2.04 Closing.
	 	 	11	 
	2.05 Post-Closing Adjustment.
	 	 	11	 
	2.06 338 Election; Allocation.
	 	 	12	 
	2.07 Deposit of Stock with Sellers’ Representative.
	 	 	13	 
	2.08 Escrow Account.
	 	 	14	 
	2.09 Options.
	 	 	14	 
	2.10 Earnout Amount.
	 	 	14	 
	 
	 	 	 	 
	ARTICLE III. REPRESENTATIONS AND WARRANTIES RELATING TO THE COMPANY
	 	 	16	 
	 
	 	 	 	 
	3.01 Corporate Existence and Power.
	 	 	16	 
	3.02 Corporate Authorization.
	 	 	16	 
	3.03 Complete Copies of Materials.
	 	 	16	 
	3.04 Governmental Authorization; Consents.
	 	 	16	 
	3.05 Non-Contravention.
	 	 	17	 
	3.06 Capitalization.
	 	 	17	 
	3.07 Subsidiaries.
	 	 	18	 
	3.08 Financial Statements.
	 	 	18	 
	3.09 Absence of Certain Changes.
	 	 	18	 
	3.10 Indebtedness.
	 	 	20	 
	3.11 Personal Property.
	 	 	20	 
	3.12 Real Property.
	 	 	20	 
	3.13 No Undisclosed Liabilities.
	 	 	21	 
	3.14 Litigation.
	 	 	21	 
	3.15 Material Contracts.
	 	 	21	 
	3.16 Government Contracts.
	 	 	22	 
	3.17 Technology and Intellectual Property.
	 	 	27	 
	3.18 Insurance Coverage.
	 	 	29	 
	3.19 Compliance with Laws; Permits; No Defaults.
	 	 	29	 
	3.20 Employees and Labor Matters.
	 	 	30	 
	3.21 Environmental Compliance.
	 	 	31	 
	3.22 Transactions with Affiliates; Intercompany Arrangements.
	 	 	32	 
	3.23 Customers.
	 	 	32	 
	3.24 Finders’ Fees.
	 	 	32	 
	3.25 Other Information.
	 	 	33	 
	 
	 	 	 	 
	ARTICLE IV. REPRESENTATIONS AND WARRANTIES RELATING TO SELLERS
	 	 	33	 
	 
	 	 	 	 
	4.01 Title to and Validity of Shares.
	 	 	33	 
	4.02 Authority.
	 	 	33	 
	4.03 Investment Representation.
	 	 	33	 
	 
	 	 	 	 
	ARTICLE V. REPRESENTATIONS AND WARRANTIES OF BUYER
	 	 	34	 
	 
	 	 	 	 
	5.01 Organization and Existence.
	 	 	34	 
	5.02 Corporate Authorization.
	 	 	35	 
	5.03 Governmental Authorization.
	 	 	35	 

i

 

	 	 	 	 	 
	5.04 Non-Contravention.
	 	 	35	 
	5.05 Litigation.
	 	 	35	 
	5.06 Finders’ Fees.
	 	 	35	 
	5.07 Purchase for Investment.
	 	 	35	 
	5.08 No Bankruptcy; Insolvency.
	 	 	35	 
	5.09 Capitalization.
	 	 	35	 
	5.10 Subsidiaries.
	 	 	36	 
	5.11 Compliance with Laws.
	 	 	36	 
	5.12 Absence of Certain Changes.
	 	 	36	 
	5.13 Other Information.
	 	 	36	 
	 
	 	 	 	 
	ARTICLE VI. COVENANTS OF THE COMPANY AND SELLERS
	 	 	36	 
	 
	 	 	 	 
	6.01 Resignations.
	 	 	36	 
	6.02 Confidentiality.
	 	 	36	 
	6.03 Company Charges.
	 	 	37	 
	6.04 Lock-up Agreements.
	 	 	37	 
	 
	 	 	 	 
	ARTICLE VII. GOVERNING LAW; JURISDICTION
	 	 	37	 
	 
	 	 	 	 
	7.01 Governing Law.
	 	 	37	 
	7.02 Consent to Jurisdiction.
	 	 	37	 
	7.03 WAIVER OF JURY TRIAL.
	 	 	38	 
	 
	 	 	 	 
	ARTICLE VIII. COVENANTS OF ALL PARTIES
	 	 	38	 
	 
	 	 	 	 
	8.01 Commercially Reasonable Best Efforts.
	 	 	38	 
	8.02 Certain Filings.
	 	 	38	 
	8.03 Public Announcements.
	 	 	38	 
	8.04 Expenses.
	 	 	39	 
	 
	 	 	 	 
	ARTICLE IX. TAX MATTERS
	 	 	39	 
	 
	 	 	 	 
	9.01 Tax Representations.
	 	 	39	 
	9.02 Tax Covenants.
	 	 	41	 
	9.03 Tax Indemnification.
	 	 	41	 
	 
	 	 	 	 
	ARTICLE X. EMPLOYEE BENEFITS
	 	 	43	 
	 
	 	 	 	 
	10.01 ERISA Representations.
	 	 	43	 
	10.02 Indemnification.
	 	 	44	 
	 
	 	 	 	 
	ARTICLE XI. CONDITIONS TO CLOSING
	 	 	44	 
	 
	 	 	 	 
	11.01 Conditions to the Obligations of Each Party.
	 	 	44	 
	11.02 Conditions to Obligation of Buyer.
	 	 	44	 
	11.03 Conditions to Obligation of Sellers.
	 	 	45	 
	 
	 	 	 	 
	ARTICLE XII. SURVIVAL; INDEMNIFICATION
	 	 	46	 
	 
	 	 	 	 
	12.01 Survival.
	 	 	46	 
	12.02 Indemnification by Sellers.
	 	 	46	 
	12.03 Indemnification by Buyer.
	 	 	47	 
	12.04 Limitations.
	 	 	47	 
	12.05 Indemnification Procedures.
	 	 	48	 
	12.06 No Waiver; No Impairment for Investigation.
	 	 	50	 
	12.07 No Subrogation.
	 	 	50	 
	12.08 Escrow and Earnout Amount.
	 	 	50	 
	12.09 Exclusive Remedy.
	 	 	50	 
	 
	 	 	 	 
	ARTICLE XIII. SELLERS’ REPRESENTATIVE
	 	 	51	 
	 
	 	 	 	 
	13.01 Appointment of Sellers’ Representative.
	 	 	51	 
	13.02 Limitation on Actions.
	 	 	52	 

ii

 

	 	 	 	 	 
	13.03 Indemnification.
	 	 	53	 
	 
	 	 	 	 
	ARTICLE XIV. MISCELLANEOUS
	 	 	53	 
	 
	 	 	 	 
	14.01 Notices.
	 	 	53	 
	14.02 Further Assurances.
	 	 	53	 
	14.03 Headings.
	 	 	54	 
	14.04 Entire Agreement.
	 	 	54	 
	14.05 Waiver of Compliance; Consents.
	 	 	54	 
	14.06 Severability.
	 	 	54	 
	14.07 Counterparts.
	 	 	54	 
	14.08 Further Representations.
	 	 	54	 
	14.09 Absence of Third Party Beneficiary Rights.
	 	 	54	 
	14.10 No Assignment.
	 	 	55	 
	14.11 No Waivers.
	 	 	55	 

iii

 

	 	 	 
	Schedules
	 	 
	 
	 	 
	Schedule 3.01

	 	 Articles and Bylaws
	Schedule 3.04

	 	 Required Consents
	Schedule 3.06

	 	 Capitalization
	Schedule 3.08

	 	 Financial Statements
	Schedule 3.09

	 	 Certain Changes
	Schedule 3.10

	 	 Indebtedness
	Schedule 3.11(a)

	 	 Personal Property
	Schedule 3.11(c)

	 	 Personal Property Not Owned or Leased
	Schedule 3.12(b)

	 	 Leased Real Property
	Schedule 3.13

	 	 Liabilities
	Schedule 3.14

	 	 Litigation
	Schedule 3.15

	 	 Material Contracts
	Schedule 3.16(a)-(t)

	 	 Government Contracts
	Schedule 3.17

	 	 Intellectual Property
	Schedule 3.18

	 	 Insurance
	Schedule 3.19

	 	 Permits
	Schedule 3.20

	 	 Employees
	Schedule 3.21

	 	 Environmental Matters
	Schedule 3.22

	 	 Affiliate Transactions
	Schedule 3.23

	 	 Installation Dates
	Schedule 9.01

	 	 Taxes
	Schedule 10.01

	 	 Employee Benefits
	 
	 	 
	Exhibits
	 	 
	 
	 	 
	Exhibit 2.01

	 	 List of Sellers
	Exhibit 2.06

	 	 338 Allocation

iv

 

STOCK PURCHASE AGREEMENT

     THIS STOCK PURCHASE AGREEMENT dated February 28, 2005 between Virtual Alert, Inc., a
California corporation (the “Company”); the stockholders of the Company listed on the
signature pages hereto (each, a “Seller” and collectively, the “Sellers”); and
GlobalSecure Holdings, Ltd., a Delaware corporation (the “Buyer”). The Company, the
Sellers and the Buyer are referred to herein collectively as the “Parties” and individually
as a “Party”.

R E C I T A L S:

     WHEREAS, the Sellers beneficially and of record own 100% of the issued and outstanding shares
of capital stock of the Company (the “Shares”);

     WHEREAS, upon the terms and conditions set forth herein, the Buyer desires to purchase the
Shares and the Non-Compete Agreements from the Sellers, and the Sellers desire to sell the Shares
to, and enter into the Non-Compete Agreements with, the Buyer.

     NOW, THEREFORE, in consideration of the premises and of the mutual representations, warranties
and covenants which are to be made and performed by the respective Parties and other good and
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each of the
Parties hereto, intending to be legally bound, hereby agrees as follows:

ARTICLE I.

DEFINITIONS

     1.01 Definitions.

     (a) The following terms, as used herein, have the following meanings:

     “Affiliate” means, with respect to any Person, any Person directly or indirectly
controlling, controlled by, or under common control with such Person.

     “Ancillary Agreements” means the Escrow Agreement, the Employment Agreements, the
Technology Quit Claim and Release Agreement, the Technology Sourcing Agreement, the Non-Compete
Agreements and the Security Agreement.

     “Balance Sheet” means the reviewed balance sheet of the Company dated as of the
Balance Sheet Date and attached to Schedule 3.08.

     “Balance Sheet Date” means December 31, 2004.

     “Benefit Arrangement” means an employment, severance or similar contract, arrangement
or policy (written or oral) and each plan or arrangement providing for severance, insurance
coverage (including any self-insured arrangements), workers’ compensation, disability benefits,
supplemental unemployment benefits, vacation benefits, pension or retirement benefits or for
deferred compensation, profit-sharing, bonuses, phantom stock, stock options, stock

 

 

appreciation rights or other forms of incentive compensation or post-retirement insurance,
compensation or benefits or any co-employment agreement that (i) is not an Employee Plan, (ii) is
entered into, maintained or contributed to, as the case may be, by the Company or any of its ERISA
Affiliates or any Co-Employer and (iii) covers any Employee or former Employee of the Company.

     “Buyer Stock” means the common stock, $.0001 par value per share of the Buyer.

     “Cash” means all cash, cash equivalents and marketable securities owned by the Company
calculated in accordance with GAAP.

     “Co-Employer” means any Subsidiary and any entity that is or was considered to be a
co-employer with the Company.

     “Closing Date” means the date of the Closing.

     “Code” means the Internal Revenue Code of 1986, as amended, and the rules and
regulations promulgated thereunder. Any reference to any particular Code section shall be
interpreted to include any revision or successor to that section regardless of how numbered or
classified.

     “Company Intellectual Property” means all Intellectual Property that is owned or held
by or on behalf of the Company or that is being, and/or has been, used, or is currently under
development for use, in the business of the Company as it has been, is currently or is currently
planned to be conducted.

     “Company Options” means any options, warrants, calls, conversion rights, commitments,
agreements, contracts, understandings, restrictions, arrangements or rights of any character to
which the Company is a party or by which the Company may be bound obligating the Company to issue,
deliver or sell, or cause to be issued, delivered or sold, additional shares of the capital stock
of the Company, or obligating the Company to grant, extend, or enter into any such option, warrant,
call, conversion right, conversion payment, commitment, agreement, contract, understanding,
restriction, arrangement or right.

     “Contract” means any written contract, agreement, license, indenture, lease, sales or
purchase order, intercompany work order or authorization, instrument or other legally binding
commitment to which the Company is a party or by which the Company’s assets are bound, and any
modifications thereto.

     “Earnout Amount” shall be that certain dollar amount equal to six (6) times the
Company’s EBITDA achieved during the fiscal year ending December 31, 2005, minus Twenty Million
U.S. Dollars ($20,000,000.00). Notwithstanding the preceding sentence, if the amount determined
under the preceding sentence is zero dollars ($0.00) or less, the Earnout Amount shall be zero
dollars ($0.00).

     “EBITDA” means the amount calculated according to the following formula and applying
the rules stated in the second paragraph of this definition:

2

 

(i) Net Income minus One Million Two Hundred Fifty Thousand U.S. Dollars
($1,250,000) plus (ii) to the extent taken into account in determining Net
Income: (A) provision for taxes based on income or profits, including the taxes of
the Company, if any, resulting from the conversion of the Company’s accounting
method from the cash method to the accrual method; (B) interest expense, whether
paid or accrued and whether or not capitalized; (C) depreciation and amortization
(including amortization of goodwill and other intangibles); (D) any losses realized
in connection with the sale or disposition of assets (including, without limitation,
dispositions pursuant to sale and leaseback transactions) other than in the ordinary
course of business or the disposition of any securities or the extinguishment of any
Indebtedness; and (E) any extraordinary non-cash charges or expenses (and excluding
the related tax effects) minus (iii) to the extent taken into account in
determining Net Income, (A) any income realized in connection with the sale or
disposition of assets (including, without limitation, dispositions pursuant to sale
and leaseback transactions) other than in the ordinary course of business or the
disposition of any securities or the extinguishment of any Indebtedness; (B) any
extraordinary non-cash income that is in each case not operating income (and
excluding the related tax effects), and (C) interest income, whether paid or
accrued.

The EBITDA formula will be calculated applying the following rules: (i) no deduction shall be made
to EBITDA due to any allocation of any of Buyer’s administrative expenses, management fees, or
general overhead costs and expenses to the Company; (ii) the Company will pay an internal return on
investment 20% per annum on any loans or advances made by the Buyer to the Company in connection
with its business operations, which amount will be charged as a cost or expense of the Company;
(iii) the purchase and sales prices of goods and services sold, with the mutual agreement of the
Company and the Buyer or its Affiliates, as applicable, by or to the Company to or from the Buyer
or its Affiliates, as the case may be, shall be adjusted to reflect the amounts that the Company or
the Buyer or its Affiliates, as the case may be, would have realized or paid if dealing with an
independent party in an arms-length commercial transaction; (iv) the compensation paid by Buyer or
any of its Affiliates to Daniel Desmond shall be charged as a cost or expense of the Company; and
(v) the Company’s costs and expenses will include (A) the direct costs incurred by the Buyer or its
Affiliates on behalf of the Company at the request of the Company or with the mutual consent of the
Buyer and the Company, including direct marketing materials or marketing campaigns, commissions
paid to National Strategies, Inc. for sales of the Company’s products and services; and (B) an
allocable share of the cost or expense to the Buyer or its Affiliates for providing any of the
Buyer’s employee benefit plans to the employees of the Company if the Company so requests; (C)
compensation (including, without limitation, bonuses) of employees of the Company attributable to
calendar year 2005 performance but paid in subsequent periods; and (D) additional items that may be
agreed from time to time between the Sellers’ Representative and the Buyer.

     “Employee” means any employee of the Company, including any employee Co-employed by
the Company and Co-Employer.

3

 

     “Employee Plan” means each “employee benefit plan,” as such term is defined in Section
3(3) of ERISA, that (i) is subject to any provision of ERISA and (ii) is maintained or contributed
to by the Company or any of its ERISA Affiliates or any Co-Employer, as the case may be.

     “Environment” means any and all environmental media, including without limitation
ambient air, surface water, ground water, drinking water supply, land surface or subsurface, soil
or strata, and also means any indoor location.

     “Environmental Law” means any and all federal, state, local and foreign statutes, laws
(including common or case law), regulations, ordinances, rules, judgments, judicial decisions,
orders, decrees, codes, plans, injunctions, or governmental restrictions relating to the protection
of human health or safety or the Environment or to emissions, discharges or Releases of any
Hazardous Substance into the Environment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of any Hazardous Substance
or the containment, removal or remediation thereof.

     “Environmental Liabilities” means any and all liabilities arising in connection with
or in any way relating to the past or present business of the Company, whether contingent or fixed,
actual or potential, known or unknown, that (i) arise under or relate to matters governed by
Environmental Law or arise in connection with or relate to any matter disclosed or required to be
disclosed in Schedule 3.21 and (ii) arise from or relate in any way to actions occurring or
conditions existing before the Closing Date.

     “Environmental Permits” means any and all governmental permits, licenses, concessions,
grants, franchises, agreements, authorizations, registrations or other governmental approvals or
filings issued or required under any Environmental Law.

     “ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

     “ERISA Affiliate” of any entity means any other entity that, together with such
entity, would be treated as a single employer under Section 414 of the Code or Section 4001 of
ERISA.

     “Escrow Agent” means a Person reasonably approved by the Buyer and the Sellers to
serve as escrow agent under the Escrow Agreement.

     “Escrow Agreement” means the Escrow Agreement among the Sellers’ Representative, the
Buyer and the Escrow Agent to be entered into on the Closing Date in a form mutually agreeable to
the parties thereto.

     “GAAP” means generally accepted accounting principles as in effect in the United
States of America from time to time set forth in the opinions and pronouncements of the Accounting
Principles Board and the American Institute of Certified Public Accountants and the statements and
pronouncements of the Financial Accounting Standards Board.

     “Government Bid” means any quotation, bid or proposal that, if accepted or awarded,
would lead or may lead to a Government Contract.

4

 

     “Governmental Authority” means any foreign, domestic, federal, territorial, nation,
state or local governmental authority, quasi-governmental authority, court, arbitration board,
arbitrator or similar tribunal, commission, board, bureau, agency or instrumentality, or any
regulatory, administrative or other department, agency, or any political or other subdivision,
department or branch of any of the foregoing or any self-regulatory organization that exercises
quasi-governmental powers and any officials of any of the foregoing.

     “Government Contract” means any Contract (including any prime contract, subcontract,
teaming agreement or arrangement, joint venture, basic ordering agreement, pricing agreement,
letter contract, purchase order, change order or other similar contract of any kind, including
modifications thereto) pursuant to which products, goods or services are sold or distributed to (i)
any Governmental Authority, (ii) any prime contractor of a Governmental Authority, or (iii) any
subcontractor at any tier with respect to any contract of a type described in clauses (i) or (ii)
above, in each case by or on behalf of the Company (including through any licensee or distributor
of the Company’s product).

     “Hazardous Substance” means any and all pollutants and contaminants, and any and all
toxic, caustic, radioactive or otherwise hazardous materials, substances or wastes that are
regulated under any Environmental Law, and includes, without limitation, petroleum and its
derivatives and by-products, and any other hydrocarbons.

     “Indebtedness” means, with respect to the Company as of any date of determination the
sum of the following (in each case determined in accordance with GAAP): (i) all obligations of the
Company for borrowed money; (ii) all obligations of the Company upon which interest charges are
customarily paid or accrued; (iii) all obligations of the Company evidenced by bonds, debentures,
notes or similar instruments; (iv) all obligations of the Company under conditional sale or other
title retention agreements relating to property or assets purchased; (v) all obligations of the
Company issued or assumed as the deferred and unpaid purchase price of property or services
(excluding trade accounts payable incurred in the ordinary course of business that are not past due
and which are classified as short term liabilities in accordance with GAAP); (vi) all obligations
of others secured by (or having an existing right, contingent or otherwise, to be secured by) any
Lien on property owned or acquired, whether or not the obligations secured thereby have been
assumed; (vii) all guarantee obligations by the Company of Indebtedness of others; (viii) all
capital lease obligations of the Company, (ix) all obligations of the Company as an account party
in respect of letters of credit or similar facilities and bankers’ acceptances, (x) the obligations
outstanding under any synthetic leases, off-balance sheet loan or similar off-balance sheet
financing of the Company, (xi) all obligations of the Company in respect of interest rate
protection agreements, foreign currency exchange agreements or other interest or exchange rate
hedging arrangements; and (xii) all obligations of any partnership or joint venture as to which the
Company is or may become personally liable to the extent such obligations are deemed to be
liabilities under GAAP.

     “Indebtedness Amount” means the aggregate amount of all Company Indebtedness as of the
Closing Date immediately prior to and without giving effect to the Closing or the consummation of
the transactions contemplated by this Agreement.

5

 

     “Intellectual Property” means all tangible or intangible proprietary information and
materials, including without limitation:

                     (i) (A) all inventions (whether patentable or unpatentable and whether or not reduced to
practice), all improvements thereon, and all patents, patent applications and patent disclosures,
together with all reissuances, continuations, continuations-in-part, divisions, revisions,
extensions and re-examinations thereof, (B) all trademarks, service marks, trade dress, logos,
trade names, domain names, and corporate names, together with all translations, adaptations,
derivations and combinations thereof and including all goodwill associated therewith, and all
applications, registrations and renewals in connection therewith, (C) all copyrights and all
applications, registrations and renewals in connection therewith, (D) all mask works and all
applications, registrations and renewals in connection therewith, (E) all trade secrets and
confidential business information (including ideas, research and development, know-how, formulas,
compositions, manufacturing and production process and techniques, methods, schematics, technology,
technical data, designs, drawings, flowcharts, block diagrams, specifications, customer and
supplier lists, pricing and cost information and business and marketing plans and proposals), and
(F) all software and firmware (including data, databases and related documentation);

                     (ii) all documents, records and files relating to design, end user documentation,
manufacturing, quality control, sales, marketing or customer support for, and tangible embodiments
of, all intellectual property described herein; and

                     (iii) all licenses, agreements and other rights in any third party product or any third party
intellectual property described in (i) and (ii) above other than any “off the shelf” third party
software or related intellectual property.

     “Key Employees” means the following Company employees and, in the case of Daniel
Desmond, consultants: Eric Shaffer, Andrew Trickett, Daniel Desmond, and Daniel Lintz.

     “Known to the Company”, “to the Company’s Knowledge” and words of similar
import means the knowledge of the officers and directors of the Company and the knowledge of each
of the Sellers (or the officers, directors or general partners thereof in the case of Sellers who
are corporations or partnerships, if any). For purposes of determining “knowledge,” the Sellers
and the Company shall be deemed to know the requirements of all Laws applicable to the business of
the Company, including without limitation, those that apply to the performance of the Company under
any Government Contract.

     “Law” means (i) any foreign, federal, state or local law (including common law),
statute, treaty, rule, regulation, ordinance, order, injunction, decree, consent decree, enacted,
adopted issued or promulgated by any Governmental Authority, and (ii) Permits.

     “Liability” means any and all claims, debts, liabilities, obligations and commitments
of whatever nature, known or unknown, fixed, absolute or contingent, matured or unmatured, accrued
or unaccrued, liquidated or unliquidated or due or to become due, and whenever or however arising
(including those arising out of any Contract or tort, whether based on negligence, strict liability
or otherwise).

6

 

     “Lien” means any mortgage, lien, pledge, charge, security interest, restriction or
encumbrance of any kind and any voting agreement, voting trust, proxy, option, right to purchase,
right of first refusal, right of first offer, restriction on transfer or other similar arrangement
or restriction of any kind whatsoever.

     “Material Adverse Change” means a material adverse change in the business, operations,
assets, liabilities, financial condition, operating results, prospects, assets or customer,
supplier, employee or sales representative relations or business of the Company taken as a whole.

     “Material Adverse Effect” means a material adverse effect upon the business,
operations, assets, liabilities, financial condition, operation results, prospects, assets or
customer, supplier or sales representative relations or business of the Company taken as whole.

     “Multiemployer Plan” means each Employee Plan that is a multiemployer plan, as defined
in Section 4001(a)(3) of ERISA.

     “Net Income” means the net income (loss) of the Company and any Subsidiaries,
determined in accordance with GAAP on a consolidated basis without duplication.

     “Net Working Capital Amount” means an amount calculated as of the Closing Date in
accordance with GAAP that equals (i) the book value of the Company’s current assets (which shall
include, without limitation, Cash, accounts receivable less allowance for doubtful accounts, and
prepaid expenses), minus (ii) the book value of the Company’s current liabilities (which,
without limitation, shall include accounts payable, accrued expenses and accrued payroll and
related expenses, but specifically shall not include the deferred revenue amount calculated in
accordance with GAAP that would be required by GAAP to be reflected on the Closing Balance Sheet.

     “Person” means an individual, corporation, partnership, limited liability company
association, trust or other entity or organization, including a government or political subdivision
or an agency or instrumentality thereof.

     “Proceeding” means any judicial or arbitral action, suit, proceeding, citation,
summons or subpoena, civil, criminal, regulatory or otherwise, in law or in equity.

     “Publicly Available Software” means each of (i) any software that contains, or is
derived in any manner (in whole or in part) from, any software that is distributed as free
software, open source software (e.g. Linux), or similar licensing and distribution models; and
(ii) any software that requires as a condition of use, modification, and/or distribution of such
software that such software or other software incorporated into, derived from, or distributed with
such software (A) be disclosed or distributed in source code form; (B) be licensed for the purpose
of making derivative works; or (C) be redistributable at no or minimal charge. Publicly Available
Software includes, without limitation, software licensed or distributed under any of the following
licenses or distribution models similar to any of the following: (1) GNU General Public License
(GPL) or Lesser/Library GPL (LGPL), (2) the Artistic License (e.g. PERL), (3) the Mozilla Public
License, (4) the Netscape Public License, (5) the Sun Community Source License (SCSL), the Sun
Industry Source License (SISL), and the Apache Server License.

7

 

     “Release” means any spilling, leaking, pumping, pouring, emitting, emptying,
discharging, injecting, escaping, leaching, dumping, or disposing into the Environment (including,
without limitation, the abandonment or discarding of barrels, containers, and other closed
receptacles containing any Hazardous Substance).

     “Subsidiary” means any entity of which securities or other ownership interests having
ordinary voting power to elect a majority of the board of directors or other persons performing
similar functions are owned directly or indirectly by another company.

     “Tax” and “Taxes” means all federal, state, local and foreign net income,
alternative or add-on minimum, estimated, gross income, gross receipts, sales, use, ad valorem,
value added, transfer, franchise, capital profits, lease, service, license, withholding, payroll,
employment, excise, severance, stamp, occupation, premium, property, environmental or windfall
profit taxes, customs duties and other taxes, governmental fees and other like assessments and
charges of any kind whatsoever (including Tax liabilities incurred or borne as a transferee or
successor, or by contract or otherwise), together with all interest, penalties, additions to tax
and additional amounts with respect thereto.

     “Tax Returns” means all returns, declarations, reports, claims for refund, information
statements and other documents relating to Taxes, including all schedules and attachments thereto,
and including all amendments thereof.

     “Tax Authority” means any Governmental Authority responsible for the imposition of any
Tax.

[this space intentionally left blank]

8

 

(b) Each of the following terms is defined in the Section set forth opposite such term:

	 	 	 
	Term

	 	Section
	 
	Accounts Receivable

	 	 3.08(d)
	Actual Net Working Capital Amount

	 	 2.05
	Benefit Arrangement

	 	 10.1
	Buyer Indemnified Party

	 	 12.02
	Claim Notice

	 	 12.05
	Closing

	 	 2.04
	Closing Balance Sheet

	 	 2.05
	Closing Date

	 	 2.04
	Closing Documents

	 	 2.03
	Company Securities

	 	 3.06
	Damages

	 	 12.02
	Disclosure Schedule

	 	Art. III
	Dispute Notice

	 	 2.05
	Earnout Payment Date

	 	 2.10
	Earnout Shares

	 	 2.10
	Employee

	 	 10.01
	Employee Plan

	 	 10.01
	Employment Agreements

	 	 11.02
	Environment

	 	 3.21
	Environmental Law

	 	 3.21
	Environmental Liabilities

	 	 3.21
	Environmental Permits

	 	 3.21
	ERISA

	 	 10.01
	ERISA Affiliate

	 	 10.01
	Executive Sellers

	 	Art III
	Financial Statements

	 	 3.08
	Hazardous Substance

	 	 3.21
	Indemnification Deductible

	 	 12.04
	Indemnifying Party

	 	Art. III
	Buyer Indemnified Party

	 	 12.02
	Initial Purchase Price

	 	 2.02
	Interested Person

	 	 3.09

	 	 	 
	Term

	 	Section
	 
	Issued Shares

	 	 2.02
	Item of Dispute

	 	 2.05
	Leases

	 	 3.12
	Loss

	 	 9.03
	Multiemployer Plan

	 	 10.01
	Options and Warrants

	 	 5.09
	Permit

	 	 3.19
	Personal Property

	 	 3.11
	Private Offering

	 	 2.10
	Purchase Price

	 	 2.02
	Real Property

	 	 3.12
	Release Agreement

	 	 11.02
	Required Consent

	 	 3.04
	Section 2.05 Accounting Firm

	 	 2.05
	Securities Act

	 	 4.03
	S Election

	 	 9.01
	Seller Indemnified Party

	 	 12.03
	Seller’s Percentage

	 	 2.02
	Sellers’ Representative

	 	 13.01
	Target Net Working Capital Amount

	 	 2.05
	Tax

	 	Art. IX
	Tax Authority

	 	 9.01
	Tax Return

	 	 9.01
	Taxes

	 	 9.01
	Third Party Claim

	 	 12.05
	Transaction Bonus

	 	 10.01

9

 

ARTICLE II.

PURCHASE AND SALE

     2.01 Purchase and Sale. On the basis of the representations, warranties, covenants
and other agreements contained herein and subject to the terms and conditions of this Agreement, at
the Closing, each Seller, severally but not jointly, shall sell and transfer to the Buyer, and the
Buyer shall purchase from each Seller, free and clear of all Liens other than applicable federal
and state securities laws restrictions, that number of Shares as is set forth next to each Seller’s
name on Exhibit 2.01, and the Executive Sellers will enter into the Non-Compete Agreements.

     2.02 Purchase Price. 

               (a) The aggregate initial purchase price (the “Initial Purchase Price”) to be paid by
the Buyer to the Sellers for the Shares and the Non-Compete Agreements at Closing is (a) Twelve
Million U.S. Dollars ($12,000,000) in cash plus (b) Five Million Three Hundred Thirty Three
Thousand Three Hundred Thirty Three (5,333,333) newly issued shares of Buyer Stock (the “Issued
Shares”). The Initial Purchase Price shall be subject to adjustment as provided in Section
2.03(b) and Section 2.05 below.

               (b) In addition to the Initial Purchase Price, the Buyer shall pay to the Sellers the Earnout
Amount, if any, pursuant to Section 2.10. The “Purchase Price” hereunder shall be the sum
of the Initial Purchase Price plus the Earnout Amount, if any. In the event the Earnout Amount is
less than or equal to zero, the Purchase Price shall equal the Initial Purchase Price.

                (c) The Purchase Price shall be distributed among each of the Sellers in accordance with the
percentages set forth in Exhibit 2.01 (each a “Seller’s Percentage”).

     2.03 Payment of Initial Purchase Price; Delivery of Certain Closing Documents. At the
Closing:

                (a) the Buyer shall deliver to the Escrow Agent pursuant to the Escrow Agreement, an amount of
the Initial Purchase Price comprised of cash and Buyer Stock as set forth in Section 2.08, for the
purposes of providing a fund from which to (i) pay any reduction of the Initial Purchase Price
pursuant to Section 2.05 and (ii) in part, to secure the indemnification obligations of the Sellers
under Sections 9.03, 10.02 and 12.02, which amount shall be deposited on behalf of the Sellers so
that the Sellers can fund the escrow account;

                (b) the Buyer shall pay to the Sellers Eleven Million U.S. Dollars ($11,000,000) of the
Initial Purchase Price in cash, minus the Indebtedness Amount (if any), via wire transfer of
immediately available funds to one account designated by the Sellers’ Representative, with the
specific amount to be paid to each Seller to be determined in accordance with each Seller’s
Percentage and to be paid by and under the direction of the Sellers’ Representative from the
designated account;

10

 

               (c) the Buyer shall deliver to the Sellers evidence, certified by a proper officer of the
Buyer, that 5,333,333 of the Issued Shares have been properly been recorded in book entry in the
names of the Sellers based on each Seller’s Percentage;

                (d) the Sellers shall deliver to the Buyer certificates for the Shares duly endorsed in blank,
with any transfer stamps affixed thereto;

                (e) each of the Parties to this Agreement shall execute and deliver to the other Parties
thereto each of the Ancillary Agreements to be entered into by it at Closing, in each case in the
form agreeable to the Parties; and

                (f) the Parties shall execute and deliver to the appropriate Parties any other instruments,
documents and certificates (the “Closing Documents”) that are required to be delivered
pursuant to this Agreement or as may be reasonably requested by any Party in order to consummate
the transactions contemplated by this Agreement.

     2.04 Closing. The closing of the transactions contemplated by this Agreement (the
“Closing”) shall take place at the offices of the Buyer, located at 2600 Virginia Avenue,
N.W., Suite 600, Washington, D.C. 20037, simultaneously with the execution and delivery of this
Agreement on February 28, 2005. The date of the Closing is referred to herein as the “Closing
Date”. The Parties hereto acknowledge and agree that all actions to be taken and all documents to
be executed and delivered by all Parties at the Closing shall be deemed to have been taken and
executed simultaneously and no actions shall be deemed taken nor any documents executed or
delivered until all have been taken, executed and delivered. For all purposes under this
Agreement, the Closing shall be deemed to have occurred as of 12:01 a.m. on the Closing Date.

     2.05 Post-Closing Adjustment.

                (a) Post-Closing Determination.

                     (i) Promptly, but in no event later than 45 days after the Closing Date, the Buyer and its
auditors shall prepare and deliver to the Sellers’ Representative a balance sheet of the Company
calculated in accordance with GAAP as of the Closing Date (the “Closing Balance Sheet”),
which will reflect the Buyer’s determination of the Net Working Capital Amount.

                     (ii) If the Sellers’ Representative disagrees with the Buyer’s determination of the Net
Working Capital Amount as reflected on the Closing Balance Sheet, the Sellers’ Representative
shall, within 30 days after receipt of the Closing Balance Sheet, deliver a written notice (the
“Dispute Notice”) to the Buyer setting forth the Sellers’ calculation of each disputed
amount (each an “Item of Dispute”). If the Buyer does not receive the Dispute Notice from
the Sellers within 30 days after the Sellers’ receipt of the Closing Balance Sheet, the Closing
Balance Sheet, including Buyer’s determination of the Net Working Capital Amount, shall be
conclusive and binding upon each of the Parties hereto. If the Buyer receives the Dispute Notice
from the Sellers within 30 days after the Sellers’ receipt of the Closing Balance Sheet, the Buyer
and the Sellers’ Representative shall use reasonable efforts to resolve each Item of Dispute, and,
if any Item of Dispute is so resolved, the Closing Balance Sheet shall be

11

 

modified to the extent necessary to reflect such resolution. If any Item of Dispute remains
unresolved as of the 20th day after the Buyer’s receipt of the Dispute Notice, the Sellers’
Representative and the Buyer shall jointly retain an independent accounting firm of recognized
national standing (the “Section 2.05 Accounting Firm”) to resolve such remaining
disagreement. If the Sellers’ Representative and the Buyer are unable to agree upon the choice of
the Section 2.05 Accounting Firm, then the Section 2.05 Accounting Firm will be a “big-four”
accounting firm selected by lot (after excluding one firm designated by the Buyer and one firm
designated by the Sellers’ Representative).

                     (iii) The Sellers’ Representative and the Buyer shall request that the Section 2.05 Accounting
Firm render a determination as to each unresolved Item of Dispute within 30 days after its
retention, and the Sellers, the Buyer and each of their respective agents and representatives shall
cooperate fully with the Section 2.05 Accounting Firm so as to enable it to make such determination
as quickly and accurately as practicable. The Section 2.05 Accounting Firm shall consider only
those Items of Dispute and amounts that were set forth in the Dispute Notice and that remain
unresolved by the Buyer and the Sellers’ Representative. In resolving any Item of Dispute, the
Section 2.05 Accounting Firm may not assign a value to any item greater than the greatest value for
such Item of Dispute claimed by either Party or less than the smallest value for such Item of
Dispute claimed by either Party. The Section 2.05 Accounting Firm’s determination shall be based
upon the definition of Net Working Capital Amount included herein. The Section 2.05 Accounting
Firm’s determination of each Item of Dispute submitted to it shall be in writing, shall conform
with this Section 2.05(a)(ii) and shall be conclusive and binding upon each of the Parties hereto,
and the Closing Balance Sheet shall be modified to the extent necessary to reflect such
determination. The Section 2.05 Accounting Firm shall allocate its fees, costs and expenses
between the Sellers and the Buyer based upon the percentage which the portion of the contested
amount not awarded to each Party bears to the amount actually contested by such Party. The Net
Working Capital Amount, as finally determined pursuant to this Section 2.05(a)(ii), is referred to
herein as the “Actual Net Working Capital Amount”.

                (b) Payment of Post-Closing Adjustment Amount. If the Actual Net Working Capital
Amount exceeds $1,550,000 (the “Target Net Working Capital Amount”), then the Initial
Purchase Price shall be increased by the amount of such excess. If the Target Net Working Capital
Amount exceeds the Actual Net Working Capital Amount, then the Initial Purchase Price shall be
decreased by the amount of such excess. If there is an adjustment to the Initial Purchase Price
hereunder, the applicable Party shall pay the appropriate amount within 15 days after determination
of the adjustment to the Initial Purchase Price. Any amount payable by the Buyer pursuant to this
Section 2.05(b) shall be made delivery of cash or wired funds to the Sellers’ Representative, who
shall allocate and distribute the funds among the Sellers in accordance with the Seller’s
Percentages. Any amount payable by the Sellers shall be made by the payment of cash or wired funds
to the Buyer. If the Sellers have not made payment in full of any amount required under this
Section 2.05 prior to 5:00 pm Washington, D.C. time on the 45th day following the final
determination of the adjustment amount, then the Buyer may make a claim against the Escrow Amount
for any such under-payment or non-payment and the Sellers’ Representative shall not dispute the
Buyer’s claim thereto.

     2.06 338 Election; Allocation.

12

 

                (a) At Buyer’s option, Buyer, Company and the Sellers shall join in making an election under
Code §338(h)(10) (and any corresponding elections under state or local law) with respect to the
purchase and sale of the Shares (the “338 Election”). If the Buyer so elects, the Buyer shall
reimburse to each of the Sellers the amount, if any, by which the income Taxes paid by each Seller
for the relevant period as a result of the sale of Shares hereunder exceeds the amount of income
Taxes that such Seller would have paid for the same relevant period as a result of the sale of the
Shares hereunder if 338 Election had not been made. Provided that the Buyer has first received
sufficient information from each Seller to verify the amount, if any, of the reimbursement
contemplated above, the Buyer shall make such reimbursement to each Seller within 30 days after the
such Seller pays its income Taxes with respect to the transactions contemplated under this
Agreement. If with respect to any Seller there is no excess, then the Buyer shall not be required
to make any reimbursement to such Seller. If there are any disputes between the Buyer and the
Seller relating to the determination of the amount, if any, that may be reimbursable by the Buyer
to a Seller under this Section 2.06(a) shall be resolved, mutatis mutandis, according to the
dispute resolution mechanisms contained in Section 2.05.

                (b) In order to determine the amount, if any, that Buyer may be required to reimburse each
Seller under Section 2.06(a), each of the Sellers shall cooperate with the Buyer and the Company to
determine the excess, if any, in the amount of income Taxes that each Seller actually paid as a
result of the sale of Shares given the 338 Election and the amount of income Taxes that each Seller
would have paid as a result of the sale of Shares if a 338 Election had not been made. Such
cooperation shall include delivering to tax accountants chosen by the Buyer copies of each Seller’s
applicable income Tax return(s), provided that the tax accountants shall first be required to sign
appropriate confidentiality agreements pursuant to which such tax accountants will agree to
maintain the confidentiality of each income Tax return and will agree to share with the Buyer and
the Company only such information from an income Tax return that may be necessary for the
calculation of the amount, if any, that the Buyer may be required to reimburse to a Seller under
Section 2.06(a).

                (c) The Purchase Price and the Liabilities of the Company will be allocated among the assets
of the Company as set forth on Exhibit 2.06, including a methodology for adjusting
Exhibit 2.06 to reflect changes in the Purchase Price and Liabilities including, for
example, the adjustments contemplated in Section 2.05. The Parties will file all Tax Returns and
information reports, including, but not limited to, Form 8883, “Asset Allocation Statement Under
Section 338,” in a manner consistent therewith. For Tax purposes, the Buyer will report the value
of the Issued Shares contained within the Initial Purchase Price in a manner consistent with the
value of such Issued Shares reported by the Sellers. The Parties agree that they will allocate
$40,000 of the Purchase Price to the obtaining of the Non-Compete Agreements.

     2.07 Deposit of Stock with Sellers’ Representative. Each Seller has deposited on or
prior to the date hereof with Chris Popov, as the Sellers’ Representative, certificates
representing the Shares owned by such Seller and the stock powers and documentary stamps
contemplated by Section 2.03(d). The Sellers’ Representative shall hold the certificates
representing the Shares deposited with it pursuant to this Section until the Closing Date, and on
the Closing Date, Sellers’ Representative shall deliver such certificates in accordance with
Section 2.03.

13

 

     2.08 Escrow Account. Sellers agree that in accordance with Section 2.03(a), at the
Closing, a portion of the Initial Purchase Price comprised of One Million U.S. Dollars ($1,000,000)
in cash shall be delivered by the Buyer to the Escrow Agent for deposit in accordance with the
terms of the Escrow Agreement. All funds deposited with the Escrow Agent shall be applied by the
Escrow Agent in accordance with the terms of the Escrow Agreement to make any payments due to the
Buyer under Section 2.05 or 2.10 and to the Buyer or the Company under Sections 9.03, 10.02 or
12.02. The escrowed funds shall earn interest as provided in the Escrow Agreement.

     2.09 Options. Buyer will not assume any Company Options held by any Person. On or
prior to Closing, the Company and the Sellers shall take all action necessary to terminate all
Company Options and shall obtain a written agreement from all holders of Company Options that all
such Company Options shall terminate prior to the Closing, such that the Buyer and the Company
shall have no liability whatsoever related to the Company Options or termination thereof.

     2.10 Earnout Amount.

                (a) As soon as reasonably practicable following the completion of the audit for the fiscal
year ending December 31, 2005 for the Company and the Buyer by the Buyer’s independent accounting
firm, but no later than April 15, 2006 (whichever such date being, the “Earnout Payment
Date”), the Buyer shall deposit with the Sellers’ Representative the Earnout Amount, if any,
determined in accordance with this Section 2.10. The Earnout Amount, if any, shall be paid sixty
percent (60%) in cash and forty percent (40%) in newly issued shares of Buyer Stock (the “Earnout
Shares”), the number of such Earnout Shares to be calculated based on the fair market value of
Buyer Stock determined as follows: (i) if the Buyer is a privately-held entity as of the Earnout
Payment Date and the Buyer has completed a private offering of equity or equity-linked securities
of at least Five Million U.S. Dollars ($5,000,000) (a “Private Offering”) within ninety (90) days
prior to the Earnout Payment Date, then the fair market value of Buyer Stock for purposes of
calculating the number of Earnout Shares hereunder shall equal the per share price of the
securities issued in the Private Offering; or (ii) if the Buyer is a privately-held entity as of
the Earnout Payment Date but the Buyer has not consummated a Private Offering within ninety (90)
days prior to the Earnout Payment Date, then the fair market value of Buyer Stock for purposes of
calculating the number of Earnout Shares hereunder shall be determined, as of the Earnout Payment
Date, by an independent valuation firm selected jointly by Buyer and Sellers’ Representative, the
cost of such firm to be shared equally by the Buyer and Sellers; or (iii) if the Buyer is a
publicly-traded entity as of the Earnout Payment Date, the fair market value of Buyer Stock for
purposes of calculating the number of Earnout Shares hereunder shall equal the volume-weighted
average closing sale price of Buyer Stock for the 30 consecutive trading days ending on the trading
day immediately prior to the Earnout Payment Date. Promptly following receipt by the Sellers’
Representative of the Earnout Amount in accordance with the above, the Sellers’ Representative
shall pay to each Seller such Seller’s Percentage of the Earnout Amount.

                (b) On the Earnout Payment Date, the Buyer shall prepare a written calculation of the Earnout
Amount payable pursuant to this Agreement and shall deliver a copy of such calculation with
reasonable back-up data and a statement showing the method of

14

 

computing the Earnout Amount to the Sellers’ Representative. The Sellers’ Representative
shall keep such calculations confidential in accordance with Section 6.05.

                (c) The Buyer’s calculation of the Earnout Amount shall be conclusive and binding on the
Parties unless the Sellers’ Representative delivers to the Buyer, within fifteen (15) days after
delivery of the documents referred to in Section 2.10(b) above, a notice declaring the Sellers’
objection to the Buyer’s calculation of the Earnout Amount (whether the disagreement relates to the
arithmetic of the calculations or the items or amounts used in calculating the Earnout Amount) and
setting forth the Sellers’ calculation of the Earnout Amount. Any such notice of disagreement
shall specify in detail those items or amounts as to which such holders disagree. The Sellers’
Representative and the Buyer shall, during the fifteen (15) days following the delivery of the
notice of disagreement by the Sellers’ Representative, use their good faith efforts to reach
agreement on the disputed items or amounts in order to determine the Earnout Amount.

                (d) If the Sellers’ Representative and the Buyer are unable to reach agreement within such
fifteen day period, they shall, promptly after the expiration of such fifteen (15) day period,
retain an independent accounting firm of recognized national standing (the “Section 2.10
Accounting Firm”) and shall cause such Section 2.10 Accounting Firm promptly to review the
disputed items or amounts for the purpose of calculating the Earnout Amount. If the Sellers’
Representative and the Buyer are unable to agree upon the choice of the Section 2.10 Accounting
Firm, then the Section 2.10 Accounting Firm will be a “big-four” accounting firm selected by lot
(after excluding one firm designated by the Buyer and one firm designated by the Sellers). The
Section 2.10 Accounting Firm may be the same firm as the Section 2.05 Accounting Firm. In making
the required calculations, the Section 2.10 Accounting Firm shall consider only those items or
amounts in the Buyer’s calculation of the Earnout Amount as to which the Sellers’ Representative
has disagreed in writing. The Section 2.10 Accounting Firm shall be supplied such information,
books and records and access to such individuals as it may reasonably require. The Section 2.10
Accounting Firm shall deliver to the Sellers’ Representative and the Buyer as promptly as
practicable, a report setting forth the Section 2.10 Accounting Firm’s calculation of the disputed
Earnout Amount (the “Section 2.10 Accounting Firm’s Earnout Report”). Such report shall be
final and binding upon the Sellers’ Representative, the Sellers, and the Buyer absent manifest
error.

                (e) The cost of such review and report of the Section 2.10 Accounting Firm shall be shared by
both the Sellers (by the Buyer’s retention of all or a portion of the Escrow Amount or the Earnout
Amount) and the Buyer proportionally based upon the relative differences between the Parties’
calculation of the disputed item or the relative differences between the Parties’ calculation of
the disputed item, on the one hand, and the calculation, if any, determined by the Section 2.10
Accounting Firm, on the other hand.

                (f) If the Section 2.10 Accounting Firm determines that the Earnout Amount is greater than the
amount paid by the Buyer to the Sellers under Section 2.10(a), then no later than 15 days following
the date of the decision of the Section 2.10 Accounting Firm, the Buyer will deliver to the
Sellers’ Representative in the proper proportions, an amount of cash and Buyer Stock equal to such
excess. If the Section 2.10 Accounting Firm determines that the amount paid by the Buyer to the
Sellers under Section 2.10(a) exceeds the Earnout Amount, then no later than

15

 

15 days following the date of the decision of the Section 2.10 Accounting Firm, the Sellers’
Representative shall deliver to the Buyer, in the proper proportions, an amount of cash and Buyer
Stock equal to such excess.

                (g) In order to secure the Buyer’s obligation to pay the Earnout Amount, if any, upon the
Earnout Payment Date, the Buyer will grant the Sellers a security interest in certain assets of the
Buyer pursuant to the terms of a Security Agreement in a form mutually agreeable to the Parties.

                (h) The Parties agree that for tax purposes the Earnout Amount shall constitute part of the
Purchase Price for the Shares.

ARTICLE III.

REPRESENTATIONS AND WARRANTIES RELATING TO THE COMPANY

     Except as set forth in the disclosure schedules (the “Disclosure Schedules”) dated as
of the date hereof and delivered herewith to the Buyer (which disclosure schedules identify the
section and subsection to which each disclosure therein relates), the Company and Chris Popov,
Daniel Desmond, Eric Shaffer, and Andrew Trickett (collectively, the “Executive Sellers”)
jointly and severally hereby represents and warrants to the Buyer as of the date hereof that:

     3.01 Corporate Existence and Power. The Company is a corporation duly organized,
validly existing and in good standing under the laws of its jurisdiction of incorporation, and has
all corporate powers and all Permits required to carry on its business as now conducted. The
Company is duly qualified to do business as a foreign corporation and is in good standing in each
jurisdiction where the character of the property owned or leased by it or the nature of its
activities makes such qualification necessary. Attached to Schedule 3.01 are true and
complete copies of the articles of incorporation and bylaws of the Company each as amended and as
currently in effect.

     3.02 Corporate Authorization. The execution, delivery and performance by the Company
of this Agreement and each Ancillary Agreement to which the Company is a party, and the
consummation by the Company of the transactions contemplated hereby and thereby, are within the
Company’s corporate powers and have been duly authorized by all necessary corporate action on the
part of the Company. This Agreement and each Ancillary Agreement to which the Company is, or will
be, a party has been, or will be, duly executed and delivered by the Company and constitutes, or
will constitute upon execution and delivery, a valid and binding agreement of the Company,
enforceable in accordance with its terms.

     3.03 Complete Copies of Materials. The Company has delivered to the Buyer true,
complete, correct and fully executed copies of each Contract, insurance policy, bond and other
document referenced on the Disclosure Schedules.

     3.04 Governmental Authorization; Consents.

16

 

                (a) The execution, delivery and performance by the Company and the Sellers of this Agreement
require no action by or in respect of, or filing with, any Governmental Authority.

                (b) Except as set forth in Schedule 3.04, no consent, approval, waiver or other action
(a “Required Consent”) by any Person (other than any Governmental Authority referred to in
(a) above) under any Contract to which the Company or any of the Sellers is a party or by which the
Company or any of the Sellers is bound is required or necessary for the execution, delivery and
performance by the Company and the Sellers of this Agreement and each Ancillary Agreement to which
the Company or any of the Sellers is a party, or for the consummation of the transactions
contemplated hereby or thereby.

     3.05 Non-Contravention. The execution, delivery and performance by the Company and
the Sellers of this Agreement and each Ancillary Agreement to which the Company or any of the
Sellers is a party, and the consummation of the transactions contemplated hereby and thereby, do
not and will not (a) contravene or conflict with the corporate charter or bylaws of the Company (b)
contravene or conflict with any provision of any Law or Permit binding upon or applicable to the
Company or any of the Sellers; (c) constitute a default (with or without notice or lapse of time,
or both) under or give rise to any right of termination, cancellation or acceleration of any right
or obligation of the Company or to a loss of any benefit to which the Company is entitled under any
provision of any Contract binding upon the Company or any of the Sellers or by which any of their
respective assets may be bound or (d) result in the creation or imposition of any Lien on any asset
of the Company.

     3.06 Capitalization. 

                (a) Schedule 3.06 sets forth (i) the designation, number of authorized shares and
number of outstanding shares of each class of capital stock of the Company, (ii) the designation of
each stock option plan, the number of shares of stock that may be issued pursuant to such plan, the
number of outstanding options and the number of outstanding options that are currently exercisable,
(iii) all relevant information regarding any outstanding convertible securities and any other
outstanding options, warrants or other rights to acquire capital stock of, or other equity
interests in, the Company and (iv) a list of all holders of capital stock or rights to acquire
capital stock of the Company, specifying the amounts of each such security held by each of them.
All outstanding shares of capital stock of the Company have been duly authorized and validly
issued, are fully paid and non-assessable and are owned as shown on Schedule 3.06.

                (b) Except as set forth on Schedule 3.06, there are no outstanding (i) shares of
capital stock, other securities or phantom or other equity interests of the Company, (ii)
securities of the Company convertible into or exchangeable for shares of capital stock or other
securities of the Company or (iii) options or other rights to acquire from the Company any capital
stock, other securities or phantom or other equity interests of the Company (the items in clauses
(i), (ii) and (iii) being referred to collectively as the “Company Securities”). There are
no outstanding obligations of the Company, actual or contingent, to issue or deliver or to
repurchase, redeem or otherwise acquire any Company Securities.

17

 

     3.07 Subsidiaries. The Company does not have and never has had any Subsidiaries or
any ownership or equity interest in or control of (direct or indirect) any other Person.

     3.08 Financial Statements. 

                (a) The Company has maintained its financial and tax books and records and general ledger
(“Financial Records”) according to proper cash basis accounting practices and has never maintained
its Financial Records in accordance with GAAP. The financial information contained in the Financial
Records is materially correct and accurate.

                (b) Attached as Schedule 3.08 are true and complete copies of:

                     (i) the unaudited balance sheet of the Company as of December 31, 2004 and the unaudited
profit and loss statement of the Company and the Subsidiaries for the 12 month period ended
December 31, 2004; and

                     (ii) the unaudited balance sheet of the Company as of January 31, 2005 and the related
unaudited profit and loss statement of the Company for the one-month period then ended ((i) and
(ii) collectively referred to as the “Financial Statements”).

                (c) Each of the balance sheets included in the Financial Statements fairly presents in all
material respects the financial position of the Company as of its date, and the other statements
included in the Financial Statements fairly present in all material respects the “results” of
operations of the Company for the periods therein set forth.

                (d) All notes and accounts receivable (collectively “Accounts Receivable”) of the
Company are accurately reflected in the books and records and the general ledger of the Company.
All Accounts Receivable represent valid obligations arising from sales actually made or services
actually performed in the ordinary course of the Company’s business, are collectible and are not
subject to any setoffs or counterclaims.

     3.09 Absence of Certain Changes. Since the Balance Sheet Date, except as reflected in
Schedule 3.09, the Company has conducted its businesses in the ordinary course consistent
with past practices and there has not been any:

                (a) Material Adverse Change or, to the Knowledge of the Company, any event, occurrence,
development or state of circumstances or facts which could reasonably be expected to result in a
Material Adverse Change, or any condition, event or occurrence that, individually or in the
aggregate, could reasonably be expected to prevent or materially delay the Company’s or the
Sellers’ ability to consummate the transactions contemplated by this Agreement or perform their
obligations hereunder or under any of the Ancillary Agreements;

                (b) other than the assignment to the Sellers’ Representative of that certain Promissory Note
dated January 2, 2004, from Andrew Trickett, any declaration, setting aside or payment of any
dividend or other distribution with respect to any Company Securities or any repurchase, redemption
or other acquisition by the Company of any outstanding shares of capital stock or other securities
of, or other ownership interests in, the Company;

18

 

                (c) payment or grant of any right by the Company to any Interested Person, or any charge by
any Interested Person to the Company, or other transaction between the Company and any Interested
Person, except in any such case for employee compensation payments in the ordinary course of
business of the Company consistent with past practice;

               (d) amendment of the terms of any outstanding Company Securities;

                (e) incurrence, assumption or guarantee by the Company of any Indebtedness;

               (f) creation or assumption by the Company of any Lien on any of the Company’s assets;

                (g) making of any loan, advance or capital contribution to, or investment in, any Person;

                (h) damage, destruction or other casualty loss (whether or not covered by insurance) affecting
the business or assets of the Company in an amount greater than $10,000;

                (i) transaction or Contract made or entered into, by the Company relating to its assets or
business (including the acquisition or disposition of any assets) or any relinquishment by the
Company of any Contract or other right, other than transactions and commitments in the ordinary
course of business consistent with past practices and those contemplated by this Agreement;

                (j) change in any method of Tax or financial accounting or accounting practice or any making
of a Tax election or change of an existing election by the Company;

                (k) (i) grant of any severance or termination pay to any director, officer or employee of the
Company, (ii) entering into of any employment, deferred compensation or other similar agreement (or
any amendment to any such existing agreement) with any director, officer or employee of the
Company, (iii) change in benefits payable under existing severance or termination pay policies of
the Company or employment agreements to which the Company is a party or (iv) change in
compensation, bonus or other benefits payable to directors, officers or employees of the Company,
other than in the ordinary course of business consistent with past practice;

                (l) labor dispute, other than routine individual grievances, or, to the Knowledge of the
Company, any activity or Proceeding by a labor union or representation thereof to organize any
employees of the Company;

                (m) termination and/or layoff of any employees;

                (n) capital expenditure, or commitment for a capital expenditure, for additions or
improvements to property, plant and equipment in an amount greater than $25,000; or

                (o) agreement, undertaking or commitment by the Company to do any of the foregoing.

19

 

     3.10 Indebtedness. Except as set forth on Schedule 3.10, the Company has no
Indebtedness.

     3.11 Personal Property. 

                (a) The Company has good and marketable title to, or in the case of leased personal property
has valid leasehold interests in, all personal property (including machinery and equipment,
inventory, receivables and furniture) (whether tangible or intangible) owned or leased by the
Company, as applicable, (the “Personal Property”), except for properties and assets sold
since the Balance Sheet Date in the ordinary course of business consistent with past practices.
None of such Personal Property is subject to any Liens, other than (i) Liens disclosed on
Schedule 3.11(a); or (ii) Liens for Taxes not yet due and payable (and for which adequate
accruals or reserves have been established on the Balance Sheet). Schedule 3.11(a)
identifies all of the Personal Property owned or leased by the Company and identifies which
Personal Property is owned and which is leased.

                (b) The Personal Property has no material defects, is in good operating condition and repair
(ordinary wear and tear excepted), and is generally adequate for the uses to which it is being put.

                (c) Except as disclosed on Schedule 3.11(c), the Company does not use in the conduct
of its business any Personal Property that is not owned or leased by the Company, or which it
otherwise has the right to use, constitutes all of the Personal Property held for use or used in
connection with the business of the Company and is generally adequate to conduct such business as
currently conducted.

     3.12 Real Property.

                (a) The Company does not own any real property. All real property used or held for use by the
Company in connection with the business of the Company is leased by the Company as lessee or
sublessee.

                (b) Schedule 3.12(b) completely and accurately describes all leases and subleases of
real property used by or held for use by the Company in connection with the business of the Company
(the “Leases”), together with a description of all buildings and material fixtures and
improvements erected thereon.

                (c) The Leases are in good standing and are valid, binding and enforceable in accordance with
their respective terms, and there does not exist under any such Lease any default by the Company
or, to the Company’s Knowledge, by any other Person, or any event that, with notice or lapse of
time or both, would constitute a default by the Company or, to the Company’s Knowledge, by any
other Person. The Company has delivered to the Buyer complete and accurate copies of all Leases,
including all amendments and agreements related thereto. All rent and other charges currently due
and payable under the Leases have been paid.

                (d) The Company is the holder of the lessee’s interest under each of the Leases and has not
assigned any of the Leases nor subleased all or any portion of the premises leased thereunder. The
Company has not made any alterations, additions or improvements to the

20

 

premises leased under the Leases that would be required to be removed (or of which the lessor
could require removal) at the termination of the respective Lease terms.

     3.13 No Undisclosed Liabilities. Except as disclosed in Schedule 3.13, the
Company has no Liabilities other than Liabilities incurred in the ordinary course of the Company’s
business. Schedule 3.13 identifies all Liabilities of the Company that do not arise from
any Contract. To the Company’s Knowledge, no condition, situation or set of circumstances exists
that could reasonably be expected to result in a Liability for the Company, other than Liabilities
that could be reasonably expected to be incurred in the ordinary course of business consistent with
past practice, which in the aggregate are not material to the Company, taken as a whole.

     3.14 Litigation. Except as disclosed in Schedule 3.14, there is no claim,
investigation or Proceeding (or any basis therefore) pending against or, to the Company’s
Knowledge, threatened against or affecting, the Company or any of its respective properties or the
transactions contemplated hereby before any court or arbitrator or any Governmental Authority.

     3.15 Material Contracts.

                (a) All of the Contracts to which the Company is a party are listed on Schedule 3.15,
but not including Government Contracts, which are required to be separately listed on Schedule
3.16.

                (b) Except for Contracts listed in Schedule 3.15, as of the date of this Agreement the
Company is not a party to or subject to any:

                     (i) Contract for the purchase of materials, supplies, goods, services, equipment or other
assets providing for annual payments by the Company of, or pursuant to which in the last 12 months
the Company has paid, $25,000 or more;

                     (ii) sales, distribution or other similar agreement providing for the sale by the Company of,
or pursuant to which in the last 12 months the Company sold, materials, supplies, goods, services,
equipment or other assets for an aggregate purchase price of $25,000 or more;

                     (iii) partnership, joint venture or other similar Contract;

                     (iv) Contract relating to Indebtedness or the deferred purchase price of property (whether
incurred, assumed, guaranteed or secured by any asset);

                     (v) employment or consulting Contract;

                     (vi) license, teaming, technology transfer, franchise or other Contract in respect of any
Intellectual Property or other property owned or used by, or to be developed for, the Company;

                     (vii) agency, dealer, sales representative or other similar Contract;

21

 

                     (viii) Contract or other document that limits the freedom of the Company to compete in any
line of business or with any Person or in any area or which would so limit the freedom of the
Company after the Closing Date;

                     (ix) contract or commitment with or for the benefit of any Interested Person; or

                     (x) other contract or commitment not made in the ordinary course of business that is material
to the Company taken as a whole.

                (c) Each Contract disclosed in any schedule to this Agreement or required to be disclosed
pursuant to Section 3.15(a) is a valid and binding agreement of the Company and is in full force
and effect, and neither the Company, nor, to the Company’s Knowledge, any other party thereto is in
default in any material respect under the terms of any such Contract, nor, to the Knowledge of the
Company, has any event or circumstance occurred that, with notice or lapse of time or both, would
constitute an event of default thereunder.

     3.16 Government Contracts.

                (a) Schedule 3.16(a) identifies each and every Government Contract to which the
Company is (or has been at any time during the past 5 years) a party.

                (b) Schedule 3.16(b) identifies all correspondence between any Governmental Authority
and the Company at any time during the past 5 years relating to (i) a complaint by a Governmental
Authority about the performance of the Company under any Government Contract, (ii) the possibility
that all or any portion of any Government Contract might not be fully performed, (iii) any
termination of a Government Contract for cause, fraud by the Company, potential debarment or
suspension of the Company, or (iv) the withholding of any funds under any Government Contract for
reasons other than ordinary course retainage.

                (c) Schedule 3.16(c) identifies each and every pending Government Bid.

                (d) Schedule 3.16(d) identifies each and every “contractor team arrangement,” as
defined in Federal Acquisition Regulation (“FAR”) 9.601 currently in effect to which the
Company is a party.

                (e) Schedule 3.16(e) identifies each and every Government Contract to which the
Company is a party and which was awarded to the Company in the past 5 years pursuant to any
set-aside program (for example, small business, small disadvantaged business, 8(a), woman owned
business, veteran owned business).

                (f) Schedule 3.16(f) identifies each and every Government Contract awarded to the
Company in the last 5 years for which the Company submitted cost or pricing data at any point, and
certified such data as being current, complete and accurate pursuant to the Truth in Negotiations
Act or similar requirement.

22

 

                (g) Schedule 3.16(g) identifies each and every Government Contract which contains an
organizational or other conflict of interest provision that restricts the Company from performing a
specific project in the future.

                (h) Schedule 3.16(h) identifies each and every Government Contract to which the
Company is a party and which requires the Company to maintain a facility security clearance and
identifies the level of such requirement.

                (i) Schedule 3.16(i) identifies each and every sales representation, consulting and
other Contract regarding marketing and selling the Company products and services to any
Governmental Authority to which the Company is a party and identifies each Contract with a
Governmental Authority to which the Company has been a party during the last 5 years under which
the Company is obligated or may be obligated to pay a contingent fee or similar payment.

                (j) Schedule 3.16(j) identifies each and every Government Contract that is a cost
reimbursable Government Contract that (i) contains a ceiling or cap on any indirect rate, and the
nature of the cap or ceiling, (ii) provides for an initially negotiated fee to be adjusted later by
a formula based on the relationship of total allowable costs to total Company costs (e.g., a
cost-plus-incentive-fee contract), or (iii) provides for a fee consisting of a base amount and an
award amount (e.g., a cost-plus-award-fee contract).

                (k) Except as set forth on Schedule 3.16(k), with respect to each current and
completed Government Contract or Government Bid to which the Company is or was a party:

                     (i) the Company has complied and is in compliance in all material respects with all terms and
conditions, clauses, provisions, of all applicable Laws and such Government Contracts;

                     (ii) no written notice has been received by the Sellers or the Company (and none has been
threatened) alleging that the Company, or any director, officer or employee of the Company, is in
breach or violation in any material respect of any Law or contractual requirement;

                     (iii) no notice of termination, stop-work notice, cure notice or show-cause notice has been
issued (whether for default, cause, or for convenience) to the Company;

                     (iv) to the Company’s Knowledge, no adverse, negative, or unfavorable Contractor Performance
Assessment Reports or past performance ratings were issued by a Governmental Authority within the
past five (5) years;

                     (v) all representations and certifications made by the Company with respect to each of its
Government Contracts and Government Bids were accurate in all material respects as of the date
made, any and all material representations or certifications required at any time to be updated
were in fact updated as required, and Company has complied with all such representations and
certifications in all material respects;

                     (vi) the cost accounting practices that the Company is using (and has used at all times during
its existence) to estimate and record costs in connection with the

23

 

submission of Government Bids and performance of Government Contracts are (and have been) in
compliance with applicable Law, including but not limited to, the FAR Cost Principles and Cost
Accounting Standards (if required), and have been properly disclosed to the appropriate
Governmental Authority (if required to be disclosed by applicable Law);

                     (vii) no pending cost item in excess of $1,000 or group, type or class of cost in excess of
$5,000 in the aggregate, which was incurred or invoiced by the Company on any Government Contract
has been questioned in writing or disallowed, or otherwise been the subject of a formal dispute,
nor has any such question or disallowance, having been made against any completed Government
Contract in the past five (5) years, not been accounted for in the Company’s financial books or
records in accordance with GAAP;

                     (viii) to the Company’s Knowledge, no money presently due to the Company on any Government
Contract to which the Company is a party has been withheld (including standard time and materials
withholds allowed under the FAR), refused to be paid or set off or subject to attempts to withhold,
refuse to pay or setoff;

                     (ix) to the Company’s Knowledge, the Company has not made any expenditures or incurred costs
or obligations in excess of any applicable limitation of government liability, limitation of cost,
limitation of funds or any similar clause limiting the Governmental Authority’s liability on any
Government Contract (including, without limitation, any work being performed “at risk” in advance
of receipt of funding);

                     (x) the Company has not received any information that would reasonably lead it to conclude
that for any Government Contract subject to incremental funding, such Government Contract will not
be fully funded to the maximum amount identified as the ceiling price of the contract, prior to the
contract’s completion date;

                     (xi) based on experience and submissions to Governmental Authorities and other entities to
date, the Company reasonably expects that its provisional rates under any Government Bid reflect
its current cost expectations for the years for which the rates were bid;

                     (xii) there are no Government Contracts that are fixed-price that the Company reasonably
expects, as of the completion of performance, can only be completed at a loss;

                     (xiii) there are no Government Contracts that include liquidated damages clauses;

                     (xiv) there are no Government Contracts under which the Company has been notified in writing
that any of its products or services have been rejected or not accepted by any customer at any tier
or that any of its products or services do not meet the acceptance criteria of such contract.
Furthermore, neither the Company nor any Key Employees, Chris Popov nor any officers has any reason
to believe the Company will be so notified with respect to any Government Contract;

                     (xv) there are no Government Contracts under which the Company is obligated to provide “most
favored customer” or similar pricing discounts, subject to the

24

 

customer’s right to acquire a subsequent price reduction or other remedy in the event the
Company is determined to have offered greater discounts to other customers or violated the discount
relationship between the customer and a defined “basis of award” or similar entity;

                (xvi) no organizational conflict of interest exists that would preclude the Company from
submitting any Government Bid in the future;

                (xvii) the Company is not nor will the Company be as a result of the Company’s execution and
delivery of this Agreement or the performance of its obligations hereunder, in violation of any
Government Contract or Government Bid;

                (xviii) the Company has not granted any customer or Governmental Authority greater than
“limited rights,” as defined in FAR 52.227-14(a), in any Company proprietary data;

                (xix) the Company has not granted any customer or Governmental Authority greater than
“restricted rights,” as defined in FAR 52.227-14(a), in any Company proprietary computer software
and

                (xx) the Company is not required to pay any Governmental Authority or other customer an
industrial funding adjustment or similar rebate based on a percentage of the dollar value of sales
made on a Government Contract.

           (l) Except as set forth on Schedule 3.16(l), with respect to Subcontract No.
S2040823-1, dated August 23, 2004, as amended, between A-Tek, Inc. and the Company:

                (i) the Company has no Knowledge or reason to believe that any facts or circumstances have
arisen or will arise that would cause A-Tek not to fully fund Subcontract No. S2040823-1 in the
amount of $43,890,693.98, or such greater fully funded amount as set forth by modification; and

                (ii) the Company has no Knowledge or reason to believe any facts or circumstances have arisen
or will arise that would cause the Company to be paid any amount less than $43,890,693.98, or such
greater fully funded amount as set forth by modification.

           (m) Except as set forth on Schedule 3.16(m):

                (i) none of the employees, consultants and agents of the Company is (or during the last five
(5) years has been) under administrative, civil or criminal investigation, indictment or
information by any Governmental Authority;

                (ii) there is no pending audit or investigation of the Company or any of its officers,
employees or representatives nor, within the last five (5) years has there been any audit or
investigation of the Company, or of any of its officers, employees or representatives resulting in
a material adverse finding with respect to any alleged irregularity, misstatement or omission
arising under or relating to any Government Contract or Government Bid;

25

 

                     (iii) during the last five (5) years the Company has not made any voluntary or other
disclosure to any Governmental Authority with respect to any alleged irregularity, misstatement or
omission arising under or relating to a Government Contract or Government Bid;

                     (iv) the Company has not had any irregularities, misstatements or omissions arising under or
relating to any Government Contract or Government Bid that has led to any of the consequences set
forth in the first two clauses of this subsection (m) or any other material damage, penalty
assessment, recoupment of payment or disallowance of cost.

                (n) Except as set forth on Schedule 3.16(n):

                     (i) neither the Company nor any of its current directors, officers, employees, agents or
consultants, is (or at any time during past 5 years has been) suspended, debarred, or excluded from
doing business with a Governmental Authority;

                     (ii) neither the Company nor any of its current directors, officers, employees, agents or
consultants, is (or was at any time during the past 5 years) the subject of a finding of
non-responsibility or ineligibility for domestic or foreign Governmental Authority contracting; and

                     (iii) no circumstances exist that could give rise in the future to the institution of
suspension or debarment Proceedings, criminal or civil fraud or other criminal or civil Proceedings
or a determination of non-responsibility or ineligibility against the Company or any of its
directors, officers or employees.

                (o) Except as set forth on Schedule 3.16(o), no statement, representation or warranty
made by the Company in any Government Contract, any Government Bid or any exhibit thereto or in any
certificate, statement, list, schedule or other document submitted or furnished to a Governmental
Authority or other entity in connection with any Government Contract or Government Bid contained on
the date so furnished or submitted (or on any other date where such statement, representation or
warranty is deemed made or brought down as of a subsequent date either under applicable Law or
pursuant to the applicable Government Contract or Government Bid or any exhibit thereto or in any
written certificate, statement, list, schedule or other document submitted or furnished to such
Governmental Authority in connection with such Government Contract or Government Bid) any untrue
statement of material fact, or failed to state a material fact necessary to make the statements
contained therein, in light of the circumstances in which they are made, not misleading, except in
the case of any untrue statement or failure to state a material fact that would not result in any
material liability to the Company as a result of such untrue statement or failure to state a
material fact.

                (p) Except as set forth on Schedule 3.16(p):

                     (i) no Governmental Authority nor any prime contractor, subcontractor, vendor or other third
party has asserted in writing any claim or initiated any dispute or Proceeding (or threatened to
assert any claim or to initiate any dispute or Proceeding) against the Company relating to
Government Contracts or Government Bids to which the Company is a party;

26

 

                     (ii) the Company is not asserting any claim or initiating any dispute or Proceeding directly
or indirectly against any Governmental Authority, prime contractor, subcontractor, vendor or other
third party concerning any Government Contract or Government Bid, in each case including under, if
applicable, the Contract Disputes Act of 1978, as amended, or any other federal or state statute;

                     (iii) the Company has no interest in any pending or potential claim or request for equitable
adjustment against any Governmental Authority or any prime contractor, subcontractor or vendor
arising under or relating to any Government Contract or Government Bid, and the Company is not a
party (either as the protester or an interested party) to any protest to the procuring agency or
the United States Government Accountability Office or other Governmental Authority; and

                     (iv) there exist no assignments of money due or to become due with respect to any Government
Contract to which the Company is a party.

                (q) The Company does not employ or engage as a consultant any former procurement official or
former high ranking military officer or other government officials who remain under any
restrictions relating to his or her former employment that may negatively affect the Company’s
business, operations, eligibility for government contracts, or the deployment of such employee or
consultant.

                (r) Except as set forth on Schedule 3.16(r), the Company has an “ethics compliance”
policy regarding how its employees are required to conduct themselves and perform work done under
Government Contracts. Each of the Company’s employees (and any consultant, agent, subcontractor or
other party covered by the terms of such policy) has been provided a copy of that policy and
instructed to comply with it, and each of the Company’s employees (or other covered person) has
indicated by signature or otherwise that he or she has reviewed its contents. Each of the
Company’s employees has conducted himself or herself in accordance with that policy.

                (s) Except as set forth on Schedule 3.16(s), the Company has a policy regarding how
its employees are to record their time and complete their time cards with respect to work done
under Government Contracts. Each of the Company’s employees has been provided a copy of that
policy and instructed to comply with it, and has indicated by signature or otherwise that he or she
has reviewed its contents. Each of the Company’s employees has conducted himself or herself in
accordance with that policy.

                (t) Each North American Industry Classification System (“NAICS”) code under which the Company
has ever identified or represented itself to a Governmental Authority or to a contract counterparty
as a “small business” under the U.S. Small Business Administration size standard regulations is
listed on Schedule 3.16(t).

     3.17 Technology and Intellectual Property.

                (a) Schedule 3.17 lists: (i) all patents and all registered trademarks, service marks,
copyrights and mask works, and any applications and renewals for any of the foregoing owned by or
on behalf of the Company; (ii) all hardware products and tools, software and

27

 

firmware products and tools and services that are currently sold, published, offered, or under
development by the Company; and (iii) all licenses (in and out), sublicenses and other agreements
to which the Company is a party and pursuant to which the Company or any other Person is authorized
to use any of the Company Intellectual Property or exercise any rights with respect thereto. The
disclosures described in clause (iii) of the preceding sentence include the identities of the
parties to the relevant agreements, a brief description of the nature and subject matter thereof,
the term thereof and a brief description of the payment terms (or a summary of any formula or
procedure for determining such payment terms).

     (b) Each item of Company Intellectual Property is either: (i) owned solely by the Company free
and clear of any Liens; or (ii) rightfully used and authorized for use by the Company and its
respective successors pursuant to a valid and enforceable written license. All of the Company
Intellectual Property that is used by the Company pursuant to a license or other grant of a right
by a third party to use its proprietary information is separately identified as such in
Schedule 3.17. The Company has all rights in the Company Intellectual Property necessary
to carry out the Company’s former, current and currently planned future activities, including
without limitation (except as noted in Schedule 3.17) rights to make, use, exclude others
from using, reproduce, modify, adapt, create derivative works based on, translate, distribute
(directly and indirectly), transmit, display and perform publicly, license, rent, lease, assign and
sell the Company Intellectual Property in all geographic locations and fields of use, and to
sublicense any or all such rights to third parties, including the right to grant further
sublicenses.

                (c) The Company is not in violation of any license, sublicense or other agreement to which the
Company is a party or otherwise bound relating to any of the Company Intellectual Property. Except
as noted in Schedule 3.17, the Company is not obligated to provide any consideration
(whether financial or otherwise) to any third party, nor is any third party otherwise entitled to
any consideration, with respect to any exercise of rights by the Company or the Buyer, as successor
to the Company, in the Company Intellectual Property.

                (d) The use of the Company Intellectual Property by the Company as currently used and as
currently proposed to be used does not infringe any other Person’s copyright, trade secret rights,
right of privacy, moral right or other intellectual property right. The use by the Company of the
Company Intellectual Property as currently used and as currently proposed to be used does not
infringe any other Person’s, patent, trademark, service mark, trade name, firm name, logo, trade
dress or mask work. No claims (i) challenging the validity, enforceability, effectiveness or
ownership by the Company of any of the Company Intellectual Property or (ii) to the effect that the
use, reproduction, modification, manufacture, distribution, licensing, sublicensing, sale, or any
other exercise of rights in any Company Intellectual Property by the Company, infringes or will
infringe on any intellectual property or other proprietary or personal right of any Person have
been asserted against the Company or, to the Company’s Knowledge, are threatened by any Person nor
does there exist any valid basis for such a claim. There are no Proceedings, including
interference, re-examination, reissue, opposition, nullity, or cancellation proceedings pending
that relate to any of the Company Intellectual Property, other than review of pending patent
applications, and neither the Company, nor any Seller is aware of any information indicating that
such Proceedings are threatened or contemplated by any governmental entity or any other Person.
All granted or issued patents and mask works, all registered trademarks and service marks, and all
copyright registrations owned by the Company

28

 

are valid, enforceable and subsisting. To the Company’s Knowledge, there is no unauthorized
use, infringement, or misappropriation of any of Company Intellectual Property by any third party,
employee or former employee.

                (e) Schedule 3.17 separately lists all parties (other than employees) who have created
any portion of, or otherwise have any rights in or to, the Company Intellectual Property. The
Company has secured from all parties (including employees) who have created any portion of, or
otherwise have any rights in or to, the Company Intellectual Property owned by the Company valid
and enforceable written assignments of any such work, invention, improvement or other rights to the
Company and has provided true and complete copies of such assignments to the Buyer.

                (f) The transactions contemplated under this Agreement will not alter, impair or otherwise
affect any rights of the Company in any Company Intellectual Property.

                (g) The Company has taken commercially reasonable measures to protect the proprietary nature
of the Company Intellectual Property and to maintain in confidence all trade secrets and
confidential information owned or used by the Company.

                (h) Company Intellectual Property does not include any Publicly Available Software and the
Company has not used Publicly Available Software in whole or in part in the development of any part
of Company Intellectual Property in a manner that may subject Company Intellectual Property in
whole or in part, to all or part of the license obligations of any Publicly Available Software.

     3.18 Insurance Coverage. Schedule 3.18 lists all of the insurance policies
and fidelity, performance or other bonds covering the assets, business, equipment, properties,
operations, employees, officers and directors of the Company or posted by the Company for the
benefit of any other Person or to secure its performance or other obligations under any Contract.
There is no claim by the Company or any other Person pending under any of such policies or bonds as
to which coverage has been questioned, denied or disputed by the underwriters of such policies or
bonds. All premiums payable under all such policies and bonds have been paid and the Company are
otherwise in full compliance with the terms and conditions of all such policies and bonds. Such
policies of insurance and bonds (or other policies and bonds providing substantially similar
insurance coverage) have been in effect since inception and remain in full force and effect. To
the Knowledge of the Company, such policies of insurance and bonds are of the type and in amounts
customarily carried by Persons conducting businesses similar to those of the Company. The Company
and Sellers do not know of any threatened termination of, or premium increase with respect to, any
of such policies or bonds.

     3.19 Compliance with Laws; Permits; No Defaults.

                (a) The Company is not in violation of, or has since inception violated, any applicable
provisions of any Laws, except for violations that have not had and would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect.

29

 

               (b) Schedule 3.19 identifies each license, permit, concession or franchise issued by
any Governmental Authority (a “Permit”) issued to the Company, together with the name of
the Governmental Authority issuing such Permit. Such Permits are valid and in full force and
effect, and none of such Permits will be terminated or impaired or become terminable as a result of
the transactions contemplated hereby.

                (c) The Company is not in default under, and no condition exists that with notice or lapse of
time or both would constitute a default under any Permit.

     3.20 Employees and Labor Matters.

                (a) Schedule 3.20(a) sets forth, with respect to each employee of the Company
(including any employee who is on a leave of absence or on layoff status subject to recall) (i) the
name of such employee and the date as of which such employee was originally hired by the Company,
and whether the employee is on an active or inactive status; (ii) such employee’s title; (iii) such
employee’s annualized compensation as of the date of this Agreement, including base salary,
vacation and/or paid time off accrual amounts, bonus and/or commission potential, equity vesting
schedule, severance pay potential, and any other compensation forms; (iv) each current benefit plan
in which such employee participates or is eligible to participate; and (v) any governmental
authorization that is held by such employee and that is used in connection with the Company’s
business. Except as disclosed in Schedule 3.20(a), the employment of each of the employees
of the Company is terminable by the Company at will.

                (b) Schedule 3.20(b) lists all Persons who are currently performing services for the
Company who are classified as “consultants” or “independent contractors,” the compensation of each
such Person and whether the Company is party to a Contract with such Person (whether or not in
writing). Any such Contracts are listed on Schedule 3.15. All Persons engaged by the
Company as independent contractors, rather than employees, have been properly classified as such
and have been engaged in accordance with all applicable foreign, federal, state and/or local Laws.

                (c) The Company is not and has never been a party to or bound by any union Contract,
collective bargaining agreement or similar Contract. There has never been any lockout, strike,
slowdown, work stoppage, labor dispute or union organizing activity, or any similar activity or
dispute, affecting the Company or any of its employees.

                (d) Schedule 3.20(d) lists all current employee manuals and handbooks, employment
policy statements, employment agreements, and other materials relating to the employment of the
current employees of the Company. The Company has delivered to the Buyer complete copies of all
such documents.

                (e) Except as disclosed in Schedule 3.20(e), (i) none of the employees of the Company
has notified or otherwise indicated to the Company that he or she intends to terminate his or her
employment with the Company, or not to accept employment with the Buyer; (ii) the Company does not
have a present intention to terminate the employment of any Key Employee; (iii) all employees of
the Company have executed the Company’s form Noncompetition,

30

 

Nondisclosure and Developments Agreement; (v) no employee of the Company is a party to or is
bound by any employment contract, patent disclosure agreement, noncompetition agreement or other
restrictive covenant or other contract with any third party that would be likely to affect in any
way (A) the performance by such employee of any of his or her duties or responsibilities as a
employee, or (B) the business or operations of the Company; (vi) to the Knowledge of the Company,
no employee of the Company is in violation of any term of any employment contract, patent
disclosure agreement, noncompetition agreement, or any other restrictive covenant to a former
employer relating to the right of any such employee to be employed by the Company; and (vii) the
Company is not and never have been engaged in any Proceeding with an employee or former employee
regarding Intellectual Property matters and there are not disputes or grievances involving any
employees that have not been resolved.

                (f) Except as disclosed in Schedule 3.20(f), (i) the Company does not have an
established severance pay practice or policy; (ii) no employee of the Company is entitled to any
severance pay, bonus compensation, acceleration of payment or vesting of any equity interest, or
other payment from the Company or the Buyer (other than accrued salary, vacation, or other paid
time off in accordance with the policies of the Company) as a result of or in connection with the
transactions contemplated by this Agreement or any of the Ancillary Agreements or as a result of
any termination by the Company on or after the Closing of any Person employed by the Company on or
prior to the Closing Date.

                (g) The Company is in compliance with all currently applicable Laws respecting employment and
employment practices, terms and conditions of employment and wages and hours. The Company is not
engaged, and to the Company’s Knowledge has never engaged, in any unfair labor practice of any
nature. The employees of the Company have been, and currently are, properly classified under the
Fair Labor Standards Act of 1938, as amended, and under any applicable state law. The Company has
not failed to pay, any of its employees, consultants or contractors for any wages (including
overtime), salaries, commissions, bonuses, benefits or other direct compensation for any services
performed by them to the date hereof or amounts required to be reimbursed to such individuals.

                (h) The Company, and each employee of the Company, is in compliance with all applicable visa
and work permit requirements, and no visa or work permit held by an employee of the Company will
expire during the six month period following the date of this Agreement.

     3.21 Environmental Compliance. Except as disclosed in Schedule 3.21:

                (a) The Company has complied in all material respects with all Environmental Laws and
Environmental Permits. The Company has no Environmental Liabilities.

                (b) The Company has applied for and received all Environmental Permits required in connection
with its business. Schedule 3.21 sets forth a list of all such Environmental Permits, each
of which is in full force and effect and will continue to be in full force and effect immediately
following the Closing in accordance with the terms thereof as in effect immediately prior to the
Closing. To the Knowledge of the Company, the consummation of the transactions

31

 

contemplated herein will not require any filing, notice or compliance under any environmental
property transfer laws and no transfer of any Environmental Permits will be required.

                (c) No notice, notification, demand, request for information, citation, summons or order has
been issued, no complaint has been filed, no penalty has been assessed and, to the Knowledge of the
Company, no investigation or review is pending or, to the Company’s Knowledge, threatened, by any
governmental or other entity with respect to any (i) alleged violation by the Company of any
Environmental Law or Environmental Permit, or any liability thereunder, (ii) alleged failure by the
Company to have any Environmental Permit, or (iii) use, generation, treatment, storage, handling,
recycling, transportation or disposal of any Hazardous Substance by the Company.

                (d) The Company has not stored, handled or transported or Released any Hazardous Substance on
any property now or previously owned or leased by the Company. No Hazardous Substance is present,
in a reportable or threshold planning quantity, where such a quantity has been established by any
Environmental Law or Environmental Permit, at, on or under any property now or previously owned or
leased by the Company.

                (e) There have been no environmental investigations, studies, audits, tests, reviews or other
analyses conducted by or for the Company, or of which the Company has Knowledge, relating to any
property or facility now or previously owned or leased by the Company that have not been delivered
to the Buyer.

     3.22 Transactions with Affiliates; Intercompany Arrangements. There are no
agreements, loans, leases, royalty agreements or other continuing transactions between the Company
and (i) any officer, director or stockholder of the Company or any of their Affiliates or (ii) any
member of any officer, director or stockholder of the Company’s family or any of their Affiliates
(“Interested Person”). To the Knowledge of the Company and except as disclosed on
Schedule 3.22, no Interested Person (x) has any material direct or indirect interest in any
entity that does business with the Company or (y) has any direct or indirect interest in any
property, asset or right that is used by the Company in the conduct of their business. No
Interested Person has any contractual relationship (including that of creditor or debtor) with the
Company other than such relationships as result solely from being an officer, director or
stockholder of the Company.

     3.23 Customers. Schedule 3.23 lists (a) the correct installation date for
each product or service sold by the Company to any of its customers since the inception of the
Company’s business, (b) the start date and end date of each maintenance period for current
installed customers of the Company for which the customer has been invoiced, (c) the start date and
end date of each maintenance period for current installed customers of the Company for which the
customer has not yet been invoiced, and (d) the annual maintenance renewal fee for each current
installed customer of the Company.

     3.24 Finders’ Fees. Except for Corporate Finance Associates, whose fees will be paid
by Sellers, there is no investment banker, broker, finder or other intermediary that has been
retained by or is authorized to act on behalf of Sellers or the Company who might be entitled to

32

 

any fee or commission from the Buyer, the Company or any of their respective Affiliates upon
consummation of the transactions contemplated by this Agreement.

     3.25 Other Information. No representation or warranty made by the Sellers or the
Company contained in this Agreement nor any of the information contained in the Disclosure
Schedules attached hereto or to be furnished by the Sellers to Buyer in connection with the
transactions contemplated by this Agreement contains or will contain any untrue statement of a
material fact or omits or will omit to state any material fact necessary in order to make any
statement contained herein or therein not misleading.

ARTICLE IV.

REPRESENTATIONS AND WARRANTIES RELATING TO SELLERS

     Each Seller, severally but not jointly, represents and warrants to the Buyer as follows:

     4.01 Title to and Validity of Shares. Such Seller now has, and on the Closing Date
will have, good and marketable title to and unrestricted power to vote and sell the Shares
designated as owned by such Seller opposite such Seller’s name on Schedule 2.01, free and
clear of any Lien and, upon purchase and payment therefor and delivery to the Buyer thereof in
accordance with the terms of this Agreement, the Buyer will obtain good and marketable title to
such Shares free and clear of any Lien.

     4.02 Authority. Such Seller has the legal power, right and authority to enter into
and perform this Agreement and each Ancillary Agreement to which it is a party, and to perform each
of his obligations hereunder and thereunder. This Agreement has been duly executed and delivered
by such Seller and constitutes a valid and binding obligation of such Seller, enforceable in
accordance with its terms. The execution, delivery and performance of this Agreement and the
applicable Ancillary Agreements by such Seller (a) require no action by or in respect of, or filing
with, or consent of, any Governmental Authority or any other Person and (b) do not contravene, or
constitute a default under, any provision of applicable Law or of any Contract binding upon such
Seller.

     4.03 Investment Representation.

               (a) Each Seller represents and warrants that:

                    (i) it is acquiring Buyer Stock solely for its account and not with a view to or for resale in
connection with a distribution thereof;

                    (ii) it has had the opportunity to ask questions of and receive complete answers from
representatives of the Buyer concerning the business, management and financial condition of the
Buyer and the terms and conditions of the Buyer Stock;

                    (iii) it is able to bear the economic risk of its investment in the Buyer Stock for an
indefinite period of time;

33

 

                     (iv) it can afford a complete loss of its investment in the Buyer Stock; and

                     (v) it has such knowledge and experience in financial and business matters as to be capable of
evaluating the merits and risks of the investment in Buyer Stock;

                    (vi) it is an “accredited investor” within the meaning of Rule 501 under the Securities Act;
and

                     (vii) it is not insolvent and will not be rendered insolvent by the consummation of the
transactions contemplated by this Agreement.

                (b) Each Seller acknowledges and agrees that:

                     (i) the shares of Buyer Stock to be issued to it hereunder have not been registered under the
Securities Act of 1933, as amended (the “Securities Act”), or under the securities Laws of
any state or other jurisdiction, and are being issued in reliance upon certain exemptions under
such Laws;

                     (ii) the shares of Buyer Stock to be issued to it hereunder may not be resold, transferred,
pledged or otherwise disposed of except pursuant to an effective registration statement under the
Securities Act and any applicable state securities Laws, or pursuant to a valid exemption from such
registration requirements, and the Buyer shall have no obligation to record any proposed transfer
of such shares on its stock transfer records unless the shares to be transferred have been
registered under the Securities Act or the request for transfer is accompanied by an opinion in
form and substance satisfactory to the Buyer that no such registration is required; and

                     (iii) the Buyer shall have no obligation to register the Buyer Stock pursuant to the
Securities Act or the securities Laws of any state or to supply the information which may be
necessary to sell such securities.

ARTICLE V.

REPRESENTATIONS AND WARRANTIES OF BUYER

     The Buyer hereby represents and warrants to the Company and Sellers that:

     5.01 Organization and Existence. The Buyer is a corporation duly incorporated,
validly existing and in good standing under the laws of the State of Delaware and has all corporate
powers and all Permits required to carry on its business as now conducted. The Buyer is duly
qualified to do business as a foreign corporation and is in good standing in each jurisdiction
where the character of the property owned or leased by it or the nature of its activities makes
such qualification necessary. Attached to Schedule 5.01 are true and complete copies of
the certificate of incorporation and bylaws of the Buyer each as amended and as currently in
effect.

34

 

     5.02 Corporate Authorization. The execution, delivery and performance by the Buyer of
this Agreement, the issuance and delivery of the Buyer Stock pursuant to this Agreement, and the
consummation by the Buyer of the transactions contemplated hereby are within the corporate powers
of the Buyer and have been duly authorized by all necessary corporate action on the part of the
Buyer. This Agreement has been duly executed and delivered by the Buyer and constitutes a valid
and binding agreement of the Buyer. The Buyer Stock, when issued and delivered in accordance with
the terms of this Agreement will validly issued, fully paid and non-assessable.

     5.03 Governmental Authorization. The execution, delivery and performance by the Buyer
of this Agreement require no action by or in respect of, or filing with, any Governmental
Authority.

     5.04 Non-Contravention. The execution, delivery and performance by the Buyer of this
Agreement and the consummation by the Buyer of the transactions contemplated hereby do not and will
not (i) contravene or conflict with the corporate charter or bylaws of the Buyer or (ii) contravene
or conflict with any provision of any Law binding upon or applicable to Buyer.

     5.05 Litigation. There is no claim, investigation or Proceeding pending, or to the
knowledge of the Buyer threatened, against the Buyer before any Governmental Authority that in any
manner challenges or seeks to prevent, enjoin, alter or materially delay the transactions
contemplated hereby or, that if adversely decided against the Buyer would have a material and
adverse effect on the Buyer.

     5.06 Finders’ Fees. Except for Morgan Keegan & Company, Inc., whose fees will be paid
by the Buyer, there is no investment banker, broker, finder or other intermediary that has been
retained by or is authorized to act on behalf of the Buyer who might be entitled to any fee or
commission from the Company thereof upon consummation of the transactions contemplated by this
Agreement.

     5.07 Purchase for Investment. The Buyer is purchasing the Shares for investment for
its own account and not with a view to, or for sale in connection with, any distribution thereof.

     5.08 No Bankruptcy; Insolvency. The transaction contemplated under this Agreement
will not render Buyer unable to pay debts as they become due. Buyer is not presently contemplating
a bankruptcy filing, nor is Buyer aware of any creditor who has threatened to file any bankruptcy
action against it.

     5.09 Capitalization. 

                (a) The authorized capital stock of the Buyer consists of 75,000,000 shares of common stock,
par value $.001 per share, of which 47,143,551 shares are issued and outstanding as of the date
hereof, and 25,000,000 shares of preferred stock, par value $.001 per share, of which 5,000,000 are
issued and outstanding as of the date hereof. All outstanding shares of capital stock of the Buyer
have been duly authorized and validly issued, are fully paid and non-assessable. There are no
stockholders agreements, voting agreements or voting trusts with respect to the shares of capital
stock of the Buyer.

35

 

                (b) The Buyer has issued options to purchase 6,025,000 shares of Buyer Stock and warrants to
purchase 2,971,997 shares of Buyer Stock (the “Options and Warrants”). Other than the
Options and Warrants, there is no outstanding subscription, option, warrant, call, right, agreement
or commitment relating to the issuance, sale, delivery or transfer by any Person of the Buyer’s
capital stock or any other outstanding security of the Buyer convertible into capital stock of the
Buyer. The Buyer has no obligation (contingent or otherwise) to purchase, redeem, or otherwise
acquire any of its equity securities or any interests therein.

     5.10 Subsidiaries. Schedule 5.10 sets forth a list of all of Buyer’s
Subsidiaries.

     5.11 Compliance with Laws. (a) The Buyer and its Subsidiaries are not in violation of
any applicable provisions of any Laws, except for violations that have not had and would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

     5.12 Absence of Certain Changes. Since January 1, 2005, the Buyer has, except for
this Agreement, conducted its business in the ordinary course consistent with past practice and
there has not occurred any circumstance, event or condition (whether or not covered by insurance)
that has resulted in, or might reasonably be expected to result in, any material and adverse effect
on the Buyer.

     5.13 Other Information. No representation or warranty made by the Buyer contained in
this Agreement nor any of the information contained in the Disclosure Schedules attached hereto or
to be furnished by the Buyer to the Sellers in connection with the transactions contemplated by
this Agreement contains or will contain any untrue statement of a material fact or omits or will
omit to state any material fact necessary in order to make any statement contained herein or
therein not misleading.

ARTICLE VI.

COVENANTS OF THE COMPANY AND SELLERS

     6.01 Resignations. The Company will deliver to the Buyer the resignations of all
officers and directors of the Company from their positions as officers and directors (but not
employees) of the Company at or prior to the Closing Date, unless otherwise specified by the Buyer.

     6.02 Confidentiality. The Company, and the Sellers and their Affiliates, will hold,
and will use their best efforts to cause their respective officers, directors, employees,
accountants, counsel, consultants, advisors and agents to hold, in confidence, unless compelled to
disclose by judicial or administrative process or by other requirements of Law, all confidential
documents and information concerning the Buyer furnished to the Company, or to the Sellers or their
Affiliates, in connection with the transactions contemplated by this Agreement, and after the
Closing Date all confidential documents and information concerning the Company, except to the
extent that such information can be shown by the Sellers to have been (a) previously known on a
nonconfidential basis by the Sellers, (b) in the public domain through no fault of the Sellers or
(c) later lawfully acquired by the Sellers from sources other than the Company or the Buyer;
provided that the Sellers may disclose such information to their respective officers,
directors,

36

 

employees, accountants, counsel, consultants, advisors and agents in connection with the
transactions contemplated by this Agreement so long as such persons are informed by the Sellers of
the confidential nature of such information and are directed by the Sellers to treat such
information confidentially in accordance with this Agreement. The obligation of the Company, and
the Sellers and their Affiliates, to hold any such information in confidence shall be satisfied if
they exercise the same care with respect to such information as they would take to preserve the
confidentiality of their own similar information. If this Agreement is terminated, the Company,
and the Sellers and their Affiliates, will, and will use their best efforts to cause their
respective officers, directors, employees, accountants, counsel, consultants, advisors and agents
to, destroy or deliver to the Buyer, upon request, all documents and other materials, and all
copies thereof, obtained by the Company, or by the Sellers or their Affiliates, or on their behalf
concerning the Buyer in connection with this Agreement that are subject to such confidence.

     6.03 Company Charges. As soon as reasonably practicable following the Closing Date,
Chris Popov will transfer any and all automatic payments currently charged to a credit card in his
name for charges made on behalf of the Company to new Company credit cards.

     6.04 Lock-up Agreements. In the event that Buyer files a registration statement with
the Securities Exchange Commission relating to the initial public offering of securities of the
Buyer, each of the Sellers agrees to enter into a customary “lock-up” agreement with respect to the
shares of Buyer Stock received by such Seller hereunder of at least the same nature and scope as
the executives, directors and stockholders of the Buyer may be required to execute, such lock-up
agreement to remain effective for the equivalent period of time as may be required of the principal
stockholders of the Buyer by the underwriter(s) in the initial public offering.

ARTICLE VII.

GOVERNING LAW; JURISDICTION

     7.01 Governing Law. THIS AGREEMENT SHALL BE GOVERNED, CONSTRUED AND ENFORCED IN
ACCORDANCE WITH THE SUBSTANTIVE LAWS OF THE STATE OF NEW YORK, EXCLUDING ITS CONFLICTS OF LAWS
PRINCIPLES TO THE EXTENT SUCH PRINCIPLES WOULD LEAD TO THE APPLICATION OF A SUBSTANTIVE LAW OTHER
THAN THE LAW OF THE STATE OF NEW YORK.

     7.02 Consent to Jurisdiction. Each of the parties hereto irrevocably submits to the
exclusive jurisdiction (subject to the immediately following sentence) of the United States
District Court for the Southern District of New York for the purposes of any suit, action or other
proceeding arising out of this Agreement or any transaction contemplated hereby. Each of the
parties hereto agrees, to the extent permitted under applicable Laws and rules of procedure, to
commence any action, suit or proceeding relating hereto either in the United States District Court
for the Southern District of New York, or if such suit, action or other proceeding may not be
brought in such court for jurisdictional reasons, then in the Commercial Division of the Supreme
Court of the State of New York, New York County. Each of the parties hereto further agrees that
service of any process, summons, notice or document by U.S. registered mail to such party’s
respective address set forth above shall be effective service of process for any action, suit or
proceeding in New York with respect to any matters to which it has submitted to jurisdiction in

37

 

this Section 7.02. Each of the parties hereto irrevocably and unconditionally waives any objection
to the laying of venue of any action, suit or proceeding arising out of this Agreement or the
transactions contemplated hereby in (a) the United States District Court for the Southern District
of New York or (b) the Commercial Division of the Supreme Court of the State of New York, New York
County, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim
in any such court that any such action, suit or proceeding brought in any such court has been
brought in an inconvenient forum. Notwithstanding the foregoing, judgments, orders or decrees
resulting from lawsuits or court actions brought in accordance with the foregoing provisions of
this Section 7.02 may be appealed to or enforced in any court of competent jurisdiction.

     7.03 WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL
RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT
OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY PARTY IN THE
NEGOTIATION, PERFORMANCE OR ENFORCEMENT HEREOF.

ARTICLE VIII.

COVENANTS OF ALL PARTIES

     8.01 Commercially Reasonable Best Efforts. Subject to the terms and conditions of
this Agreement, each Party will use its commercially reasonable best efforts to take, or cause to
be taken, all actions and to do, or cause to be done, all things necessary or desirable under
applicable Laws to consummate the transactions contemplated by this Agreement. The Sellers and the
Buyer each agree, and the Sellers, prior to the Closing, and the Buyer, after the Closing, agree to
cause the Company, to execute and deliver such other documents, certificates, agreements and other
writings and to take such other actions as may be necessary or desirable in order to consummate or
implement expeditiously the transactions contemplated by this Agreement.

     8.02 Certain Filings. The Company, the Sellers and the Buyer shall cooperate with
each other (a) in determining whether any action by or in respect of, or filing with, any
Governmental Authority is required, or any actions, consents, approvals or waivers are required to
be obtained from parties to any material Contracts, in connection with the consummation of the
transactions contemplated by this Agreement and (b) in taking such actions or making any such
filings, furnishing information required in connection therewith and seeking timely to obtain any
such actions, consents, approvals or waivers.

     8.03 Public Announcements. The Parties agree to consult with each other before
issuing any press release or making any public statement with respect to this Agreement or the
transactions contemplated hereby and, except as may be required by applicable Law or stock exchange
regulation, will not issue any such press release or make any such public statement prior to such
consultation.

38

 

     8.04 Expenses. In connection with the transactions contemplated hereunder, Buyer, on
the one hand, and Sellers, on the other hand, shall each pay one-half of (a) any fees payable to
the Escrow Agent. Except as All costs and expenses incurred in connection with this Agreement, the
Ancillary Agreements and the consummation of the transactions hereby and thereby shall be paid by
the Party incurring such cost or expense. The Sellers shall pay, on or prior to the Closing, all
expenses of the Company incurred in connection with the transactions contemplated by this
Agreement, the Ancillary Agreements and the consummation of the transaction hereby and thereby,
including without limitation the fees to Corporate Finance Associates.

ARTICLE IX.

TAX MATTERS

     9.01 Tax Representations. The Company and each Seller, jointly and severally, hereby
represent and warrant to the Buyer as of the date hereof that:

                (a) The Company has timely filed all Tax Returns required to be filed (determined without
regard to extensions) on or before the date hereof. The Company has paid all Taxes owed (whether
or not shown, or required to be shown, on Tax Returns) on or before the date hereof. The Company
has withheld and paid all Taxes required to have been withheld and paid in connection with amounts
paid or owing to any employee, independent contractor, creditor, stockholder, or other third party.
All Tax Returns filed by the Company were complete and correct in all respects, and such Tax
Returns correctly reflected the facts regarding the income, business, assets, operations,
activities, status and other matters of the Company and any other information required to be shown
thereon. There are no liens for Taxes upon any of the Company’s assets, other than Liens for Taxes
not yet due and payable.

                (b) None of the Tax Returns filed by the Company or Taxes payable by the Company have been the
subject of an audit, action, suit, proceeding, claim, examination, deficiency or assessment by any
governmental authority, and no such audit, action, suit, proceeding, claim, examination, deficiency
or assessment is currently pending or, to the Company’s Knowledge, threatened.

                (c) The Company is not currently the beneficiary of any extension of time within which to file
any Tax Return, and the Company has not waived any statute of limitation with respect to any Tax or
agreed to any extension of time with respect to a Tax assessment or deficiency. All material
elections with respect to Taxes affecting the Company, as of the date hereof, are set forth in
Schedule 9.01.

                (d) The Company is not a party to any agreement, contract, arrangement or plan that has
resulted or would result, separately or in the aggregate, in the payment of (i) any “excess
parachute payments” within the meaning of Section 280G of the Code (without regard to the
exceptions set forth in Sections 280G(b)(4) and 280G(b)(5) of the Code) or (ii) any amount for
which a deduction would be disallowed or deferred under Section 162 or Section 404 of the Code.
None of the shares of outstanding capital stock of the Company is subject to a “substantial risk of
forfeiture” within the meaning of Section 83 of the Code. No portion of the Purchase

39

 

Price is subject to the Tax withholding provisions of Section 3406 of the Code, or of
Subchapter A of Chapter 3 of the Code or of any other provision of law.

                (e) None of the assets of the Company directly or indirectly secures any debt the interest on
which is tax exempt under Section 103(a) of the Code. None of the assets of the Company is
“tax-exempt use property” within the meaning of Section 168(h) of the Code. The Company is not a
party to or member of any joint venture, partnership, limited liability company or other
arrangement or contract which could be treated as a partnership for federal income tax purposes.
The Company is not, or has not been, a U.S. real property holding company (as defined in Section
897(c)(2) of the Code) during the applicable period specified in Section 897(c)(1)(A)(ii) of the
Code. The Company has not made or agreed to make any adjustment under Section 481 (a) of the Code
(or any corresponding provision of state, local or foreign Tax Law) by reason of a change in
accounting method or otherwise, and will not be required to make such an adjustment as a result of
the transactions contemplated by this Agreement.

                (f) The Company is not a party to any Tax sharing agreement or similar arrangement (including,
but not limited to, an indemnification agreement or arrangement). The Company has never been a
member of a group filing a consolidated federal income Tax Return or a combined, consolidated,
unitary or other affiliated group Tax Return for state, local or foreign Tax purposes (other than a
group the common parent of which is the Company), and the Company has no liability for the Taxes of
any Person (other than the Company) under Treasury Regulation Section 1.1502-6 (or any
corresponding provision of state, local or foreign Tax law), or as a transferee or successor, or by
contract, or otherwise.

                (g) The unpaid Taxes of the Company did not, as of the Balance Sheet Date exceed the reserve
for actual Taxes (as opposed to any reserve for deferred Taxes established to reflect timing
differences between book and Tax income) as shown on the Balance Sheet, and will not exceed such
reserve as adjusted for the passage of time through the Closing Date in accordance with the
reasonable past custom and practice of the Company in filing Tax Returns. The Company will not
incur any liability for Taxes from the Balance Sheet Date through the Closing Date other than in
the ordinary course of business and consistent with reasonable past practice.

                (h) Schedule 9.01 hereto contains a list of all jurisdictions (whether foreign or
domestic) to which any Tax is properly payable by the Company. No claim has ever been made by a
Tax Authority in a jurisdiction where the Company does not file Tax Returns that the Company is or
may be subject to Tax in that jurisdiction. The Company has not, and has never had, a permanent
establishment or other taxable presence in any foreign country, as determined pursuant to
applicable foreign law and any applicable Tax treaty or convention between the United States and
such foreign country.

                (i) Schedule 9.01 hereto lists all Tax Returns filed with respect to any of the
Company for taxable periods ended on or after January 1, 2000. The Company has delivered to the
Buyer correct and complete copies of all income Tax Returns, examination reports, and statements of
deficiencies assessed against or agreed to by the Company since January 1, 2000.

40

 

                (j) On March 13, 2002, the Company made an election under Code §1382 and analogous State
provisions to be treated as an S Corporation and such election has been in effect at all times
through the date hereof.

     9.02 Tax Covenants. The following provisions shall govern the allocation of
responsibility as between the Buyer and the Sellers for certain tax matters:

                (a) Tax Periods Ending on or Before the Closing Date. If not already prepared and
filed prior to the Closing Date, the Sellers shall prepare or cause to be prepared and file or
cause to be filed all Tax Returns for the Company for all periods ending on or prior to the Closing
Date which are filed after the Closing Date. In such instance, the Sellers shall permit Company to
review and comment on each such Tax Return described in the preceding sentence prior to filing.
The Sellers shall reimburse the Buyer for Taxes of the Company with respect to such periods within
fifteen (15) days after payment by the Buyer or the Company of such Taxes to the extent such Taxes
were not reflected as a liability in determining the Purchase Price pursuant to Section 2.02 of
this Agreement.

                (b) Tax Periods Beginning Before and Ending After the Closing Date. The Buyer shall
prepare or cause to be prepared and file or cause to be filed any Tax Returns of the Company for
Tax periods which begin before the Closing Date and end after the Closing Date. The Sellers shall
pay to the Buyer within fifteen (15) days after the date on which Taxes are paid those Taxes
attributable to the Pre-Closing Date period as determined under Section 9.03(b).

                (c) Certain Taxes. All transfer, documentary, sales, use, stamp, registration and
other such Taxes and fees (including any penalties and interest) incurred in connection with this
Agreement shall be paid by the Sellers when due, and the Sellers will, at their own expense, file
all necessary Tax Returns and other documentation with respect to all such transfer, documentary,
sales, use, stamp, registration and other Taxes and fees, and, if required by applicable law, the
Buyer will, and will cause its affiliates to, join in the execution of any such Tax Returns and
other documentation.

                (d) S Status. Sellers shall take no action from the date hereof through the Closing
Date that would have the effect of terminating the Company’s S election for Federal or State tax
purposes.

9.03 Tax Indemnification.

                (a) The Sellers hereby jointly and severally indemnify the Buyer against and agree to hold it
harmless from any (i) Tax of the Company and (ii) any damages arising out of or incident to the
imposition, assessment or assertion of any Tax, including those incurred in the contest in good
faith of appropriate proceedings for the imposition, assessment or assertion of any Tax, and any
liability as transferee, in each case related to the Tax Indemnification Period and in each case
incurred or suffered by the Buyer or, effective upon the Closing, the Company (the sum of (i) and
(ii) being referred to herein as a “Tax Loss”).

                (b) For purposes of this Section, in the case of any Taxes that are imposed on a periodic
basis and are payable for a Taxable period that includes (but does not end on) the

41

 

Closing Date, the portion of such Tax related to the portion of such Taxable period ending on
the Closing Date shall (i) in the case of any Taxes other than Taxes based upon or related to
income, be deemed to be the amount of such Tax for the entire Taxable period multiplied by a
fraction the numerator of which is the number of days in the Taxable period ending on the Closing
Date and the denominator of which is the number of days in the entire Taxable period, and (ii) in
the case of any Tax based upon or related to income be deemed equal to the amount which would be
payable if the relevant Taxable period ended on the Closing Date. Any credits relating to a
Taxable period that begins before and ends after the Closing Date shall be taken into account as
though the relevant Taxable period ended on the Closing Date. All determinations necessary to give
effect to the foregoing allocations shall be made in a manner consistent with prior practice of the
Company.

                (c) Upon payment by the Buyer, any of its Affiliates or, effective upon the Closing, the
Company of any Loss, the Sellers shall discharge their obligation to indemnify the Buyer against
such Tax Loss by paying to the Buyer an amount equal to the amount of such Tax Loss.

                (d) Any payment pursuant to this Section 9.03 shall be made not later than 30 days after
receipt by the Sellers’ Representative of written notice from the Buyer stating that any Tax Loss
has been paid by the Buyer, any of its Affiliates or, effective upon the Closing, the Company and
the amount thereof and of the indemnity payment requested. Any payment required under this Section
and not made when due shall bear interest at the rate per annum determined, from time to time,
under the provisions of Section 6621(a)(2) of the Code for such day until paid.

                (e) The Buyer agrees to give prompt notice to the Sellers’ Representative of the assertion of
any claim, or the commencement of any investigation or Proceeding in respect of which indemnity may
be sought hereunder and of any Tax Loss, which the Buyer deems to be within the ambit of this
Section 9.03 (specifying with reasonable particularity the basis therefore) and will give the
Sellers’ Representative such information with respect thereto as the Sellers’ Representative may
reasonably request. The Sellers’ Representative may, at its own expense, (i) participate in and,
(ii) except in the case of a claim that relates to Taxes described in Section 9.03(b), upon notice
to the Buyer, assume the defense of any such suit, action or proceeding; provided that
(iii) the Sellers’ counsel is reasonably satisfactory to the Buyer, (iv) the Sellers’
Representative shall thereafter consult with the Buyer upon the Buyer’s reasonable request for such
consultation from time to time with respect to such suit, action or proceeding and (v) the Sellers
shall not, without the Buyer’ consent, agree to any settlement with respect to any tax if such
settlement could adversely affect the past, present or future Tax liability of the Buyer, any of
its Affiliates or, upon the Closing, the Company. If the Sellers’ Representative assumes such
defense, the Buyer shall have the right (but not the duty) to participate in the defense thereof
and to employ counsel, at its own expense, separate from the counsel employed by the Sellers. The
Sellers shall be liable for the fees and expenses of counsel employed by the Buyer for any period
during which the Sellers have not assumed the defense thereof. Whether or not the Sellers’
Representative chooses to defend or prosecute any claim, all of the Parties hereto shall cooperate
in the defense or prosecution thereof.

42

 

                (f) The Seller shall not be liable under this Section with respect to any Tax resulting from a
claim or demand the defense of which it was not offered the opportunity to assume as provided under
Section 9.03(e) hereof to the extent the Seller’s liability under this Section is adversely
affected as a result thereof. No investigation by the Buyer or any of its Affiliates at or prior
to the Closing Date shall relieve the Seller of any liability hereunder.

ARTICLE X.

EMPLOYEE BENEFITS

     10.01 ERISA Representations. The Company and each Seller, jointly and severally,
hereby represent and warrant to the Buyer as of the date hereof that:

               (a) Schedule 10.01 lists each Employee Plan that covers any Employee, copies of all of
which, and a summary plan description of each, have previously been furnished to Buyer. With
respect to each Employee Plan, all annual reports (Form 5500) required to be filed with the
Internal Revenue Service or Department of Labor have been properly filed on a timely basis and the
Company has provided the most recently filed Form 5500.

                (b) Schedule 10.01 also includes a list of each Benefit Arrangement of the Company,
copies or descriptions of which have been made available or furnished previously to Buyer.

                (c) None of the Employee Plans or Benefit Arrangements listed on Schedule 10.01 is
subject to the laws of any jurisdiction outside the United States.

                (d) No non-exempt “prohibited transaction,” as defined in Section 406 of ERISA or Section 4975
of the Code, has occurred with respect to any Employee Plan.

                (e) Neither the Company, nor any ERISA Affiliate maintains or has ever maintained or
contributed to or expects to incur liability with respect to any Multiemployer Plan or Employee
Plan subject to Title IV of ERISA. Neither the Company, nor any ERISA Affiliate has incurred nor
does it reasonably expect to incur any liability with respect to any transaction described in
Section 4069 of ERISA.

                (f) Each Employee Plan which is intended to be qualified under Section 401(a) of the Code is
so qualified and has been so qualified during the period from its adoption to date, and each trust
forming a part thereof is exempt from tax pursuant to Section 501(a) of the Code. The Company has
furnished to the Buyer copies of the most recent Internal Revenue Service determination or opinion
letter with respect to each such Employee Plan. Each Employee Plan and Benefit Arrangement has
been maintained in compliance with its terms and with the applicable requirements prescribed by any
and all statutes, orders, rules and regulations.

                (g) With respect to the Employees and former Employees, there are no employee post-retirement
health or welfare plans in effect, except as required by Section 4980B of the Code or applicable
state law. No tax under Section 4980B or 4980D of the Code has been incurred in respect of any
Employee Plan that is a group health plan, as defined in Section 5000(b)(1) of the Code.

43

 

                (h) All contributions and payments accrued under each Employee Plan and Benefit Arrangement,
determined in accordance with prior funding and accrual practices, as adjusted to include
proportional accruals for the period ending on the Closing Date, will be discharged and paid on or
prior to the Closing Date. There has been no amendment to, written interpretation of or
announcement (whether or not written) by the Company, or any of its respective ERISA Affiliates
relating to, or change in employee participation or coverage under, any Employee Plan or Benefit
Arrangement that would increase materially the expense of maintaining such Employee Plan or Benefit
Arrangement above the level of the expense incurred in respect thereof for the fiscal year ended
prior to the date hereof.

                (i) Except as disclosed on Schedule 10.01, no Employee will become entitled to any
material bonus, retirement, severance or similar benefit or enhanced benefit solely as a result of
the transactions contemplated hereby (each such disclosed payment being a “Transaction Bonus”).
The Sellers agree that all Transaction Bonuses shall be for the account of the Sellers and not of
the Company and shall be paid by the Sellers.

     10.02 Indemnification. Sellers hereby indemnify Buyer and from and after the Closing
Date the Company, against and agree to hold them harmless from any and all Damages incurred or
suffered as a result of any breach by the Sellers of any representation or warranty made in this
Article or any failure by the Sellers to satisfy and discharge their obligations under this
Article. The indemnification provided for in this Section 10.02 shall be subject to the procedures
set out in Section 12.05.

ARTICLE XI.

CONDITIONS TO CLOSING

     11.01 Conditions to the Obligations of Each Party. The obligations of the Buyer, the
Company and the Sellers to consummate the Closing are subject to the satisfaction of the following
conditions:

                (a) No provision of any applicable Law shall prohibit the consummation of the Closing.

                (b) Each other Party to this Agreement shall have executed and delivered each of the Ancillary
Agreements to be entered into by it at Closing and any other Closing Documents required to be
delivered by it pursuant to Section 2.03 or elsewhere in this Agreement.

     11.02 Conditions to Obligation of Buyer. The obligation of the Buyer to consummate
the Closing is subject to the satisfaction of the following further conditions:

                (a) No Governmental Authority shall have issued any order, and there shall not be any Law,
restraining the effective operation by the Buyer of the business of the Company after the Closing
Date and no Proceeding challenging this Agreement or the transactions contemplated hereby or
seeking to prohibit, alter, prevent or materially delay the Closing shall have been instituted by
any Person before any Governmental Authority and be pending.

44

 

                (b) The Buyer shall have received an opinion of the Watkins firm, APC, dated the Closing Date,
to the effect specified in Sections 3.01, 3.02, 3.04 through 3.06 and 3.14 and with respect to such
other matters as the Buyer may reasonably request.

                (c) The Company shall have received all of the Required Consents.

                (d) The Sellers shall have paid all sales, use, transfer, stamp, documentary and other similar
Taxes and recording and filing fees incurred in connection with the transactions contemplated by
this Agreement.

                (e) Andrew Trickett, Eric Shaffer and Daniel Lintz shall each have entered into an employment
agreement with the Company (the “Employment Agreements”) and Daniel Desmond shall have
entered into a consulting agreement with the Buyer (the “Consulting Agreement”), each dated as of
the Closing Date, in a form acceptable to the Buyer.

                (f) The Simi Group shall have entered into Technology Quit Claim and Release Agreement and a
Technology Sourcing Agreement with the Company, each dated as of the Closing Date and each in a
form acceptable to the Buyer (the “Simi Agreements”).

                (g) The Company and the Sellers shall have terminated all Company Options pursuant to Section
2.09 and shall have delivered to the Buyer written evidence of such terminations satisfactory to
the Buyer.

                (h) Any and all outstanding Indebtedness from or to the Company to or from its employees,
including without limitation, Indebtedness from Jim Ripp for the benefit of the Company shall have
been repaid to the Company, and evidence thereof satisfactory to the Buyer shall have been
delivered to the Buyer and the Indebtedness from Andrew Trickett to the Company shall have be
assigned from the Company to the Sellers’ Representative.

                (i) The Buyer shall have received copies of the resignations described in Section 6.04.

                (j) A Certificate of Good Standing for the Company, dated as of a recent date, issued by the
Secretary of State of the State of California and Certificates of Good Standing for all other
states in which the Company is qualified to do business shall have been delivered to the Buyer.

                (k) A California Tax Certificate shall have been delivered to the Buyer.

                (l) The minute and record books of the Company shall have been delivered to the Buyer.

                (m) Each of the Executive Sellers shall have executed and delivered to the Buyer a Non-Compete
Agreement in a form acceptable to the Buyer (the “Non-Compete Agreements”).

     11.03 Conditions to Obligation of Sellers. The obligation of the Sellers to
consummate the Closing is subject to the satisfaction of the following further conditions:

45

 

                (a) A Certificate of Good Standing for the Buyer, dated as of a recent date, issued by the
Secretary of State of the State of Delaware shall have been delivered to the Sellers.

                (b) The Ancillary Agreements shall have been executed and delivered.

ARTICLE XII.

SURVIVAL; INDEMNIFICATION

     12.01 Survival. All representations, warranties and covenants made by the Sellers,
the Company and Buyer in or pursuant to this Agreement or in any document delivered pursuant hereto
shall be deemed to have been made on the date of this Agreement. The representations and
warranties of the Executive Sellers (other than those made in Article IV) and the Company will
survive the Closing and will remain in effect until, and will expire upon, the termination of the
relevant indemnification obligation as provided in Section 12.04. The representations and
warranties of the Sellers made in Article IV shall survive the Closing indefinitely. The
representations and warranties of the Buyer will survive the Closing and will remain in effect
until, and will expire upon the one-year anniversary of the Closing Date. All covenants of the
Parties that are to be performed after the Closing shall continue in effect and expire in
accordance with their respective terms.

     12.02 Indemnification by Sellers. 

                (a) Subject to the limitations provided in Section 12.04(a) and in addition to any other
indemnities provided by the Sellers in this Agreement, from and after the Closing, each of the
Executive Sellers, jointly and severally, covenants and agrees to indemnify, defend, protect and
hold harmless Buyer and its respective officers, directors, employees, stockholders, assigns,
successors and Affiliates, including without limitation, the Company after the Closing
(individually, a “Buyer Indemnified Party”, and collectively, “Buyer Indemnified
Parties”) from, against and in respect of all liabilities, losses, claims, damages, punitive
damages, causes of action, lawsuits, administrative proceedings (including informal proceedings),
investigations, audits, demands, assessments, adjustments, judgments, settlement payments,
deficiencies, penalties, fines, interest (including interest from the date of such damages) and
costs and expenses (including reasonable attorneys’ fees) (collectively, “Damages”)
suffered, sustained, incurred or paid by any of the Buyer Indemnified Parties in connection with,
resulting from or arising out of, directly or indirectly:

                     (i) any inaccuracy in or breach of any representation or warranty of the Company or the
Sellers set forth in this Agreement, the Schedules hereto, and any Closing Documents delivered by
or on behalf of either of the Sellers or the Company in connection herewith (but not including the
Ancillary Agreements), but excluding the representations and warranties made severally by the
Sellers in Article IV;

                     (ii) any non-fulfillment or breach of any covenant or agreement on the part of any of the
Sellers or, prior to the Closing Date, the Company, in this Agreement or in any

46

 

Closing Documents delivered by or on behalf of any of the Sellers or the Company in connection
herewith;

                     (iii) any and all Damages incident to any of the foregoing or to the enforcement of this
Section 12.02(a).

                (b) Each Seller, severally and not jointly, hereby indemnifies the Indemnified Parties and
agrees to hold each of them harmless from and against all Damages incurred or suffered by any of
the Indemnified Parties arising out of any misrepresentation or breach of warranty by such Seller
pursuant to Article IV (Representations and Warranties Relating to Sellers).

     12.03 Indemnification by Buyer. Subject to the limitations provided in Section
12.04(c), from and after the Closing, Buyer shall indemnify, pay, defend, protect and hold harmless
each of the Sellers and each of their respective officers, directors, employees, stockholders,
assigns, successors and Affiliates (each a “Seller Indemnified Party” and collectively, the
“Seller Indemnified Parties”) from, against and in respect of all Damages suffered,
sustained, incurred or paid by any of the Seller Indemnified Parties in connection with, resulting
from or arising, directly or indirectly, out of (a) any inaccuracy in or breach of any
representation or warranty of the Buyer set forth in this Agreement, or any Closing Documents
delivered by or on behalf of Buyer in connection herewith, (b) any non-fulfillment of any covenant
or agreement by Buyer under this Agreement, and (c) any and all Damages incident to any of the
foregoing or to the enforcement of this Section 12.03.

12.04 Limitations. 

                (a) The Executive Sellers shall have no liability for indemnification under Section 12.02(a)
unless and until the aggregate amount of Damages exceeds Fifty Thousand U.S. Dollars ($50,000) (the
“Indemnification Deductible”), after which point the Executive Sellers will be obligated to
indemnify the Buyer Indemnified Parties only with respect to the aggregate amount of such Damages
that is in excess of the Indemnification Deductible; provided, however, that the Indemnification
Deductible shall not apply to Damages arising out of or relating to any breaches of the covenants
of the Company or the Sellers set forth in Section 8.04, any affirmative payment obligations of the
Company or the Sellers under this Agreement or any of the Closing Documents to which any of them is
a party. The maximum aggregate amount of the Executive Sellers’ liability under Section 12.02(a)
will be the amount of the funds contained in the Escrow Account plus the Earnout Amount, if any
(the “Indemnification Cap”); provided however that this Indemnification Cap shall not apply to
Damages arising out of relating to any breaches of the covenants of the Company or the Sellers set
forth in Section 8.04, any affirmative payment obligations of the Company or the Sellers under this
Agreement or any of the Closing Documents to which any of them is a party. For purposes of the
indemnifications contained in this Agreement, all of the funds and shares of Buyer Stock subject to
the Escrow Agreement and that may be payable as the Earnout Payment Amount, regardless of a
Seller’s Percentage, shall be available to satisfy the Executive Sellers’ indemnification
obligations up until the point in time that such funds and shares shall have been distributed by
the Sellers’ Representative to the various Sellers or be required to be reflected on the stock
ledger of the Buyer as beneficially

47

 

owned by the Sellers individually, after which point, the indemnification obligations shall
extend only to the applicable portion of the Purchase Price distributed to the Executive Sellers.

                (b) Except as provided in Section 12.05, the indemnification obligations of the Executive
Sellers under Section 12.02(a) shall terminate at 11:59 p.m. Eastern Time on the Earnout Payment
Date, with the exception of indemnification with respect to those representations and warranties
contained in (i) Section 3.21, which shall survive until the expiration of the statutory period of
limitations applicable to third party claims pertaining to such matters, if later (giving effect to
any waiver, mitigation or extension thereof), and, if no such mandatory statutory period of
limitations exists, indefinitely; and (ii) Sections 3.06 (Capitalization), which shall survive
indefinitely.

                (c) The Sellers shall have unlimited liability for their indemnification obligations under
Section 12.02(b), and such indemnification obligation shall survive the Closing indefinitely.

                (d) Buyer shall have no liability for indemnification under Section 12.03 unless and until the
aggregate amount of Damages exceeds an amount equal to the amount of the Indemnification Deductible
(the “Buyer Indemnification Deductible”), after which point Buyer will be obligated to indemnify
the Seller Indemnified Parties only with respect to the aggregate amount of such Damages in excess
of the Buyer Indemnification Deductible; provided, however, that the Buyer Indemnification
Deductible shall not apply to Damages arising out of any breaches of the covenants of Buyer set
forth in Section 8.04 or any affirmative payment obligations of Buyer as set forth in this
Agreement or any of the Buyer Ancillary Documents; and further provided that the aggregate amount
of the liability of Buyer under Section 12.03 shall not exceed Three Million U.S. Dollars
($3,000,000). Except as provided in Section 12.05, the indemnification obligations of Buyer under
Section 12.03 shall terminate at 11:59 p.m. Eastern Time on the date that is the one-year
anniversary of the Closing Date.

                (e) The limitations provided in this Section 10.4 shall not apply in respect of any Claims for
Damages relating to any fraud or intentional misrepresentation of any party hereto.

                (f) The indemnification provided in Sections 9.03 and 10.02 shall survive the Closing until
the expiration of the statutory period of limitations applicable to third party claims pertaining
to such matters, if later (giving effect to any waiver, mitigation or extension thereof), and, if
no such mandatory statutory period of limitations exists, indefinitely.

Notwithstanding the preceding sentence, any covenant, agreement, representation or warranty in
respect of which indemnity may be sought under Section 12.02 shall survive the time at which it
would otherwise terminate pursuant to the preceding sentence, if notice of the inaccuracy or breach
thereof giving rise to such right to indemnity shall have been given to the Party against whom such
indemnity may be sought prior to such time.

     12.05 Indemnification Procedures. All claims or demands for indemnification under
Section 10.02 or this Article 12 (“Claims”) shall be asserted and resolved as follows:

48

 

               (a) If any Buyer Indemnified Party, on the one hand, or any Seller Indemnified Party, on the
other hand (each an “Indemnified Party”) has a Claim against any party obligated to provide
indemnification pursuant to Section 10.02 or this Article 12 (an “Indemnifiying Party”) that does
not involve a Claim being asserted against or sought to be collected by a third party, the
Indemnified Party shall with reasonable promptness notify the Indemnifying Party of such Claim,
specifying the nature of such Claim and the amount or the estimated amount thereof to the extent
then feasible (the “Claim Notice”). If the Indemnifying Party does not notify the Indemnified
Party within 30 days after the date of delivery of the Claim Notice that it disputes such Claim
through a reasonably detailed statement of the basis of such dispute (the “Dispute Notice”), the
amount of such Claim shall be conclusively deemed a liability of the Indemnifying Party hereunder.
If a Dispute Notice is delivered to an Indemnified Party in accordance with this Section 12.05, the
Indemnifying Party and the Indemnified Party shall undertake in good faith to or to have their
representatives promptly meet and attempt to resolve such dispute. If a resolution is not reached
within 30 days from the date of the delivery of the Dispute Notice, the Indemnifying Party or the
Indemnified Party may pursue their rights and remedies at law or in equity to resolve the dispute.

                (b) If any Claim for which the Indemnifying Party would be liable to an Indemnified Party
hereunder is asserted against an Indemnified Party by a third party (a “Third-Party
Claim”), the Indemnified Party shall deliver a Claim Notice to the Indemnifying Party. The
Indemnifying Party shall have 30 days from date of delivery of the Claim Notice to notify the
Indemnified Party (i) whether the Indemnifying Party disputes liability to the Indemnified Party
hereunder with respect to the Third-Party Claim, and, if so, the basis for such a dispute, and (ii)
if such party does not dispute liability, whether or not the Indemnifying Party desires, at the
sole cost and expense of the Indemnifying Party, to defend against the Third-Party Claim, provided
that the Indemnified Party is hereby authorized (but not obligated) to file any motion, answer or
other pleading and to take any other action which the Indemnified Party shall deem necessary or
appropriate to protect the Indemnified Party’s interests. If the Indemnifying Party notifies the
Indemnified Party that the Indemnifying Party does not dispute the Indemnifying Party’s obligation
to indemnify with respect to the Third-Party Claim, the Indemnifying Party shall defend the
Indemnified Party against such Third-Party Claim by appropriate proceedings, provided that, unless
the Indemnified Party otherwise agrees in writing, which shall not be unreasonably withheld, the
Indemnifying Party may not settle any Third-Party Claim (in whole or in part) if such settlement
does not include a complete and unconditional release of the Indemnified Party. If the Indemnified
Party desires to participate in any such defense or settlement the Indemnified Party may do so at
its sole cost and expense. If the Indemnifying Party elects not to defend the Indemnified Party
against a Third-Party Claim, whether by failure of such party to give the Indemnified Party timely
notice as provided herein or otherwise, then the Indemnified Party, without waiving any rights
against such party, may settle or defend against such Third-Party Claim in the Indemnified Party’s
sole discretion and the Indemnified Party shall be entitled to recover from the Indemnifying Party
the amount of any settlement or judgment and, on an ongoing basis, all indemnifiable costs and
expenses of the Indemnified Party with respect thereto, including interest from the date such costs
and expenses were incurred. If at any time, in the reasonable opinion of the Indemnified Party,
notice of which shall be given in writing to the Indemnifying Party, any Third-Party Claim seeks
material prospective relief which could have a material and adverse effect on any Indemnified
Party, the Indemnified Party shall have the right at its sole cost and expense to control or assume
(as the case may be)

49

 

the defense of any such Third-Party Claim and the amount of any judgment or settlement and the
reasonable costs and expenses of defense shall be included as part of the indemnification
obligations of the Indemnifying Party hereunder. If the Indemnified Party elects to exercise such
right, the Indemnifying Party shall have the right to participate in, but not control, the defense
of such Third-Party Claim at the sole cost and expense of the Indemnifying Party.

                (c) Subject to the provisions of Section 12.04, an Indemnified Party’s failure to give
reasonably prompt notice as required by this Section 12.05 of any actual, threatened or possible
claim or demand which may give rise to a right of indemnification hereunder shall not relieve the
Indemnifying Party of any liability which the Indemnifying Party may have to the Indemnified Party
unless the failure to give such notice materially and adversely prejudiced the Indemnifying Party
or the Indemnifying Party’s ability to properly defend (or mitigate Damages in connection with)
such claim; provided however that if an Indemnified Party fails to deliver a Claim Notice prior to
the expiration of the applicable survival periods stated in this Agreement, all rights of the
Indemnified Party with respect to such Claims shall terminate and be forever waived.

     12.06 No Waiver; No Impairment for Investigation. The right to indemnification,
payment of Damages or other remedy based on the representations, warranties, covenants, and
obligations of the parties to this Agreement will not be affected by any investigation conducted
with respect to, or any knowledge acquired (or capable of being acquired) at any time, whether
before or after the execution and delivery of this Agreement or the Closing Date, with respect to
the accuracy or inaccuracy of or compliance with, any such representation, warranty, covenant, or
obligation. The waiver of any condition based on the accuracy of any representation or warranty,
or on the performance of or compliance with any covenant or obligation, will not affect the right
to indemnification, payment of Damages, or other remedy based on such representations, warranties,
covenants, and obligations.

     12.07 No Subrogation. Following the Closing, the Sellers shall have no right of
indemnification, contribution or subrogation against the Company with respect to any
indemnification payments by any Seller or the Sellers under Section 12.02 if the transactions
contemplated by this Agreement are consummated. The Sellers shall have a right of contribution
against each other with respect to amounts actually paid pursuant to Section 12.02, but such right
of contribution shall in no way limit or affect the Buyer’s and the Company’s rights contained in
this Article XII.

     12.08 Escrow and Earnout Amount. The Buyer’s claims for indemnification pursuant to
this Article XII shall be satisfied first from funds withheld or deposited and held in escrow
pursuant to Article II and then, to the extent the funds then held in escrow are insufficient to
pay all such claims, shall be deducted from the Earnout Payment.

     12.09 Exclusive Remedy. After the Closing, Sections 9.03 ,10.02 and 12.02, as
applicable, shall provide the exclusive remedy for any misrepresentation or breach of warranty,
covenant or other agreement or other claim arising out of this Agreement or the transactions
contemplated hereby, except that the foregoing limitation shall not apply to claims for fraud,
willful misrepresentation or willful breach or that arise from the breach of Section 6.05

50

 

(Confidentiality), and, in addition, the Parties shall have such rights of offset and recoupment as
may exist at law or in equity.

ARTICLE XIII.

SELLERS’ REPRESENTATIVE

     13.01 Appointment of Sellers’ Representative.

                (a) Each Seller hereby irrevocably constitutes and appoints Chris Popov as such Seller’s
attorney-in-fact and agent in connection with the transactions contemplated by this Agreement and
the Escrow Agreement (the “Sellers’ Representative”). This power is irrevocable and
coupled with an interest, and shall not be affected by the death, incapacity, illness or other
inability to act of any Seller.

                (b) Each Seller hereby irrevocably grants the Sellers’ Representative, full power and
authority on behalf of such Seller:

                     (i) to execute and deliver, and to accept delivery of, such documents as may be deemed by the
Sellers’ Representative, in his sole discretion, to be appropriate to consummate the transactions
contemplated by this Agreement and the Escrow Agreement.

                     (ii) to accept, at the Closing, the purchase price for each Share sold by such Seller at the
Closing, as payment in full for such Shares, and to certify as to the accuracy of the
representations and warranties of the Company and of such Seller under, or pursuant to the terms
of, this Agreement.

                     (iii) to (A) dispute or refrain from disputing any claim made by Buyer under this Agreement;
(B) negotiate and compromise any dispute that may arise under, and to exercise or refrain from
exercising any remedies available under, this Agreement and the Escrow Agreement and (C) execute
any settlement agreement, release or other document with respect to such dispute or remedy;

                     (iv) to waive any closing condition contained in Article X of this Agreement and to give or
agree to any and all consents, waivers, amendments or modifications deemed by the Sellers’
Representative, in his sole discretion, to be necessary or appropriate under this Agreement or the
Escrow Agreement, and, in each case, to execute and deliver any documents that may be necessary or
appropriate in connection therewith;

                     (v) to enforce any claim against the Buyer arising under this Agreement or the Escrow
Agreement.

                    (vi) to engage attorneys, accountants and agents at the expense of Sellers; and

                     (vii) to give such instructions and to take such action or refrain from taking such action as
the Sellers’ Representative deems, in his sole discretion, necessary or appropriate to carry out
the provisions of, and to consummate the transactions contemplated by, this Agreement or the Escrow
Agreement.

51

 

                (c) Each Seller hereby agrees that:

                     (i) the Company and the Buyer shall be entitled to rely on any and all action taken by the
Sellers’ Representative under this Agreement and the Escrow Agreement notwithstanding any dispute
or disagreement among the Sellers or the Sellers’ Representative notwithstanding any knowledge on
the part of the Company or the Buyer of any such dispute or disagreement;

                     (ii) notice to the Sellers’ Representative, delivered in the manner provided herein, shall be
deemed to be notice to such Seller for the purposes of this Agreement and the Escrow Agreement;

                     (iii) the authority of the Sellers’ Representative, as described in this Agreement, shall be
effective until the rights and obligations of the Sellers’ Representative under this Agreement and
the Escrow Agreement shall terminate by virtue of the termination of any and all rights and
obligations of such Seller to the Buyer under this Agreement and the Escrow Agreement;

                     (iv) if the Sellers’ Representative resigns or is removed or otherwise ceases to function in
his capacity as such for any reason whatsoever, and no successor acceptable to the Buyer is
appointed by a majority-in-interest of the Sellers within thirty 30 days, then the Buyer shall have
the right to appoint an alternate representative to serve as described in this Agreement (who shall
be a Seller) and, under such circumstances, the Buyer and the Company shall be entitled to rely on
any and all actions taken by such alternate representative;

                     (v) the Seller’s Representative shall not be liable to any Seller for Damages with respect to
any action taken or any omission by the Sellers’ Representative pursuant to this Article XIII,
except to the extent such Damages are caused by the Sellers’ Representative’s gross negligence or
willful misconduct.

                (d) Each Seller agrees that, notwithstanding the foregoing, at the request of Buyer, he shall
take all actions necessary or appropriate to consummate the transactions contemplated by this
Agreement or the Escrow Agreement (including, without limitation, delivery of his Shares and
acceptance of the purchase price therefore) individually on his own behalf. Each Seller has
delivered to the Sellers’ Representative certificates for the Shares to be sold by such Seller
pursuant to this Agreement, duly endorsed or accompanied by stock powers duly endorsed in blank, to
be held by the Sellers’ Representative and delivered by the Sellers’ Representative to Buyer at the
Closing if the Closing shall occur and the Sellers’ Representative acknowledges receipt thereof.

     13.02 Limitation on Actions. Any claim, investigation or Proceeding, whether at law
or in equity, to enforce any right, benefit or remedy granted to Sellers under this Agreement shall
be asserted, brought, prosecuted, or maintained only by the Sellers’ Representative on behalf of
Sellers. Any claim, investigation or Proceeding, whether at law or in equity, to enforce any
right, benefit or remedy granted under this Agreement, including without limitation any right of
indemnification provided in this Agreement, may be asserted, brought, prosecuted or maintained by
Buyer against Sellers by service of process on the Sellers’ Representative and without the

52

 

necessity of serving process on, or otherwise joining or naming any other Seller as a defendant in
such claim, action, suit or other proceeding. With respect to any matter contemplated by this
Section, a Seller shall be bound by any determination in favor of or against the Sellers’
Representative or the terms of any settlement or release to which the Sellers’ Representative shall
become a party.

     13.03 Indemnification. Each Seller shall indemnify the Sellers’ Representative
against any Damages that the Sellers’ Representative may suffer or incur in connection with any
action taken or any omission by the Sellers’ Representative as the Sellers’ Representative except
to the extent such Damages were caused by such the Sellers’ Representative willful misconduct.

ARTICLE XIV.

MISCELLANEOUS

     14.01 Notices. All notices, requests, demands or other communications that are
required or may be given pursuant to the terms of this Agreement shall be in writing and shall be
deemed to have been duly given: (a) on the date of delivery, if personally delivered by hand, (b)
upon the third day after such notice is deposited in the United States mail, if mailed by
registered or certified mail, postage prepaid, return receipt requested, (c) upon the date
scheduled for delivery after such notice is sent by a nationally recognized overnight express
courier or (d) by fax upon written confirmation (including the automatic confirmation that is
received from the recipient’s fax machine) of receipt by the recipient of such notice:

	 	 	 
	if to the Buyer, to:

	 	with a copy to:
	 
	 	 
	     GlobalSecure Holdings, Ltd

     2600 Virginia Avenue, Suite 600

     Washington, DC 20037-1905 

     Attention: Eric S. Galler, Esq.

     Fax: 202-333-0082

	 	     DLA Piper Rudnick Gray Cary US LLP

     1200 19th Street, N.W.

     Washington, DC 20036

     Attention: Anthony H. Rickert, Esq.

     Fax: (202) 223-2085
	 
	 	 
	if to the Sellers, to:

	 	with a copy to:
	     Chris Popov

     Sellers’ Representative

     Box 2985

     La Jolla, California 92038

     Fax: 858-777-3536

	 	     R. Zebulon Law

     4100 MacArthur Blvd., #100

     Newport Beach, CA 92660

     Fax: (949) 203-8533

     Such information may be changed, from time to time, by means of a notice given in the manner
provided in this Section 14.01.

     14.02 Further Assurances. Each of the Sellers, the Company and Buyer will, upon
request of any other party and without further consideration, from time to time after the Closing,
execute and deliver and use their commercially reasonable efforts to cause other Persons to execute
and deliver all such further documents and instruments, and will do or use its commercially
reasonable efforts to cause to be done such other acts as a party may reasonably

53

 

request more completely to consummate and make effective the transactions contemplated by this
Agreement.

     14.03 Headings. The headings and table of contents in this Agreement are included for
ease of reference only and shall not control or affect the meaning or construction of the
provisions of this Agreement.

     14.04 Entire Agreement. This Agreement, the Disclosure Schedules, and all Closing
Documents, the Escrow Agreement, and other documents to be delivered by the parties pursuant
hereto, collectively represent the entire understanding and agreement among Buyer, the Company and
Sellers with respect to the subject matter hereof. This Agreement supersedes all prior
negotiations, agreements and correspondence among the parties with respect to such subject matter,
and cannot be amended, supplemented, or modified except by an agreement in writing that makes
specific reference to this Agreement and which is signed by the party against which enforcement of
any such amendment, supplement, or modification is sought.

     14.05 Waiver of Compliance; Consents. Except as otherwise provided in this Agreement,
any failure of any of the parties to comply with any obligation, representation, warranty,
covenant, agreement, or condition herein may be waived by the party entitled to the benefits
thereof only by a written instrument signed by the party granting such waiver, but such waiver or
failure to insist upon strict compliance with such obligation, representation, warranty, covenant,
agreement, or condition shall not operate as a waiver of, or estoppel with respect to, any
subsequent or other failure.

     14.06 Severability. In the event that any term or provision of this Agreement is
determined to be void, unenforceable, or contrary to law, the remainder of this Agreement shall
continue in full force and effect provided that such continuation would not materially diminish the
benefits or materially increase the burdens of this Agreement for any party hereto.

     14.07 Counterparts. This Agreement may be executed in any number of counterparts and
any party hereto may execute any such counterpart, each of which when executed and delivered shall
be deemed to be an original and all of which counterparts taken together shall constitute but one
and the same instrument. This Agreement shall become binding when one or more counterparts taken
together shall have been executed and delivered (which deliveries may be by telefax) by the
parties.

     14.08 Further Representations. Each party to this Agreement acknowledges and
represents that it has been represented by its own legal counsel in connection with the
transactions contemplated by this Agreement, with the opportunity to seek advice as to its legal
rights from such counsel. Each party further represents that it is being independently advised as
to the tax consequences of the transactions contemplated by this Agreement and is not relying on
any representation or statements made by any other party as to such tax consequences.

     14.09 Absence of Third Party Beneficiary Rights. Except as specifically provided
herein, no provision of this Agreement is intended, nor will be interpreted, to provide or to
create

54

 

any third party beneficiary rights or any other rights of any kind in any client, customer,
Affiliate, shareholder, employee, partner of any party hereto or any other Person.

     14.10 No Assignment. No party to this Agreement may assign any of its rights or
delegate any of its obligations hereunder without the express prior written consent of all of the
other parties hereto.

     14.11 No Waivers. No failure or delay by either Party in exercising any right, power
or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise
thereof preclude any other or further exercise thereof or the exercise of any other right, power or
privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any
rights or remedies provided by law.

55

 

     IN WITNESS WHEREOF, the Parties hereto have duly executed this Agreement as of the day and
year first above written.

GLOBALSECURE HOLDINGS, LTD

By: /s/ Craig R. Bandes

      Name: Craig R. Bandes

      Title: Chief Executive Officer

VIRTUAL ALERT, INC.

By: /s/ Eric Shaffer

      Name: Eric Shaffer

      Title: President

SELLERS’ REPRESENTATIVE

(in his capacity as such)

/s/ Chris Popov

Chris Popov

SELLERS:

/s/ Daniel Desmond

Daniel Desmond

/s/ Eric Shaffer

Eric Shaffer

/s/ Chris Popov

Chris Popov

/s/ Andrew Trickett

Andrew Trickett

[signatures continued on following page]

 

 

/s/ James A. Ripp

James A. Ripp

/s/ Carolina Finch

Carolina Finch

Lincoln Trust Company Trustee FBO David Goss

By: ___________________

Name: _________________

Title: __________________

The David E. Blalack Family Trust

By: /s/ David E. Blalack

Name: David E. Blalack

Title: Trustee

 

 

Exhibit 2.01

Purchased Shares and Purchase Price

	 	 	 	 	 	 	 	 	 
	Name and Address of Seller	 	# of Shares Sold	 	 	Seller's Percentage	 
	Dan Desmond

2298 Sierra Blvd #B

Sacramento, CA 95825	 	 	1,500,000	 	 	 	29.786	 
	 
	 	 	 	 	 	 	 	 
	Eric Shaffer

5005 Bluffton Cove

Austin, TX 78730	 	 	1,500,000	 	 	 	29.786	 
	 
	 	 	 	 	 	 	 	 
	Chris Popov

Box 2985

La Jolla CA 92038	 	 	1,550,000	 	 	 	30.779	 
	 
	 	 	 	 	 	 	 	 
	Andrew Trickett

14011 Hummingbird Lane

Austin, TX 78732	 	 	295,851	 	 	 	5.875	 
	 
	 	 	 	 	 	 	 	 
	The David E. Blalack Family Trust

79-400 Citrus Ave

La Quinta, CA. 92253	 	 	25,000	 	 	 	.497	 
	 
	 	 	 	 	 	 	 	 
	Lincoln Trust Company Trustee

FBO David Gross

Acct # 050061140575

PO Box 5831

Denver, CO 80217-5831	 	 	50,000	 	 	 	.993	 
	 
	 	 	 	 	 	 	 	 
	Carolina Finch

925 Rosecrans

San Diego CA 92106	 	 	75,000	 	 	 	1.489	 
	 
	 	 	 	 	 	 	 	 
	James A. Ripp

9 Bellevue

Newport Coast, CA 92657	 	 	40,000	 	 	 	.795	 
	 
	 	 	 	 	 	 	 	 
	Total
	 	 	5,035,851	 	 	 	100	 
	 
	 	 	 	 	 	 

 

 

Schedule 5.10

Subsidiaries of the Buyer

Global Secure Safety Products, Inc.

Global Secure Safety, Inc.

HazTrain, Inc.

Neoterik Health Technologies, Inc. (c. 92%)

Neoterik Liaison Corporation

Homeland Gas Masks, Inc.exv10w45

 

EXHIBIT
10.45

STOCK PURCHASE AGREEMENT

     THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made effective as of April 10, 2003,
between Neoterik Health Technologies, Inc., a Maryland corporation (the “Company”), Kenneth
V. Vaughan (“Vaughan”) and James R. Wiggins (“Wiggins” and Vaughan and Wiggins, jointly and
severally the “Principals”) and GlobalSecure Ltd., a Delaware corporation (the
“Purchaser”).

RECITALS

     The Company desires to sell to the Purchaser and the Purchaser desires to purchase from the
Company up to 5,000,000 shares of Common Stock, $0.015 par value, of the Company (the
“Shares”). Principals are substantial shareholders of the Company and are, and for a
substantial period of time have been, executive officers of the Company and therefore will derive
substantial benefit from the transactions herein contemplated.

     NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein and
other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the parties hereto agree as follows:

ARTICLE I

AUTHORIZATION AND SALE OF THE SECURITIES

	1.1	 	Authorization.

     The Company will have authorized before the Closing (as defined below) the sale and issuance
of up to 5,000,000 Shares which shall have the rights, preferences, privileges, and restrictions as
set forth in the Company’s Articles of Incorporation.

	1.2	 	Sale of the Shares.

     Subject to the terms and conditions hereof, the Company shall sell and issue to Purchaser, and
Purchaser shall purchase from the Company, the Shares for a purchase price of up to $500,000 ($0.10
per share).

ARTICLE II

CLOSING DATES; DELIVERY

	2.1	 	Initial and Additional Closings.

          (a) The initial closing of the purchase and sale of $250,000 of Shares hereunder (the
“Initial Closing”) shall take place at the offices of Purchaser, 110 Wall Street, New York,
New York 10005, at 10:00 a.m. on the third business day on which the last conditions in Articles V
and VI to be fulfilled or waived (other than those conditions that by their nature are to be
satisfied at the Initial Closing, but subject to the fulfillment or waiver of those conditions)
shall be satisfied or waived in accordance with this Agreement (the “Closing Date”) or at
such other place or time upon which the Company and the Purchaser shall agree.

 

 

          (b) Additional closings (each, an “Additional Closing”; and the Initial Closing and each
Additional Closing being referred to as a “Closing”) pursuant to which the Company will issue and
sell to the Purchaser, and the Purchaser will purchase, additional Shares (up to an additional
2,500,000 Shares) may take place at such date and time prior to September 30, 2003 as requested
from time to time by the Company or the Purchaser and as specified in a notice (a “Sales Notice”)
delivered by the Company or Purchaser to the other, as the case may be, at least ten (10) business
days in advance of such Additional Closing. Purchaser shall not be obligated to, but may, satisfy
a Sales Notice for a greater amount, or earlier, than is contemplated by the Projections, as
hereinafter defined. If the Sales Notice is given by Purchaser, the condition in the foregoing
sentence shall not be applicable. It is the intention of the parties that the Purchaser shall have
the right to acquire the Shares to be issued on the Additional Closings at its option even if the
Company has not requested that it do so.

	2.2	 	Delivery.

     At the Initial Closing and at any Additional Closing, the Company shall deliver to Purchaser
the appropriate certificate(s) representing the Shares purchased by Purchaser at the Closing, which
shall be delivered against payment of the purchase price therefor, (i) by certified check or wire
transfer of same day funds (or any combination thereof) or (ii) by the surrender of one or more
promissory notes issued by the Company to the Purchaser (with the face value of such promissory
note(s) and all accrued interest payable thereon to be credited toward such Purchaser’s purchase of
Shares).

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company and the Principals, jointly and severally, hereby represent and warrant to and, in
the case of Section 3.31, also covenant to and agree with Purchaser that, except as set forth on
the disclosure schedule attached hereto as Exhibit A (the “Disclosure Schedule”)
(which specifically identifies the relevant subparagraph(s) hereof which Disclosure Schedule shall
be deemed to be part of the representations and warranties as if made hereunder).

	3.1	 	Organization and Qualification.

     Each of the Company and its subsidiaries is a corporation duly organized, validly existing and
in good standing under the laws of its jurisdiction of organization, and has the requisite
corporate power and authority to own, lease and operate its assets, properties and business and to
carry on its business as it is now being conducted or proposed to be conducted. Each of the
Company and its subsidiaries is duly qualified as a foreign corporation to transact business, and
is in good standing, in each jurisdiction where it owns or leases real property or maintains
employees or where the nature of its activities makes each qualification necessary, except where
the failure to be so qualified is not reasonably likely to have a material adverse change in or
effect on the business, assets, properties, operations, results of operations or condition
(financial or otherwise) or prospects of the Company and its subsidiaries taken as a whole, the
legality or validity as to the Company and its subsidiaries, the enforceability as against the
Company of, or the ability of the Company to perform its obligations under this Agreement, any
Ancillary Agreement or its Articles of Incorporation (a “Material Adverse Effect”).

2

 

	3.2	 	Articles of Incorporation and By-laws.

     The Company has delivered to the Purchaser true, correct, and complete copies of the Company’s
and its subsidiaries’ (i) Certificates of Incorporation and (ii) By-laws, each as amended through
the date hereof.

	3.3	 	Corporate Power.

     The Company has all requisite legal and corporate power and authority to execute and deliver
this Agreement and each of the Ancillary Agreements (as defined in Section 3.6), to sell and issue
the Shares hereunder and to carry out and perform its obligations in accordance with the respective
terms of this Agreement, the Articles of Incorporation and each of the Ancillary Agreements.

	3.4	 	Subsidiaries.

     Except as set forth on Section 3.4 of the Disclosure Schedule, neither the Company nor any of
its subsidiaries has direct or indirect subsidiaries. Except as set forth on Section 3.4 of the
Disclosure Schedule, neither the Company nor any of its subsidiaries, directly or indirectly, owns
or controls or has any capital or other equity interest or participation in (or any interest
convertible into or exchangeable or exercisable for, any capital or other equity interest or
participation in), nor is the Company or any of its subsidiaries, directly or indirectly, subject
to any obligation or requirement to provide funds to or invest in, any Person. The Company owns
100% of the outstanding equity and voting interests in each of its subsidiaries and each of its
subsidiaries owns 100% of the outstanding equity and voting interest in each of its respective
subsidiaries.

	3.5	 	Capitalization.

          (a) The authorized capital stock of the Company consists of 20,000,000 shares all of which
presently are designated Common Stock, par value $0.015 per share (“Common Stock”). Immediately
prior to the Closing, 1,754,765 shares of Common Stock will be issued and outstanding. Of the
authorized shares of Common Stock, 550,939 shares are reserved for issuance upon conversion of
stock options issued pursuant to the Company’s stock option plan. All issued and outstanding
shares of the Company’s capital stock have been duly authorized and validly issued, are fully paid
and nonassessable, and were issued in compliance with all applicable federal and state securities
laws and are owned of record and, to the best knowledge of the Company, beneficially, by the
stockholders and in the amounts set forth in Section 3.5 of the Disclosure Schedule. Each of the
outstanding shares of capital stock of each of the Company’s subsidiaries has been duly authorized
and is validly issued, fully paid and nonassessable and is owned by the Company or a direct or
indirect wholly owned subsidiary of the Company, free and clear of any lien, pledge, security
interest, clam or other encumbrance. The relative rights, privileges and preferences of each class
or series of the Company’s capital stock are as stated in the Articles of Incorporation. Set forth
on Section 3.5 of the Disclosure Schedule is a limited capitalization table of the Company as of
February 28, 2003;

          (b) Except as set forth in Section 3.5 of the Disclosure Schedule, there are no outstanding
options, warrants, conversion or exchange privileges, stock appreciation rights,

3

 

phantom equity or similar rights, or preemptive or other rights or agreements of any kind
relating to the capital stock of the Company or any of its subsidiaries, including any commitment
to purchase or otherwise acquire any authorized but unissued shares of the capital stock or other
securities of the Company or any of its subsidiaries;

          (c) Except as set forth in Section 3.5 of the Disclosure Schedule or as contemplated hereby
and by the Ancillary Agreements, neither the Company nor any of its subsidiaries are a party to or
are subject to any agreement or understanding, and, to the Company’s and Principals’ knowledge,
there is no agreement or understanding that affects or relates to the voting or giving of written
consents with respect to (i) any security of the Company or any of its subsidiaries or (ii) the
voting by a director of the Company or any of its subsidiaries.

          (d) Except as set forth in Exhibit B hereto (the “Registration Rights
Agreement”), no Person has any right to cause the Company to effect the registration of any
shares of its capital stock under the Securities Act of 1933, as amended (the “Securities
Act”). To the Company’s and Principals’ knowledge, no stockholder has granted options or other
rights to purchase any shares of Common Stock or other equity securities of the Company or any of
its subsidiaries from such stockholder. Neither the Company nor any of its subsidiaries holds any
shares of its capital stock in its treasury.

	3.6	 	Authorization.

     All corporate action on the part of the Company, its officers, directors, and its stockholders
necessary for the authorization, execution, deliver, and performance of this Agreement, the
Articles of Incorporation, the Registration Rights Agreement, to be dated as of the Closing Date,
by and among the Company, the Purchaser and the other parties thereto, and substantially in the
form of Exhibit B, and all other agreements executed in connection with the transactions
contemplated hereby (the Registration Rights Agreement, the Articles of Incorporation, and such
other agreements contemplated hereby being sometimes hereinafter referred to individually as an
“Ancillary Agreement” and collectively as the “Ancillary Agreements”) by the
Company, the authorization, sale, issuance and delivery of the Shares have been taken or will be
taken prior to the Closing. This Agreement constitutes, and each of the Ancillary Agreements, when
executed and delivered by the Company, will constitute, a valid and legally binding obligation of
the Company, enforceable against the Company in accordance with its respective terms, subject to
applicable bankruptcy, reorganization, insolvency and similar laws affecting creditors’ rights
generally and to general principles of equity. When issued in accordance with this Agreement, the
Shares will be duly authorized, validly issued, fully paid, and nonassessable. The Shares when
issued, will be free of any liens, claims, encumbrances or restrictions on transfer, except as
specifically set forth herein. The Shares are not being issued in violation of any preemptive
rights or rights of first refusal. None of the issuance and sale of the Shares to the Purchaser
pursuant to this Agreement shall require or result in any adjustment in the number of shares of
Common Stock or the kinds or amounts of other securities or property deliverable upon the exercise,
conversion or exchange of any of the options, warrants, convertible securities or other rights to
acquire Common Stock outstanding as of the Closing, or in kind or amount of consideration payable
by the holders thereof upon such exercise, conversion or exchange.

4

 

	3.7	 	Title to Properties and Assets.

     Each of the Company and its subsidiaries has good and marketable title to all of its owned
real property (including fixtures), good, valid and legal title to all its personal property and
assets, and has good title to all its leasehold interests, in each case subject to no mortgage,
pledge, lien, lease, conditional sale agreement, security interest, encumbrance, or charge, except
as set forth in Section 3.7 of the Disclosure Schedule, other than (i) liens for current taxes not
yet due and payable, (ii) as reflected in the Financials (as defined below) and (iii) possible
minor liens and encumbrances which have arisen in the ordinary course of business (not in respect
of indebtedness for borrowed money) and which do not, in any one case or in the aggregate, detract
in any material respect from the value of the property subject thereto or impair in any material
respect the operations of the Company and its subsidiaries individually or taken as a whole
(clauses (i)-(iii), “Permitted Liens”). With respect to property it leases, each of the
Company and its subsidiaries is in compliance with such leases in all material respects and holds a
valid leasehold interest, free of any liens, claims or encumbrances, subject to clauses (i), (ii)
and (iii) above.

	3.8	 	Financial Statements.

          (a) The unaudited consolidated balance sheets of the Company and its subsidiaries as of May
31, 2000, 2001 and 2002 and the related consolidated statements of income and retained earnings and
statement of cash flows for the years then ended, and the unaudited consolidated balance sheet of
the Company and its subsidiaries as of February 28, 2003, and the related consolidated unaudited
statements of income and retained earnings, and consolidated statement of cash flows for the 9
month period then ended, which have been delivered to the Purchaser, fairly present the financial
position of the Company and its subsidiaries at such dates and the results of operations and
retained earnings and the cash flows of the Company and its subsidiaries for the periods then ended
in accordance with generally accepted accounting principles applied on a consistent basis (except
that the unaudited balance sheet as of February 28, 2003, omits footnotes and is subject to normal
year end adjustments, which adjustments are not reasonably likely, either individually, or in the
aggregate, to have a Material Adverse Effect) and show all liabilities, absolute or contingent, of
the Company as at such dates which are required by generally accepted accounting principles to be
reflected thereon. The foregoing financial statements are hereinafter referred to collectively, as
the “Financials”; the balance sheet as at May 31, 2002, included in the Financials is
hereinafter referred to as the “Balance Sheet”; and May 31, 2002, is hereinafter referred
to as the “Balance Sheet Date”.

          (b) Except as set forth in Section 3.8(b) of the Disclosure Schedule, neither the Company nor
the Principals’ are aware, after a reasonable investigation, of any material liabilities, absolute
or contingent, of the Company or any of its subsidiaries other than those reflected on the
Financials and the Disclosure Schedule.

          (c) Since the Balance Sheet Date, except as set forth in Section 3.8(c) of the Disclosure
Schedule, each of the Company and its subsidiaries has conducted its business in the ordinary
course of business and there has not been any event or condition of any character that has resulted
or might be expected to result in a change in the assets, liabilities, financial

5

 

condition, operating results or business of the Company and its subsidiaries taken as a whole
from that reflected in the Financials, except changes in the ordinary course of business and that
have not had and could not reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect.

          (d) Neither the Company nor any of its subsidiaries has any liabilities, absolute or
contingent, which are, individually or in the aggregate, material to the assets, liabilities,
business, condition (financial or otherwise) or operating results of the Company and its
subsidiaries taken as a whole which are not reflected on the Financials or in Section 3.8(d) of the
Disclosure Schedule. Except as set forth in Section 3.8(d) of the Disclosure Schedule, neither the
Company nor any of its subsidiaries has any indebtedness for borrowed money that the Company or its
subsidiaries has directly or indirectly created, incurred, assumed, or guaranteed, or with respect
to which the Company or its subsidiaries has otherwise become directly or indirectly liable which
are not reflected on the Financials.

          (e) To the best knowledge of the Company and Principals’, the Financials are capable of being
audited.

	3.9	 	Related-Party Transactions.

     No employee, stockholder, officer, director or consultant of the Company or member of his or
her immediate family is indebted to the Company, and, except as set forth in Section 3.9 of the
Disclosure Schedule, the Company is not indebted (or committed to make loans or extend or guarantee
credit) to and has no obligation to any of them, other than (i) for payment of salary for services
rendered, (ii) reimbursement for reasonable expenses incurred on behalf of the Company, and (iii)
for other standard employee benefits made generally available to all employees under the Company’s
Stock option plan (including stock option agreements outstanding under any stock option plan
approved by the Board of Directors of the Company). To the best knowledge of the Company and the
Principals, no employee, officer, director or consultant of the Company or member of his or her
immediate family has any direct or indirect ownership interest in any firm or corporation with
which the Company is affiliated or with which the Company has a business relationship, or any firm
or corporation that competes with the Company except passive stock ownership (not in excess of 1%
thereof) by employees, stockholders, officers, or directors of the Company and members of their
immediate families in publicly traded companies. No stockholder, officer or director or any member
of their immediate families has any direct or indirect interest in any material contract with the
Company (other than such contracts related to any such person’s ownership of capital stock of or
employment with the Company).

	3.10	 	Permits.

     Each of the Company and its subsidiaries has all franchises, permits, licenses,
authorizations, approvals and any similar authority (“Permits”) necessary for the conduct of its
business as now being conducted by it and believes it can obtain, without undue burden or expense,
any similar authority for the conduct of its business as planned by it to be conducted unless such
absence or failure is not reasonably likely to have a Material Adverse Effect.

6

 

Neither the Company nor any of its subsidiaries is in violation, in any material respect of or
in default in, under any Permits.

	3.11	 	Intellectual Property.

          (a) Set forth in Section 3.11 of the Disclosure Schedule is a list and brief description of
all domestic and foreign patents, patent applications, registered trademarks, trademark
applications, registered service marks, service mark applications, trade names, registered
copyrights and copyright applications which are in the process of being prepared, owned by or
registered in the name of the Company or any of its subsidiaries, of which the Company or its
subsidiaries is a licensee. Each of the Company and its subsidiaries is the sole and exclusive
owner or a licensee of all Intellectual Property (as defined below) material to the conduct of its
business as presently or proposed to be conducted (the “Company Intellectual Property”),
free and clear of any liens, claims, encumbrances or adverse interests, except that one or more
lenders to the Company or its subsidiaries may have a security interest in such Company
Intellectual Property. Each of the Company and its subsidiaries owns or possesses adequate
licenses or other rights to use and license its customers the right to use (in the manner and to
the extent presently or proposed to be used or licensed) all Intellectual Property currently or
proposed to be used in its business unless such absence or failure is not reasonably likely to have
a Material Adverse Effect. None of the Intellectual Property that the Company or any of its
subsidiaries owns or purports to own, or, to the knowledge of the Company, any of the other Company
Intellectual Property infringes or conflicts with, and neither the Company nor any of its
subsidiaries has interfered with, infringed upon, misappropriated, or otherwise come into conflict
with, any Intellectual Property Rights (as defined below) of third parties and, to the knowledge of
the Company, no third party has interfered with, infringed upon, misappropriated, or otherwise come
into conflict with any Intellectual Property Rights of the Company or any of its subsidiaries. No
claim is pending or, to the best of the Company’s or Principals’ knowledge, threatened to the
effect that the operations of the Company or any of its subsidiaries or the use by the Company’s or
any of its subsidiaries’ customers of any of the Company Intellectual Property licensed to them as
provided in such license infringe upon or conflict with the asserted rights of any other Person.
No claim is pending, or to the best of the Company’s or Principals’ knowledge, threatened to the
effect that any such Intellectual Property owned or licensed by the Company or any of its
subsidiaries, or which the Company or any of its subsidiaries otherwise has the right to use, is
invalid or unenforceable by the Company. All prior art known to the Company which may be or may
have been pertinent to the examination of any United States patent or patent application listed in
Section 3.11 of the Disclosure Schedule has been cited to the United States Patent and Trademark
Office. Each of the Company and its subsidiaries uses reasonable measures to safeguard any
confidential technical information developed by and belonging to the Company and such subsidiary.

          (b) None of the Intellectual Property that the Company or any of its subsidiaries owns or
purports to own, is subject to any outstanding judgment or contract restricting the use thereof by
the Company or such subsidiary. Neither the Company nor any of its subsidiaries has entered into
or become subject to any agreement to indemnify any other Person against any charge of infringement
of any Intellectual Property Rights, except for infringement indemnification obligations incurred
in the ordinary course of business.

7

 

          (c) All licenses, sublicenses or other rights of use that the Company or any of its
subsidiaries has or purports to have granted to customers are valid and authorized by the terms
under which the Company or such subsidiary licenses or otherwise uses such rights. Neither the
Company nor any of its subsidiaries is in default in the payment of any royalties, license fees or
other consideration to any owner or licensor of any Intellectual Property used in or necessary for
the conduct of its business as now conducted and/or as proposed to be conducted or to any agent or
representative of any such owner or licensor by reason of the use thereof by the Company or any of
its subsidiaries nor otherwise is in default in any material respect in the performance of any of
its obligations to any such owner or licensor, and no such owner or licensor, nor any such agent or
representative thereof, has notified the Company or any of its subsidiaries in writing of any claim
of any such default.

          (d) “Intellectual Property” means (i) all inventions (whether patentable or
unpatentable and whether or not reduced to practice), all improvements thereto, and all patents,
patent applications, and patent disclosures, (ii) all trademarks, service marks, trade dress,
logos, trade names and corporate names, including all goodwill associated therewith, and all
applications, registrations, and renewals in connection therewith, (iii) all copyrightable works,
all copyrights, and all applications, registrations, and renewals in connection therewith, (iv) all
trade secrets and confidential business information (including ideas, research and development,
know-how, formulas, compositions, manufacturing and production processes and techniques, technical
data, designs, drawings, specifications, customer and supplier lists, pricing and cost information,
and business and marketing plans and proposals), (v) all computer software (including data and
related documentation), (vi) all other proprietary rights, and (vii) all copies and tangible
embodiments thereof (in whatever form or medium). Such term, when used with reference to the
Company or any of its subsidiaries, includes, without limitation, the Information Technology.

               “Intellectual Property Rights” means, with reference to any Intellectual Property, any
or all of the legally enforceable rights (including any or all inchoate rights, whether such rights
are perfected or not perfected) and moral rights, if any, with respect to such Intellectual
Property under the laws of any jurisdiction, including (i) any and all patents, patents pending,
inventor’s certificates, trademarks, service marks, copyrights, any and all applications therefor
or for registration thereof, and any and all substitutions, extensions, reissues, renewals,
divisions, continuations, or continuations-in-art thereof and (ii) any rights under laws relating
to trade secrets.

	3.12	 	Material Contracts.

     Except as set forth in Section 3.12 of the Disclosure Schedule, the Company does not have any
contract, agreement, lease, commitment or proposed transaction, written or oral, absolute or
contingent, other than (i) contracts for the purchase of supplies and services that were entered
into in the ordinary course of business and that do not involve more than $50,000 (ii) sales and
license contracts entered into in the ordinary course of business that do not involve more than
$50,000 and (iii) contracts terminable at will by the Company on no more than thirty (30) days’
notice without cost or liability to the Company and that do not involve any employment or
consulting arrangement and are not material to the conduct of the Company’s business. For the
purpose of this paragraph, employment and consulting contracts and contracts with labor unions, and
license agreements and any other agreements relating to the acquisition or

8

 

disposition of the Company’s technology (other than standard end user license agreements)
shall not be considered to be contracts entered into in the ordinary course of business. True and
complete copies of such contracts, agreements, and instruments have been provided to the Purchaser
or their counsel. Section 3.12 of the Disclosure Schedule lists all such contracts, agreements and
instruments (collectively the “Material Contracts”).

	3.13	 	Compliance with Other Instruments.

     Neither the Company nor any of its subsidiaries is in violation or breach in any material
respect of any term of its Articles of Incorporation or by-laws (each as amended through the date
hereof), or, in any material respect, any judgment, order or decree, nor has it received or
delivered notice concerning a breach of any Material Contract (nor, to the best of the Company’s
and Principals’ knowledge is there any reasonable basis therefor), and it is not in violation in
any material respect of any order, statute or other law, rule, or regulation (collectively,
“Laws”) applicable to the Company or any of its subsidiaries. The execution, delivery,
performance of and compliance with this Agreement and the Ancillary Agreements, the issuance of the
Shares and the consummation of the transactions contemplated hereby and thereby, have not and will
not (i) violate, conflict with or result in a breach of any provision of or constitute a default
(or an event which, with notice or lapse of time or both, would constitute a default) under, or
result in the termination of, or accelerate the performance required by, or result in a creation of
any lien, claim or encumbrance upon any of the assets, properties or business of the Company or any
of its subsidiaries under, any of the terms, conditions or provisions of (x) the Articles of
Incorporation or the by-laws of the Company (each as amended through the date hereof) or any of its
subsidiaries; or (y) any Material Contract; or (ii) violate any judgment, ruling, order, writ,
injunction, award, decree, or, to its knowledge, law of any court or foreign, federal, state,
county or local government or any other governmental, regulatory or administrative agency or
authority which is applicable to the Company or any of its subsidiaries or any of their respective
assets, properties or businesses; or (iii) to its knowledge, result in the suspension, revocation,
impairment, forfeiture, or non-renewal of any franchise, permit, license, authorization or approval
material to the Company or any of its subsidiaries.

	3.14	 	Litigation.

     Except as set forth in Section 3.14 of the Disclosure Schedule, there are no actions, suits,
proceedings, or investigations pending or, to the best of the Company’s and Principals’ knowledge,
threatened against the Company or any of its subsidiaries or any of their respective properties or
assets before any court or governmental agency (nor, to the best of the Company’s or Principals’
knowledge, is there any reasonable basis therefor). Neither the Company nor any of its
subsidiaries is a party to, or to the best of the Company’s and Principals’ knowledge, named in any
order, writ, injunction, judgment, or decree of any court, government agency, or instrumentality.
Except as set forth in Section 3.14 of the Disclosure Schedule, there is no action, suit or
proceeding by the Company or its subsidiaries currently pending or that the Company or any of its
subsidiaries currently intends to initiate.

9

 

	3.15	 	Registration Rights.

     Except as set forth in the Registration Rights Agreement, neither the Company nor any of its
subsidiaries is under any obligation to register any of its presently outstanding securities or any
of its securities, which may hereafter be issued.

	3.16	 	Governmental Consent.

     No consent, approval, or authorization of, or designation, declaration, notification or filing
with any governmental authority on the part of the Company or any of its subsidiaries is required
in connection with the valid execution, delivery and performance of this Agreement or any of the
Ancillary Agreements, the offer, sale or issuance of the Shares or the consummation of any other
transaction contemplated hereby or by the Ancillary Agreements except the qualification (or the
taking of such action as may be necessary to secure an exemption from qualification, if available)
of the offer and sale of the Shares under applicable blue sky laws, which filings and
qualifications, if required, will be accomplished in a timely manner.

	3.17	 	Employees.

     To the best of the Company’s or Principals’ knowledge, no officer or key employee of the
Company is or will be in violation of any judgment, decree, or order, or any term of any employment
contract, patent disclosure agreement, or other contract or agreement relating to the relationship
of any such officer or key employee with the Company, or any other party because of the nature of
the business conducted or proposed to be conducted by the Company or the use by any such officer or
key employee of his best efforts with respect to such business. Except as set forth in Section
3.17 of the Disclosure Schedule, the Company is not a party to or bound by any currently effective
employment contract, deferred compensation agreement, bonus plan, incentive plan, profit sharing
plan, retirement plan or agreement or other employee compensation agreement. To the best of the
Company’s and Principals’ knowledge, no officer or key employee, or any group of key employees,
intends to terminate his or their employment with the Company, nor does the Company have a present
intention to terminate the employment of any of the foregoing. Subject to general principles
related to wrongful termination of employees and except as set forth in Section 3.17 of the
Disclosure Schedule, the employment of each officer and employee of the Company is terminable at
the will of the Company. No contract exists between the employees of the Company (or a union
representing any of such employees) and the Company and, to the best of the Company’s and
Principals’ knowledge, no union has attempted to organize or represent the labor force of the
Company. Except as set forth in Section 3.17 of the Disclosure Schedule, to the best of the
Company’s and Principals’ knowledge, no person (including, but not limited to, any foreign,
federal, state, county or local government or other governmental, regulatory or administrative
agency or authority) has any claim or basis for any suit, action, claim, proceeding or
investigation against the Company arising out of any statute, law, ordinance, code, rule or
regulation relating to discrimination in employment or employment practices or occupational safety
and health standards (including, without limitation, the Fair Labor Standards Act, as amended,
Title VII of the Civil Rights Act of 1964, as amended, the Rehabilitation Act of 1973, as amended,
the Age Discrimination in Employment Act of 1967, as amended, or the Americans with Disabilities
Act of 1990) which, in each case, if upheld, is reasonably likely to have a Material Adverse
Effect.

10

 

	3.18	 	Tax Returns, Payments, and Elections.

     Each of the Company and its subsidiaries has filed all tax returns and reports as required by
law. To the best of the Company’s and the Principals’ knowledge these returns and reports are true
and correct in all material respects. Each of the Company and its subsidiaries has paid all taxes
and other assessments due. The Company has not elected pursuant to Section 1362(a) of the Internal
Revenue Code of 1986, as amended (the “Code”), and applicable provisions of state law, to be
treated as an S corporation. The Company has not elected to be treated as a collapsible
corporation pursuant to Section 341(f) of the Code, nor has it made any other elections pursuant to
the Code (other than elections that relate solely to methods of accounting, depreciation, or
amortization) that are reasonably likely to have a Material Adverse Effect. The Company has never
had any tax deficiency assessed, or, to the best of the Company’s and Principals’ knowledge,
proposed, against it and has not executed any waiver of any statute of limitations on the
assessment or collection of any tax or governmental charge. Except as set forth in Section 3.18 of
the Disclosure Schedule, none of the Company’s federal income tax returns and none of its state
income or franchise tax or sales or use tax returns have ever been audited by governmental
authorities. The Company has withheld or collected from each payment made to each of its
employees, the amount of all taxes, including, but not limited to, federal income taxes, Federal
Insurance Contribution Act taxes and Federal Unemployment Tax Act taxes required to be withheld or
collected therefrom, and had paid the same to the proper tax receiving officers or authorized
depositories. Since the date of the Financials, each of the Company and its subsidiaries has made
adequate provision on its books or account for all taxes, assessments, and governmental charges
with respect to its business, properties, and operations for such period.

	3.19	 	Environmental and Safety Laws.

     Neither the Company nor any of its subsidiaries has caused or allowed, or contracted with any
party for, the generation, use, transportation, treatment, storage or disposal of any Hazardous
Substances (as defined below) in violation of any applicable Environmental Law (as defined below)
in connection with the operation of its business or otherwise. Each of the Company and its
subsidiaries, the operation of its business, and any real property that it owns, leases or
otherwise occupies or uses (collectively, the “Premises”) are in compliance in all material
respects with all applicable Environmental Laws and orders or directives of any governmental
authorities having jurisdiction under such Environmental Laws, including, without limitation, any
Environmental Laws or orders or directives with respect to any cleanup or remediation of any
release or threat of release of Hazardous Substances. Neither the Company nor any of its
subsidiaries has received any written notice, citation, directive, letter or other communication
about any proceeding, claim or lawsuit, from any Person concerning the ownership or occupation of
the Premises, or the conduct of its operations in material violation of any applicable
Environmental Laws. Each of the Company and its subsidiaries has obtained and is maintaining in
full force and effect all necessary permits, licenses and approvals required by all Environmental
Laws applicable to the Premises and the business operations conducted thereon (including operations
conducted by tenants on the Premises), and is in compliance in all material respects with all such
permits, licenses and approvals. Neither the Company nor any of its subsidiaries has caused or
allowed a release, or, to the best of the Company’s and Principals’ knowledge, a threat of release,
of any Hazardous Substance into, at or near the Premises, and the

11

 

Premises have not been subject to a release, or, to the best of the Company’s and Principals’
knowledge, a threat of release, of any Hazardous Substance. For the purposes of this Agreement,
the term “Environmental Laws” shall mean any Federal, state or local law or ordinance or
regulation pertaining to the protection of human health or the environment, including, without
limitation, the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C.
Sections 9601, et seq., the Emergency Planning and Community Right-to-Know Act, 42 U.S.C. Sections
11001, et seq., and the Resource Conservation and Recovery Act, 42, U.S.C. Sections 6901, et seq.
For purposes of this Agreement, the term “Hazardous Substances” shall include oil and
petroleum products, asbestos, polychlorinated biphenyls, urea formaldehyde and any other materials
classified as hazardous or toxic under any Environmental Laws.

	3.20	 	Marketing Rights.

     Except as set forth in Section 3.20 of the Disclosure Schedule, the Company has not granted
rights to license, market or sell its products to any other person or entity and is not bound by
any agreement that affects the Company’s exclusive right to develop, manufacture, assemble,
distribute, market or sell its products.

	3.21	 	Brokers or Finders.

     Except as set forth in Section 3.21 of the Disclosure Schedule, the Company has not incurred,
and will not incur, directly or indirectly, as a result or any action taken by the Company, any
liability for brokerage or finders’ fees or agents’ commissions or any similar charges in
connection with this Agreement or any transaction contemplated hereby.

	3.22	 	ERISA.

     (a) Neither the Company nor any entity required to be aggregated with the Company under
Sections 414(b), (c), (m), (n) or (o) of the Code sponsors, maintains, has any obligation to
contribute to, has any liability under, or is otherwise a party to, any Benefit Plan. For purposes
of this Agreement, “Benefit Plan” shall mean any plan, fund, program, policy, arrangement
or contract whether formal or informal, which is in the nature of (i) an employee pension benefit
plan (as defined in Section 3(2) of the Employment Retirement Income Security Act of 1974, as
amended (“ERISA”)) or (ii) an employee welfare benefit plan (as defined in Section 3(1) of ERISA).

	3.23	 	Disclosure.

     Neither this Agreement, nor the Disclosure Schedule, nor any Exhibit to this Agreement, nor
any due diligence materials, nor other information furnished by or on behalf of the Company to any
Purchaser contains an untrue statement of a material fact or omits a material fact necessary to
make the statements contained herein or therein, in light of the circumstances in which they were
made, not misleading. None of the Ancillary Agreements or certificates prepared or supplied by the
Company with respect to the transactions contemplated hereby or thereby contains an untrue
statement of a material fact or omits a material fact necessary to make the statements contained
therein, in light of the circumstances in which they were made, not misleading. There is no fact
which the Company has not disclosed to the Purchaser and their counsel in writing and of which the
Company or its Principals’ is aware, which materially and

12

 

adversely affects the business, financial condition, operations, prospects, property or assets
of the Company. The financial projections provided by or on behalf of the Company to Purchaser
(collectively, “Projections”) were prepared in good faith based on the experience of the Company in
the industry and on reasonable assumptions of fact and opinion as to future events. As of the date
hereof no facts have come to the attention of the Company which would, in its opinion, require the
Company to revise the assumptions underlying such projections and other estimates or the
conclusions derived therefrom.

	3.24	 	Securities Act.

     Subject to the accuracy of the Purchaser’s representations in Section 4, the offer, sale and
issuance of the Shares in conformity with the terms of this Agreement constitute transactions
exempt from the registration requirements of Section 5 of the Securities Act.

	3.25	 	Insurance.

     The Company has in full force and effect fire and casualty insurance policies, with extended
coverage, which it reasonably believes are sufficient in amount (subject to reasonable deductibles)
to allow it to replace any of its properties that might be damaged or destroyed, and such other
policies of insurance in such amounts as in the Company’s best judgment, after advice from its
insurance broker, is acceptable for the nature and extent of the business of the Company and its
subsidiaries as currently being conducted, and as currently proposed to be conducted.

	3.26	 	Confidentiality and Noncompetition Agreements.

     Each officer of the Company set forth in Section 3.26 of the Disclosure Schedules has executed
a Proprietary Information and Confidentiality Agreement substantially in form or forms, which have
been delivered to the Purchaser. Each officer of the Company set forth in Section 3.26 of the
Disclosure Schedule has executed an agreement with noncompetition provisions which have been
delivered to the Purchaser.

	3.27	 	Proprietary Information of Third Parties.

     To the best of the Company’s and Principals’ knowledge, no third party has claimed or has
reason to claim that any person employed or engaged by the Company or any of its subsidiaries has
(a) violated or may be violating any of the terms or conditions of his employment, non-competition
or non-disclosure agreement with such third party, (b) disclosed or may be disclosing or utilized
or may be utilizing any trade secret or proprietary information or documentation of such third
party or (c) interfered or may be interfering in the employment relationship between such third
party and any of its present or former employees. No third party has requested information from
the Company or any of its subsidiaries which suggests that such a claim might be contemplated. To
the best of the Company’s and Principals’ knowledge, no person employed by or affiliated with the
Company or any of its subsidiaries has employed or proposes to employ any trade secret or any
information of documentation proprietary to any former employer, and to the best of the Company’s
and Principals’ knowledge, no person employed by or affiliated with the Company or any of its
subsidiaries has violated any confidential relationship which such person may have had with any
third party, in connection with the development or sale of any service or proposed service of the
Company or any of its

13

 

subsidiaries, and the Company has no reason to believe there will be any such employment or
violation.

	3.28	 	Officers.

     Set forth in Section 3.28 of the Disclosure Schedule is a list of the officers of the Company,
together with the title or job classification of each such person and the total compensation paid
to each such person by the Company in 2001 and 2002, and if different, the total compensation
currently agreed to be paid in 2003. Except as set forth in Section 3.17 of the Disclosure
Schedule, none of such persons has an employment agreement or understanding, whether oral or
written, with the Company, which is not terminable on thirty (30) days’ notice by the Company
without cost or other liability to the Company.

	3.29	 	U.S. Real Property Holding Corporation.

     Neither the Company nor any of its subsidiaries is now or has ever been a “United States real
property holding corporation,” as defined in Section 897(c)(2) of the Code and Section 1.897-2(b)
of the Regulations promulgated by the Internal Revenue Service.

	3.30	 	Foreign Corrupt Practices Act.

     Neither the Company nor any of its subsidiaries has taken any action which would cause it to
be in violation of the Foreign Corrupt Practices Act of 1977, as amended, or any rules or
regulations thereunder. To the best of the Company’s and Principals’ knowledge, there is not now,
and there has never been, any employment by the Company or any of its subsidiaries of, or
beneficial ownership in the Company or any of its subsidiaries by, any governmental or political
official in any country in the world.

	3.31	 	Use of Proceeds.

     The Company covenants and agrees with Purchaser that it shall use the funds from the purchase
of Shares by the Purchaser to fund capital expenditures, working capital and other general
corporate purposes as shown on the Projections.

	3.32	 	Books and Records.

     The books of account, ledgers, order books and records of the Company accurately and
completely reflect all material information relating to the business of the Company, the nature,
acquisition, maintenance, location and collection of the assets of the Company, and the nature of
all transactions giving rise to the obligations or accounts receivable of the Company.

	3.33	 	Customers.

     Section 3.33 of the Disclosure Schedule identifies the ten largest customers (or group of
affiliated customers) of the Company’s products and services (based on total sales volume for the
latest full fiscal year), indicating for each the total sales volume for the latest full fiscal
year. None of such Persons has cancelled or otherwise terminated, purported to or made any threat
to cancel or otherwise terminate or given any notice of intended cancellation or termination of its

14

 

relationship with the Company, nor has any such Person indicated in writing an intent or
desire to materially decrease its purchase volume or change its relationship or the terms of its
relationship with the Company.

	3.34	 	Events Subsequent to Most Recent Fiscal Period End.

     Since the Balance Sheet Date, there has not been any Material Adverse Effect or any
development that can reasonably be expected to result in a Material Adverse Effect and each of the
Company and its subsidiaries has conducted its business in the ordinary course, consistent with
past practices, including with respect to quantity and frequency (“Ordinary Course of
Business”). Without limiting the generality of the foregoing, except as set forth in Section
3.34 of the Disclosure Schedule, since the Balance Sheet Date:

          (a) neither the Company nor any of its subsidiaries has sold, leased, transferred, or assigned
any of its assets, other than immaterial assets sold, leased, transferred or assigned in the
Ordinary Course of Business;

          (b) neither the Company nor any of its subsidiaries has entered into any agreement, contract
or license (or series of related contracts) either involving more than $50,000 or outside the
Ordinary Course of Business;

          (c) no party (including the Company or any of its subsidiaries) has accelerated, terminated
(other than upon the expiration of its term), modified, or canceled any Contract (or series of
related contracts) involving more than $25,000 to which the Company or any of its subsidiaries is
or was a party or by which it is or was bound;

          (d) neither the Company nor any of its subsidiaries has imposed or suffered to exist any lien
upon any of its assets, other than Permitted Liens;

          (e) neither the Company nor any of its subsidiaries has purchased, leased or acquired any
assets or made any capital or operating expenditure (or series of related capital or operating
expenditures), capital addition or improvement, in either case, outside of the Ordinary Course of
Business involving more than $25,000;

          (f) neither the Company nor any of its subsidiaries has made any capital investment in, any
loan to, or any acquisition of the securities or assets of, any other Person (or series of related
capital investments, loans, and acquisitions) either involving more than $10,000 or outside the
Ordinary Course of Business;

          (g) neither the Company nor any of its subsidiaries has issued any note, bond or other debt
security or redeemable equity or created, incurred, assumed, or guaranteed any indebtedness for
borrowed money or capitalized lease obligations involving more than $10,000 singly or $25,000 in
the aggregate;

          (h) there has been no change made or authorized in the Articles of Incorporation or by-laws of
the Company or any of its subsidiaries;

15

 

          (i) neither the Company nor any of its subsidiaries has declared, set aside, or paid any
dividend or made any distribution with respect to its capital stock (whether in cash, securities,
property or otherwise) or redeemed, purchased, or otherwise acquired any of its capital stock;

          (j) neither the Company nor any of its subsidiaries has experienced any damage, destruction,
or loss (whether or not covered by insurance) to any material amount of the assets of the Company
and its subsidiaries taken as a whole;

          (k) neither the Company nor any of its subsidiaries has made any loan to, or entered into any
other transaction with or for the benefit of, any of the Company’s or its subsidiaries’
stockholders, directors, officers, or employees (except for payment of compensation to officers and
employees in the Ordinary Course of Business);

          (l) neither the Company nor any of its subsidiaries has entered into any employment contract
or collective bargaining agreement, written or oral, or modified the terms of any existing such
contract or agreement or adopted, amended, modified, or terminated any Benefit Plan;

          (m) neither the Company nor any of its subsidiaries has discharged or satisfied any lien, or
paid, canceled, compromised or otherwise satisfied any obligation, indebtedness or liability
(absolute or contingent) other than the payment in the Ordinary Course of Business of current
liabilities shown on the Balance Sheet or incurred since the date thereof in the Ordinary Course of
Business;

          (n) neither the Company nor any of its subsidiaries has made any material change in any method
of accounting or any accounting practice;

          (o) except as expressly contemplated by this Agreement there has not been any other
transaction outside of the Ordinary Course of Business involving the Company or any of its
subsidiaries;

          (p) neither the Company nor any of its subsidiaries has (i) increased the rate of compensation
payable or to become payable by it to any of its officers, directors, employees or agents, except
for increases in the Ordinary Course of Business or required under the terms of employment
agreements, (ii) granted, made or accrued any bonus, incentive compensation, service award or other
like benefit, contingently or otherwise, to or for the credit of any of its officers, directors,
employees or agents, other than in the Ordinary Course of Business, or made any employee welfare,
pension, retirement, profit sharing or similar payment except pursuant to regularly scheduled
payments required pursuant to the existing plans and arrangements described in the Disclosure
Schedule or (iii) paid or granted any right to receive any material (either individually or in the
aggregate) severance or termination pay to any officer, director, employee or agent outside the
Ordinary Course of Business; and

          (q) neither the Company nor any of its subsidiaries has entered into or made any contract,
agreement or commitment to do any of the foregoing.

16

 

     The Company covenants and agrees that from the date hereof through the Closing Date, it will
not, and it will cause its subsidiaries not to, take any action inconsistent with this Section
3.34.

	3.35	 	Business Activity Restriction.

     There is no non-competition or other similar agreement, commitment, judgment, injunction,
order or decree to which the Company is a party or subject to that has or could reasonably be
expected to have the effect of prohibiting or impairing the conduct of business by the Company.
The Company has not entered into any agreement under which the Company is restricted from selling,
licensing or otherwise distributing any of its technology or products to, or providing services to,
customers or potential customers or any class of customers, in any geographic area, during any
period of time or in any segment of the market or line of business.

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE PURCHASER

     Purchaser hereby represents and warrants to the Company with respect to the purchase of the
Shares as follows:

	4.1	 	Organization and Qualification.

     Purchaser is a corporation duly organized, validly existing and in good standing under the
laws of its jurisdiction of organization, and has the requisite corporate power and authority to
own, lease and operate its assets, properties and business and to carry on its business as it is
now being conducted or proposed to be conducted. Purchaser is duly qualified as a foreign
corporation to transact business, and is in good standing, in each jurisdiction where it owns or
leases real property or maintains employees or where the nature of its activities makes each
qualification necessary, except where the failure to be so qualified is not reasonably likely to
have a Material Adverse Effect.

	4.2	 	Corporate Power.

     Purchaser has all requisite legal and corporate power and authority to execute and deliver
this Agreement and each of the Ancillary Agreements, to purchase the Shares hereunder and to carry
out and perform its obligations in accordance with the respective terms of this Agreement, the
Articles of Incorporation and each of the Ancillary Agreements.

	4.3	 	Experience.

     Purchaser has such experience in evaluating and investing in private placement transactions of
securities in companies similar to the Company so as to be capable of evaluating the merits and
risks of such Purchaser’s investment in the Company and has the capacity to protect such
Purchaser’s own interests. Such Purchaser represents and warrants to the Company that it is aware
that the purchase of Shares involves substantial risk and that its financial condition and
investments are such that it is in a financial position to hold such shares for an indefinite
period of time and to bear the economic risk of and withstand a complete loss of such investment.

17

 

	4.4	 	Investment.

     Purchaser is acquiring the Shares for investment for such Purchaser’s own account, not as a
nominee or agent, and not with the view to, or for resale in connection with, any distribution
thereof. Purchaser understands that the Shares have not been, and will not be, registered under
the Securities Act or the securities laws of any state by reason of exemptions from the
registration provisions of the Securities Act and such state laws which depend upon, among other
things, the bona fide nature of the investment intent and the accuracy of Purchaser’s
representations as expressed herein, and the Company’s reliance on such exemption is predicated on
Purchaser’s representations set forth herein.

	4.5	 	Rule 144.

     Purchaser acknowledges that the Shares must be held indefinitely unless subsequently
registered under the Securities Act or an exemption from such registration is available. Such
Purchaser is aware of the provisions of Rule 144 promulgated under the Securities Act which permit
the limited resale of shares purchased in a private placement subject to the satisfaction of
certain conditions, including, among other things, (i) the existence of a public market for the
shares, (ii) the availability of certain current public information about the Company, (iii) the
resale occurring not less than one year after a party (who is not an “affiliate”) has purchased and
fully paid for the shares to be sold, (iv) the sale being effected through a “broker’s transaction”
or in transactions directly with a “market maker” (as provided by Rule 144(f)) and (v) the number
of shares being sold during any three-month period not exceeding specified limitations.

	4.6	 	No Public Market.

     Purchaser understands that a only a limited public market now exists for any of the securities
issued by the Company, the Company does not file periodic reports under the Securities Exchange Act
of 1934 and that there is no assurance that any public market will continue to exist for the
Shares.

	4.7	 	Access to Data.

     Purchaser has had an opportunity to discuss the Company’s business, management, and financial
affairs with the Company’s management and the opportunity to review the Company’s facilities and
business plan. Purchaser has also had an opportunity to ask questions of officers of the Company.

	4.8	 	Authorization.

     This Agreement and the Ancillary Agreements to which Purchaser is a party, when executed and
delivered by Purchaser, will constitute valid and legally binding obligations of Purchaser,
enforceable against Purchaser in accordance with their respective terms, subject to applicable
bankruptcy, reorganization, insolvency, and similar laws affecting creditors’ rights generally and
to general principles of equity. Purchaser has full corporate power and authority to enter into
and to perform its obligations under this Agreement and the Ancillary Agreements to which it is a
party in accordance with their respective terms. Purchaser represents that it has not

18

 

been organized, reorganized or recapitalized for the purpose of investing in the Company
specifically.

	4.9	 	Brokers or Finders.

     The Purchaser has not incurred, and will not incur, directly or indirectly, as a result of any
action taken by such Purchaser, any liability for brokerage or finders’ fees or agents’ commissions
or any similar charges in connection with this Agreement or any transaction contemplated hereby.

	4.10	 	Sophisticated Investor.

     Purchaser (i) has no need for liquidity in its investment in the Shares, and (ii) is able to
bear the economic risk of losing its entire investment in Shares. Purchaser is an “accredited
investor” as such term is defined in Rule 501(a) of Regulation D promulgated under the Securities
Act.

ARTICLE V

CONDITIONS TO THE OBLIGATIONS OF THE PURCHASER

	 	 	The obligations of Purchaser to purchase the Shares at the Initial Closing is, at the option
of Purchaser, subject to the fulfillment or waiver on or prior to the Closing Date of the following
conditions:

	5.1	 	Representations and Warranties.

     All representations and warranties of the Company contained in this Agreement shall have been
true and correct when made, and shall be true and correct as of the Closing Date as though made at
such time.

	5.2	 	Covenants.

     All covenants, agreements, and conditions contained in this Agreement to be performed by the
Company on or prior to the Closing shall have been fully performed or complied with in all
respects.

	5.3	 	Compliance Certificate.

     The Company shall have delivered to the Purchaser (i) a Compliance Certificate executed by an
executive officer of the Company, dated the Closing Date, certifying to the fulfillment of the
conditions specified herein, (ii) certified copies of the resolutions adopted by the Company’s
board of directors and stockholders, if required authorizing the execution, delivery and
performance of the transactions contemplated by this Agreement, (iii) certified copies of the
Company’s Articles of Incorporation and by-laws as in effect at the Closing, and (iv) a certificate
of incumbency identifying and showing the signature of each officer of the Company as of the
Closing.

19

 

	5.4	 	Consents.

     The Company shall have obtained, or shall obtain within the time periods required by
applicable law, all necessary blue sky law permits and qualifications, or secured exemptions
therefrom, required by any state for the offer and sale of the Shares at the Closing and shall have
obtained all other approvals, consents, permits and waivers necessary to consummate the
transactions contemplated by this Agreement, including any consents required under any agreements,
licenses, leases or commitments of the Company, and any and all other permits and approvals from
any governmental or regulatory body required for the lawful consummation of the transactions
contemplated by this Agreement shall have been obtained and delivered to Purchaser.

	5.5	 	Articles of Incorporation.
	 
	 	 	The Articles of Incorporation shall be in full force and effect.
	 
	5.6	 	Due Diligence Review.

     The Purchaser shall have completed its due diligence investigation of the Company, including,
but not limited to confirmation of the Company’s capital structure, which shall be satisfactory to
the Purchaser in its sole discretion.

	5.7	 	Proceedings and Documents.

     All corporate and other proceedings in connection with the transactions contemplated hereby
and all documents and instruments incident to such transactions shall be reasonably satisfactory in
substance and form to counsel for the Purchaser, and they shall have received all such counterpart
originals or certified or other copies of such documents as they may reasonably request.

	5.8	 	Related Transactions.

     The transactions contemplated by the memorandum attached to the letter of intent dated March
31, 2003 between the Company and Purchaser, and relating to the transactions contemplated herein,
shall have been consummated as provided therein or on other terms satisfactory to the Purchaser.

	5.9	 	No Litigation.

     No action, suit or other proceeding shall be pending or threatened before any court, tribunal,
or government or regulatory authority, or instituted or threatened by any governmental or
regulatory authority, seeking or threatening to restrain, modify or prohibit the consummation of
the transactions contemplated hereby, or seeking to obtain damages in respect thereof or which is
otherwise reasonably likely to have a material adverse change or effect on the business, assets,
properties, operations, results of operations, prospects or condition (financial or otherwise) of
the Company and its subsidiaries taken as a whole.

20

 

	5.10	 	Compromise of Indebtedness.

     The Company’s indebtedness to Alex Goren in the approximate amount of $105,000 shall have been
settled or discharged on terms acceptable to Purchaser in its sole discretion.

	5.11	 	Registration Rights Agreement.

     The Company, Purchaser and the other parties thereto shall have entered into the Registration
Rights Agreement satisfactory in form and substance to the Purchaser and his counsel.

	5.12	 	Stockholders’ Voting Agreement.

     The Company, Purchaser and the other parties thereto shall have entered into the Stockholders’
Voting Agreement dated as of the Closing date (substantially in the form of Exhibit C hereto), and
satisfactory in form and substance to the Purchaser and his counsel.

	5.13	 	Compliance with Laws.

     The offer, purchase and sale of the Shares to the Purchaser shall be legally permitted by all
laws and regulations to which the Purchaser or the Company are subject, and there shall not be in
effect any injunction, order or decree of a court of competent jurisdiction prohibiting,
restraining or delaying the consummation of the transactions contemplated hereby.

	5.14	 	Material Adverse Effect.

     There shall not have occurred any Material Adverse Effect and there shall not exist any facts
or circumstances that, individually or in the aggregate, are reasonably likely to have a Material
Adverse Effect.

	5.15	 	Employee Matters.

     The stock options previously granted by the Company to Principals shall have been terminated
with the agreement of the optionee and the Principals shall have entered into amended and restated
employment agreements with the Company in the form attached hereto as Exhibit D (“Employment
Agreement(s)”.

	5.16	 	Approval of Budget.

     Purchaser shall have approved Company’s budget and projections for the fiscal year ending May
31, 2004.

21

 

ARTICLE V-A

CONDITIONS TO THE OBLIGATIONS OF THE PURCHASER

TO ADDITIONAL CLOSINGS

     The obligations of Purchaser to purchase Shares at an Additional Closing is, at the option of
Purchaser (and in addition to the other conditions thereto set forth herein), subject to the
fulfillment or waiver on or prior to such Additional Closing of the following condition:

	5-A.1	 	Representations and Warranties.

     All representations and warranties of the Company contained in this Agreement shall have been
true and correct when made, and shall be true and correct as of the Additional Closing as though
made at such time.

	5-A.2	 	Material Adverse Effect.

     Between the date of the Initial Closing and the date of the Additional Closing, there shall
not have occurred any Material Adverse Effect and there shall not exist any facts or circumstances
that, individually or in the aggregate, are reasonably likely to have a Material Adverse Effect.

	5-A.3	 	Effectiveness of Certain Agreements.

     The Articles of Incorporation and By-laws, amended as provided herein shall be in full force
and effect and unmodified. The Employment Agreements referred to in Exhibit D and the Registration
Rights Agreement referred to in Exhibit B shall be in full force and effect and unmodified.

	5-A.4	 	Compliance Certificate.

     The Company shall have delivered to the Purchaser, a Compliance Certificate executed by an
executive officer of the Company, dated the Closing Date certifying to the fulfillment of the
conditions to such Additional Closing have been satisfied.

     In the event the Additional Closing is being held as a result of a Sales Notice given by
Purchaser, and the Company believes it cannot satisfy the above conditions, the Company shall
notify the Purchaser of such fact, by written notice given promptly after the giving of the Sales
Notice, which shall specify the facts or circumstances forming the basis of the Company’s inability
to satisfy such conditions. Upon receipt of such notice, Purchaser shall have the right either to
(i) withdraw its Sales Notice, in which event the Additional Closing shall not occur or (ii) waive
the condition which cannot be satisfied, which waiver may be limited to the particular facts or
circumstances set forth in the Company’s notice.

22

 

ARTICLE VI

CONDITIONS TO OBLIGATIONS OF THE COMPANY

     The Company’s obligations to sell and issue any Shares at the Closing is, at the option of the
Company, subject to the fulfillment or waiver on or prior to the Closing Date of the following
conditions:

	6.1	 	Representations and Warranties.

     The representations and warranties made by Purchaser in Section 4 of this Agreement shall have
been true and correct when made, and shall be true and correct in all material respects as of the
Closing Date.

	6.2	 	Covenants.

     All covenants, agreements, and conditions contained in this Agreement to be performed by the
Purchaser on or prior to the Closing shall have been fully performed or complied with in all
material respects.

	6.3	 	Blue Sky Law.

     The Company shall have obtained all necessary blue sky law permits and qualifications, or
secured exemptions therefrom, required by any state for the offer and sale of the Shares at the
Closing.

	6.4	 	Employment Agreements.

     The Employment agreements referred to in Exhibit D shall have been executed and delivered by
the Company.

	6.5	 	Compromise of Indebtedness.

     Purchaser shall provide evidence of acceptance of the terms of settlement or discharge for the
Company’s indebtedness to Alex Goren in the approximate amount of $105,000.

	6.6	 	Approval of Budget.

     Purchaser shall provide evidence of approval of Company’s budget and projections for the
fiscal year ending May 31, 2004.

	6.7	 	No Litigation.

     No action, suit or other proceeding shall be pending or threatened before any court, tribunal,
or governmental authority seeking or threatening to restrain or prohibit the consummation of the
transactions contemplated hereby, or seeking to obtain substantial damages in respect thereof or
which would otherwise materially and adversely affect the Company, its business, assets, prospects
or financial condition.

23

 

ARTICLE VII

GENERAL PROVISIONS

	7.1	 	Governing Law.

     All or part of this Agreement and the legal relations between the parties hereto has been
negotiated in the State of New York and will be enforced under the laws of the State of New York
without regard to its conflicts of laws provisions.

	7.2	 	Successors and Assigns; Third Party Beneficiaries.

     Except as otherwise expressly limited herein, the provisions hereof shall inure to the benefit
of, and be binding upon, the successors (including successor trustees, in the case of a trustee),
assigns, heirs, executors, and administrators of the parties hereto. Except as expressly provided
in Article VII, nothing in this Agreement, expressed or implied, is intended to confer upon any
party other than the parties hereto and their respective successors and assigns any rights,
remedies, obligations or liabilities under or by reason of this Agreement.

	7.3	 	Entire Agreement; Amendment and Waiver.

     This Agreement and the Ancillary Agreements constitute the full and entire understanding and
agreement between the parties with regard to the subject matter hereof and thereof and supersede
all prior agreements among the parties. All prior negotiations and agreements shall be merged into
this Agreement.

	7.4	 	Survival of Representations and Warranties; Compliance.

     All representations and warranties contained in this Agreement or in the Ancillary Agreements
or in any certificate delivered pursuant hereto or thereto shall survive the Closing for a period
of thirty-six (36) months (the “Survival Period”), and shall not be deemed waived or otherwise
affected by any investigation made or any knowledge acquired with respect thereto, or by any notice
delivered pursuant to this Agreement; provided, however, that any claim based on
fraud shall survive the Closing indefinitely. The covenants and agreements contained in this
Agreement or in the Ancillary Agreements shall survive the Closing and shall continue until all
obligations with respect thereto shall have been performed or satisfied or shall have been
terminated in accordance with their terms. The waiver of any condition based on the accuracy of
any representation or warranty, or on the performance of or compliance with any covenant or
obligation, will not affect the right to indemnification or any other remedy based on such
representations, warranties, covenants and obligations.

	7.5	 	Indemnification by the Company and Principals.

     On the terms and conditions, and subject to the limitations, set forth in this Article VII,
from and after the Closing, each of the Company and the Principals (the “Seller Indemnifying
Parties”), jointly and severally, shall indemnify and hold Purchaser, its officers, directors,
employees, agents, representatives and Affiliates (the “Purchaser Indemnified Parties”) harmless
from and against, and shall reimburse the Purchaser Indemnified Parties for, any and all actual
losses, damages, debts, liabilities, obligations, judgments, orders, awards, writs, injunctions,

24

 

decrees, fines, penalties, Taxes, costs or expenses (including, but not limited to, any
reasonable legal or accounting fees or expenses (“Losses”) based upon, arising out of or related to
(i) any inaccuracy or misrepresentation in, or breach of, any representation or warranty made by
the Company and/or the Principals in this Agreement or in any Ancillary Agreement or (ii) any
failure by the Company or the Principals to perform or comply, in whole or in part, with any
covenant or agreement in this Agreement or in any Ancillary Agreement.

	7.6	 	Indemnification by the Purchaser.

     On the terms and conditions, and subject to the limitations set forth in this Article VII,
from and after the Closing, Purchaser (the “Purchaser Indemnifying Party”) shall indemnify and hold
the Company, its officers, directors, employees, agents, representatives and Affiliates and the
Principals (the “Seller Indemnified Parties”) harmless from and against, and shall reimburse the
Seller Indemnified Parties for, any and all Losses based upon, arising out of or related to (i) any
inaccuracy or misrepresentation in, or breach of, any representation or warranty made by Purchaser
in this Agreement or in any Ancillary Agreement or (ii) any failure by Purchaser to perform or
comply, in whole or in part, with any covenant or agreement in this Agreement or in any other
Ancillary Agreement.

	7.7	 	Matters Involving Third Parties.

          (a) For purposes of this Article VII, (i) the Purchaser Indemnifying Party and the Seller
Indemnifying Parties shall be referred to herein as the “Indemnifying Parties” or an “Indemnifying
Party” as the context requires and (ii) the Purchaser Indemnified Parties and the Seller
Indemnified Parties shall be referred to as the “Indemnified Parties” or an “Indemnified Party” as
the context requires.

          (b) if any third party shall notify an Indemnified Party with respect to any matter (a
“Third Party Claim”) which may give rise to a claim for indemnification against the Company
under this Article VII, then the Indemnified Party shall promptly notify each Indemnifying Party
thereof in writing; provided, however, that no delay on the part of the Indemnified Party in
notifying any Indemnifying Party shall relieve the Indemnifying Party from any obligation hereunder
unless (and then solely to the extent) the Indemnifying Party thereby is materially prejudiced; it
being understood and agreed that the failure of the Indemnified Party to so notify the Indemnifying
Party prior to settling a Third Party Claim (whether by paying a claim or executing a binding
settlement agreement with respect thereto) or the entry of a judgment or issuance of an award with
respect to a Third Party Claim shall constitute actual material prejudice to the Indemnifying
Party’s ability to defend against such Third Party Claim.

          (c) Any Indemnifying Party will have the right to defend the Indemnified Party against the
Third Party Claim with counsel of its choice reasonably satisfactory to the Indemnified Party so
long as (i) the Indemnifying Party notifies the Indemnified Party in writing within thirty (30)
calendar days after the Indemnified Party has given notice of the Third Party Claim that the
Indemnifying Party or Parties will indemnify the Indemnified Party from, arising out of, relating
to, in the nature of, or caused by the Third Party Claim (it being understood by the Parties that
the Indemnified Party may take such actions as are reasonable in connection with

25

 

its defense until it receives such notice from the Indemnifying Party), and (ii) the
Indemnifying Party conducts the defense of the Third Party Claim actively and diligently.

          (d) So long as the Indemnifying Party is conducting the defense of the Third Party Claim in
accordance with Section 7.6(b) above, (i) the Indemnified Party may retain separate co-counsel at
its sole cost and expense and participate in the defense of the Third Party Claim (provided that
the Indemnified Party will have the right to employ separate counsel to represent the Indemnified
Party (the fees and expenses of which will be borne by the Indemnifying Party) if, in the
Indemnified Party’s reasonable judgment, a conflict of interest between the Indemnified Party and
the Indemnifying Party exists with respect to such claim), (ii) the Indemnified Party will not
consent to the entry of any judgment or enter into any settlement with respect to the Third Party
Claim without the prior written consent of the Indemnifying Party (not to be withheld
unreasonably), and (iii) the Indemnifying Party will not, without the prior written consent of the
Indemnified Party, consent to the entry of any judgment or enter into any settlement with respect
to the Third Party Claim in which any relief other than the payment of money damages is sought
against any Indemnified Party, unless such settlement, compromise or consent (i) includes as an
unconditional term thereof the giving by the claimant, petitioner or plaintiff, as applicable, to
such Indemnified Party of a release from all liability with respect to such Third Party Claim and
(ii) does not include a statement as to or an admission of fault, culpability or a failure to act
by or on behalf of any Indemnified Party.

          (e) In the event any of the conditions in Section 7.6(b) is or becomes unsatisfied, however,
(i) the Indemnified Party may defend against, and consent to the entry of any judgment or enter
into any settlement with respect to, the Third Party Claim in any manner it reasonably may deem
appropriate (and the Indemnified Party need not consult with, or obtain any consent from, any
Indemnifying Party in connection therewith), (ii) the Indemnifying Parties will reimburse the
Indemnified Party promptly and periodically for the costs of defending against the Third-Party
Claim. The Parties will remain responsible for any Losses the Indemnified Party may suffer
resulting from, arising out of, relating to, in the nature of, or caused by the Third Party Claim
to the fullest extent provided in this Article VII.

	7.8	 	Notices, etc.

     All notices and other communications required or permitted hereunder shall be in writing and
shall be (i) mailed by registered or certified mail, postage prepaid, (ii) delivered by reliable
overnight courier service, or (iii) otherwise delivered by hand or by messenger, addressed (A) if
to Purchaser, at 110 Wall Street, New York, New York 10005, or at such other address as such
Purchaser shall have furnished to the Company in writing, with a copy to Frederic J. Gruder, Esq.
775 Park Avenue, Suite 255, Huntington, NY 11743, telecopier number (631) 614-4545, (B) if to the
Company Neoterik Center, Woodsboro, MD 21798 Attention: President, telecopier no. (301) 845-2213,
or at such other address as the Company shall have furnished to the Purchaser, with a copy to Sonia
Galindo, Esquire, Whiteford, Taylor & Preston L.L.P., 7 Saint Paul Street, Baltimore, Maryland
21202, telecopier number (410) 347-9414.

26

 

	7.9	 	Delays or Omissions.

     No delay or omission to exercise any right, power, or remedy accruing to any party upon any
breach or default under this Agreement, shall be deemed a waiver of any other breach or default
theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or
character on the part of any party of any provisions or conditions of this Agreement, must be in
writing and shall be effective only to the extent specifically set forth in such writing. All
remedies, either under this Agreement or by law or otherwise afforded to any of the parties, shall
be cumulative and not alternative.

	7.10	 	References.

     Unless the context otherwise requires, any reference to a “Section” refers to a section of
this Agreement. Any references to “this Section” refers to the whole number section in which such
reference is contained.

	7.11	 	Severability.

     If any provision of this Agreement is held to be unenforceable under applicable law, then such
provision shall be excluded from this Agreement and the balance of this Agreement shall be
interpreted as if such provision were so excluded and shall be enforceable in accordance with its
terms. The court in its discretion may substitute for the excluded provision an enforceable
provision, which in economic substance reasonably approximates the excluded provision.

	7.12	 	Pronouns.

     All pronouns and any variations thereof refer to the masculine, feminine or neuter, singular
or plural, as the identity of the person or persons may require.

	7.13	 	Counterparts.

     This Agreement may be executed in any number of counterparts and via facsimile, each of which
shall be deemed an original and enforceable against the parties actually executing such
counterpart, and all of which, when taken together, shall constitute one instrument.

	7.14	 	Remedies.

     The parties to this Agreement acknowledge and agree that a breach of any of the covenants of
the Company or the Purchaser set forth in this Agreement may not be compensable by payment of money
damages and, therefore, that the covenants of the foregoing parties set forth in this Agreement may
be enforced in equity by a decree requiring specific performance.

	7.15	 	Certain Definitions.

     As used in this Agreement, the following terms shall have the meanings unless the context
otherwise required:

27

 

“Affiliate” shall mean a Person that, directly or indirectly, controls or is controlled by,
or is under common control with, any Person.

“Control” (including, with correlative meaning, the terms “controlled by” and “under common
control with”) as used with respect to any Person, means the possession, directly or indirectly, of
the power to direct or cause the direction of the management and policies of such Person, whether
through ownership of voting securities or by contract or otherwise.

“Person” means any individual, corporation, general or limited partnership, limited
liability company, firm, joint venture, association, enterprise, joint stock company, trust
unincorporated organization or other entity.

“Subsidiary” shall mean any Person as to which the Company, directly, or indirectly, owns
or has the power to vote, or to exercise a controlling influence with respect to, fifty percent
(50%) or more of the securities of any class of such Person, the holders of which class are
entitled to vote for the election of directors (or persons performing similar functions) of such
Person.

	7.16	 	Publicity.

     The Company shall not release any information to any third party (except its board members,
employees, consultants, agents, shareholders, accountants, lenders and legal counsel) with respect
to the financial terms of this Agreement or the transactions contemplated hereby without the prior
written consent of the Purchaser, other than as may be required by applicable law or court order.

	7.17	 	Access.

     The Company covenants and agrees, upon reasonable notice, and except as may otherwise be
required by applicable law, that the Company shall afford Purchaser’s officers, employees, counsel,
accountants and other authorized representatives reasonable access, during normal business hours
throughout the period prior to the Closing, to the Company’s and its subsidiaries’ properties,
books, contracts and records and, during such period, the Company shall furnish promptly to
Purchaser access to (and, where reasonable, copies of,) all information concerning the Company’s
and its subsidiaries’ business, properties and personnel as may reasonably be requested, provided
that no investigation pursuant to this Section 7.16 shall affect or be deemed to modify any
representation or warranty made by the Company herein.

	7.18	 	Further Assurances.

     The Company covenants and agrees that it shall execute such documents and papers, and perform
such further acts, as may be reasonably required or desirable to carry out the provisions hereof
and the transactions contemplated hereby before and after the Closing and that it shall use its
reasonable best efforts to fulfill or obtain the fulfillment of the conditions set forth in
Articles V and VI hereof, including, without limitation, the execution and delivery of any
documents or other papers, the execution and delivery of which are conditions precedent to Closing,
subject to the other provisions of this Agreement.

[SIGNATURE PAGE IMMEDIATELY FOLLOWS]

28

 

     IN WITNESS WHEREOF, the parties hereto have entered into and signed this Stock Purchase
Agreement as of the date and year first above written.

	 	 	 	 	 
	 	 	NEOTERIK HEALTH TECHNOLOGIES, INC.
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Kenneth V. Vaughan
	 

	 	 	 	 
	 

	 	 	 	Kenneth V. Vaughan, President & CEO
	 
	 	 	 	 
	 	 	PRINCIPALS:
	 
	 	 	 	 
	 	 	/s/ Kenneth V. Vaughan
	 	 	 
	 	 	Kenneth V. Vaughan
	 
	 	 	 	 
	 	 	/s/ James R. Wiggins
	 	 	 
	 	 	James R. Wiggins
	 
	 	 	 	 
	 	 	GLOBALSECURE, LTD.
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Craig Bandes
	 

	 	 	 	 
	 

	 	 	 	Craig Bandes, President

29

 

EXHIBIT A

DISCLOSURE SCHEDULE

	 	 	 
	Section 3.4

	 	Subsidiaries.
	 
	 	 
	Section 3.5

	 	Capitalization
	 
	 	 
	Section 3.7

	 	Title to Property and Assets
	 
	 	 
	Section 3.8

	 	Financial Statements
	 
	 	 
	Section 3.9

	 	Related-Party Transactions
	 
	 	 
	Section 3.11

	 	Intellectual Property
	 
	 	 
	Section 3.12

	 	Material Contracts
	 
	 	 
	Section 3.14

	 	Litigation
	 
	 	 
	Section 3.17

	 	Employees
	 
	 	 
	Section 3.18

	 	Tax Returns, Payments, and Elections
	 
	 	 
	Section 3.20

	 	Marketing Rights
	 
	 	 
	Section 3.21

	 	Brokers and Finders
	 
	 	 
	Section 3.26

	 	Confidentiality and Noncompetition Agreements
	 
	 	 
	Section 3.28

	 	Officers
	 
	 	 
	Section 3.33

	 	Customers
	 
	 	 
	Section 3.34

	 	Events Subsequent to Most Recent Fiscal Period End

 

 

EXHIBIT B

FORM OF REGISTRATION RIGHTS AGREEMENT

 

 

EXHIBIT C

FORM OF STOCKHOLDERS’ VOTING AGREEMENT

 

 

EXHIBIT D

FORM OF EMPLOYMENT AGREEMENTS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]